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ABSTRACT OF THE DISSERTATION

Synergism of Gingipains in Endothelial Cell Adhesion Disruption and Apoptosis
by
Shaun Michellee Sheets
Doctor of Philosophy, School of Medicine
Department of Microbiology and Molecular Genetics
Loma Linda University, September 2006
Dr. Hansel M. Fletcher, Co-Chairperson
Dr. Carlos A. Casiano, Co-Chairperson
The presence of Porphyromonas gingivalis in the periodontal pocket and the high
levels of gingipain activity detected in gingival crevicular fluid could implicate a role for
gingipains in the destruction of the highly vascular periodontal tissue. To explore the
effects of these proteases on endothelial cells, we exposed bovine coronary artery
endothelial cells (BCAEC) and human microvascular endothelial cells (HMVEC) to
gingipain-active extracellular protein preparations and/or purified gingipains from P.
gingivalis. Treated cells exhibited a rapid loss of cell adhesion properties that was
followed by apoptotic cell death. Cleavage of N- and VE-cadherin and integrin (31 was
observed in immunoblots of cell lysates. Loss of cell adhesion, as well as N- and VEcadherin and integrin p 1 cleavage, could be inhibited or significantly delayed by
preincubation of gingipain-active extracts with the cysteine protease inhibitor TLCK.
Furthermore, purified gingipains also induced endothelial cell detachment; however,
Kgp-induced detachment was temporary and only HRgpA and RgpB induced apoptosis.
Apoptosis-associated events, including Annexin-V positivity, caspase-3 activation, and
cleavage of the caspase substrates poly(ADP-ribose) polymerase (PARP) and
Topoisomerase I (Topo I) were observed in endothelial cells after detachment. We have

xxiv

demonstrated that Kgp activity can be inhibited by synthetic peptide caspase inhibitors.
Using z-VAD-FMK to inhibit Kgp activity and leupeptin to inhibit Rgp activity, we
further investigated the specific roles of the gingipains in producing the observed
morphological changes. In the presence of z-VAD-FMK or leupeptin, gingipain-induced
cell detachment was only delayed. There was partial cleavage of N-cadherin and delayed
cleavage of VE-cadherin. Degradation of integrin (31 was inhibited only in the presence
of z-VAD-FMK. Interestingly, in the absence of active caspases, both gingipain-active
extracts and purified HRgpA and RgpB induce apoptotic morphology, suggesting the
gingipains can induce apoptosis by a caspase-independent mechanism. Collectively, our
results indicate that the gingipains, at concentrations naturally occurring in the
periodontal pocket, can cleave CAMs to varying degrees with differing kinetics. Kgp
and HRgpA work together to quickly detach endothelial cells with HRgpA and RgpB
triggering caspase-dependent and caspase-independent apoptosis. These results have
further clarified the role P. gingivalis plays in tissue destruction occurring in the
periodontal pocket.
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CHAPTER ONE

A. Anatomy of the Periodontium and Periodontal Disease
A.l. Periodontal Anatomy
The periodontium is a highly vascularized tissue that is made up of four main
tissues: the periodontal ligament, root cementum, alveolar bone, and gingiva that function
together as a unit (Fig. 1) (23, 59). Mature periodontal ligament consists of three regions:
a bone-related region that is rich in cells and blood vessels, a cementum-related region
identified by its dense well ordered collagen bundles, and a middle zone that contains
fewer cells and thinner collagen fibrils (59). Mature periodontal ligament contains
undifferentiated stem cells that can differentiate into osteoblasts, cementoblasts, and
fibroblasts (59). Fibroblasts are responsible for the metabolism of extracellular matrix
(ECM) components and are the most abundant cells in the periodontal ligament (59).
Fibroblasts adhere to the ECM via surface receptors, such as integrin a5(31, and to
collagen and fibronectin, allowing ligament tension status to be relayed to the fibroblast
nucleus (59).
Cementum is a mineralized avascular tissue that forms the interface between root
dentin and the periodontal ligament (Fig. 1) (59). It is formed by cementoblasts and it
seems to be similar to bone (306). Cementum is classified by the presence or absence of
cells (cellular versus acellular) and the source of collagen fibers (extrinsic versus
intrinsic) (306). The formation of cementum is critical for the proper maturation of the
periodontium (306). Integrins are thought to also be involved in the adhesion of
cementum to the root surface, but the specific ligands involved in this process are not
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Figure 1. Anatomy of the tooth and surrounding tissues. This diagram illustrates the
structures of the tooth and periodontium and their relative locations.
http://www.communityhealth.dhhs.state.nc.us/dental/ed_resources/Tooth Anatomy.pdf
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known at this time (306).
Alveolar bone is constantly being remodeled, provides the primary support for the
teeth (327), and distributes the pressures generated during tooth contacts (Fig.l) (59).
Alveolar bone has a sieve-like structure that allows the connection of the periodontal
ligament and the bone marrow and also allows the passage of blood and lymphatic
vessels and nerve fibers (59). Regeneration of tissues lost during periodontitis requires
the formation of alveolar bone in the presence of inflammation, which is extremely
difficult to attain (327).
The healthy gingiva normally covers the alveolar bone and tooth root to just
above the cementoenamel junction (Fig. 2 and 3) (23). There are two distinct
components of the gingiva: the overlying epithelial structures and the underlying
connective tissue (23). The epithelial cells provide surfaces for adhesion of bacterial
species, while the gingival crevicular fluid (GCF), or tissue breakdown products, provide
nutrients for bacterial growth and survival (326). The epithelial structures are designated
oral gingival epithelium, oral sulcular epithelium, and junctional epithelium (Fig. 2 and
3) (59). The oral gingival and oral sulcular epithelia mainly function in protection, while
the junctional epithelium has numerous roles and is mainly involved in the regulation of
tissue health (23) and can, therefore, be considered the most interesting structure of the
gingiva (34). The junctional epithelium attaches directly to the tooth surface and allows
the bidirectional movement of molecules between the gingival connective tissue and the
oral cavity (23). Junctional epithelial cells express numerous cell adhesion molecules
(CAMs), including integrins (23) and cadherins, whose function may be destroyed by
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Figure 2. Anatomy of the gingiva. Clinical landmarks include the free gingiva at the
cervical margin of the teeth (FGM); the interdental papilla (IP); and the mucogingival
junction (MGJ), which separates the attached gingiva (AG) from the alveolar mucosa
(AM). Taken from (23).
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Figure 3. Light microscopic view of young, healthy human
gingiva illustrating its dimensions and relations. ABC, alveolar
bone crest; AEFC, acellular extrinsic fiber cementum; CEJ,
cementoenamel junction; CT, gingival connective tissue; D, dentin;
ES, enamel space; GM, gingival margin; JE, junctional epithelium;
OGE, oral gingival epithelium; OSE, oral sulcular epithelium; PL,
periodontal ligament. Taken from (34).
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bacterial products penetrating the junctional epithelium at the bottom of the sulcus
providing access to deeper tissues, such as the gingival connective tissue (34) and
endothelial cells of the periodontal vasculature.
The gingiva has one of the largest end organ blood supplies in the body (23). The
gingival arterial supply is primarily from arterioles running towards the gingival crest
from the oral mucosa overlying the alveolar bone and terminating in a network of
capillaries that drain into venules (403). The endothelium of the gingival vascular
network is in intimate contact with the bacterial biofilm; there may be only one or two
epithelial cells and a negligible layer of ECM separating the endothelium and circulating
blood from the bacterial biofilm (403). This close involvement is significant in the
changes that occur to the vasculature in gingivitis and periodontitis (403) and possibly
systemic diseases, such as cardiovascular disease [see Chapter 1 section C.4].

A.2. Periodontal Disease and Progression
Periodontitis is one of the oldest and most common diseases of humans and was
once thought of as an inevitable consequence of aging (113). Periodontitis affects more
than 67 million American adults (2), and is the greatest reason for tooth loss in older
adults (351). In the first-ever Surgeon General’s Report on the Oral Health of America,
he states that “the mouth reflects general health and well being... and that oral signs and
symptoms often are part of a general health condition” and there needs to be an
“intensified effort to understand the relationships between oral infections and their
managements, and other illnesses and conditions” (355). Normal healthy gingiva is pink
in color, firm in consistency, does not bleed upon probing, and fills the space below the
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contact areas between the teeth. Even in the very healthy state, the gingiva has a
leukocyte infiltrate that is predominantly comprised of neutrophils or polymorphonuclear
leukocytes, whose primary purpose is to kill bacteria after migrating through and out of
the tissues into the gingival crevicular area (187). Neutrophils are recruited to the
periodontal pocket because of chemotactic peptides released by the bacteria and as the
bacteria damage gingival epithelial cells, the epithelial cells release cytokines that attract
leukocytes to the crevice. If the neutrophil is overloaded with phagocytosed bacteria, it
degranulates releasing toxic enzymes that damage periodontal tissue (187).
Gingivitis is an inflammatory condition of the tissues surrounding the teeth in
response to the accumulation of bacterial plaque on the teeth (187). Periodontitis is a
chronic inflammatory disease of the gingival and tooth supporting structures. It can be
thought of as progressing continuously with periods of exacerbation (187) and is
characterized by clinical attachment loss, alveolar bone loss, periodontal pocketing,
gingival inflammation (100), and increased GCF (66) (Fig. 4). Other clinical symptoms
that may occur are enlargement or recession of the gingiva; gingival bleeding upon
probing; and increased tooth mobility, drifting, and/or loss (100). Attachment loss can
differ between patients and sites within the same patient (66). Gingivitis must precede
periodontitis and is similarly influenced by the host’s immune and inflammatory
response, but it does not always progress to periodontitis, which is initiated in only a
subset of the population (187). The primary purpose of the inflammation is to promote
the influx of cells and blood proteins to neutralize the injurious agents and to confine the
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Figure 4. The progression of periodontitis. This
illustrates the changes that occur in the gingiva and alveolar
bone as dental plaque accumulates. The gingiva becomes
inflamed and bleeds upon probing. A gingival sulcus, or
pocket, forms and alveolar bone loss occurs. Taken from
http://www.perio.org/consumer/2a.html.
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bacteria to superficial surfaces localizing the damage (225). There have been a plethora
of studies that have identified predictors for progressing periodontitis; they include age,
extent of periodontitis, plaque retaining factors, subgingival colonization by associated
bacterial species, diabetes, and smoking [reviewed in (100)].
Periodontitis is differentiated from gingivitis by the loss of the attachment of
connective tissue to the teeth in the presence of gingival inflammation (66). If the
inflammatory response contained within a gingivitis lesion spreads to the deeper
periodontal tissues causing the loss of alveolar bone, then the lesion is termed
periodontitis (23). In fact, thorough removal of plaque usually results in the healing of a
chronic gingivitis lesion without residual tissue damage (66), while the damage of
periodontitis is irreversible (187). It has not been established that gingivitis is always a
precursor to periodontitis; furthermore, it is unclear the exact factors that cause gingivitis
to progress to periodontal lesions (66). Destructive periodontal diseases are different
from other inflammatory diseases in that the presence of the infectious agents does not
inevitably lead to the development or periodontal tissue loss (1). However, it appears that
there are three general factors required for periodontal disease initiation: first, the host
must be susceptible to the pathogens and hosts can have a differing threshold to
susceptibility that is determined by heredity (66); second, there must be the right type of
pathogens present and in sufficient amounts; and third, the periodontal environment must
allow expression of virulence factors (324) and allow the bacteria to reach sufficient
numbers to initiate the disease or allow its progression (134). Bacteria are necessary for
disease initiation, but they are not sufficient to allow periodontitis progression, unless
there is an accompanying inflammatory response by the host (23).
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The exact mechanism of periodontal tissue destruction is unclear, but involves the
invading Gram-negative bacteria and the host’s response to this infection. The dental
plaque biofilms are required for the manifestation of the inflammatory process at the
infection site, but the host’s excessive reaction may promote periodontal tissue damage
(1) and the evidence is increasing that the majority of the periodontal tissue destruction in
established lesions is a result of the activation of neutrophils, monocytes, lymphocytes,
fibroblasts, and other host cells (66). In normal gingiva in response to the bacterial
plaque, a series of host immune and inflammatory substances are produced and released
to ward of the infection and promote healing. However, the overabundance of toxic and
antigenic bacterial factors can result in an excessive amount of periodontal destruction by
immune cells. A periodontal lesion can be initiated by connective tissue destruction from
host-derived proteolytic enzymes and bone-resorbing factors, culminating in a chronic
process of tissue destruction with insufficient healing (310). Therefore, these destructive
processes are initiated by the bacteria, but are propagated by host cells to ultimately expel
the tooth to resolve the inflammation and prevent deeper infections from occurring (187).
However, it is conceivable that a portion of the changes in the periodontium could be
directly caused by the infecting bacteria. For example, Porphyromonas gingivalis is
known to produce several enzymes, metabolic by-products, and lipopolysaccharide (LPS)
that could directly degrade periodontal tissue of the gingival pocket, cause host cell
injury, or alveolar bone resorption [reviewed in (34, 66)]. Therefore, the tissue damage is
the result of local uncontrolled proteolysis by proteases of both the bacteria and the host,
with the most profound manifestation being the degradation of collagen fibers of the
periodontal ligament and alveolar bone resorption (282). Evidence indicates that
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connective tissue destruction occurs within 3 to 4 days of the onset of inflammation
caused by plaque accumulation and can spread to deeper tissues causing alveolar bone
loss if left untreated (23). There are changes to the vasculature, as well. Vessels of the
gingival sulcus and crest are mainly affected with an increase in the vessel diameter and
the vessels are more tortuous in shape (403). The total surface area of periodontal
ligament membrane in a complete dentition has been compared to the size of the palm of
an adult hand and the epithelium of the periodontal pocket can be breached as a result of
the enzymes and toxins released by subgingival bacteria, allowing bacterial entry to the
general circulation (128) and involvement in systemic illnesses.

B. Risk Factors for Periodontal Disease
B.l. Genetics
A risk factor is commonly defined as a particular characteristic, behavioral aspect,
or environmental exposure that is associated with disease occurrence (113). The
appearance and progression of periodontitis is influenced by a wide range of determinants
and factors that include subject characteristics, social and behavioral factors, systemic
factors, genetic factors, tooth level factors, microbial composition of dental plaque, and
other emerging factors (271). It has become clear that susceptibility to periodontitis
differs widely among people and that the disease is not evenly distributed throughout the
population (113). Evidence is beginning to accumulate that points to a significant
proportion of the variability between periodontal disease patients in the prevalence and
severity of periodontitis may be from differences in genetic factors and not to specific
behaviors (1, 271). The genetic component of periodontitis has been studied in
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monozygotic and dizygotic twins. It is assumed that twins growing up together would
have mostly the same habits and practices, therefore, the environmental components of
periodontitis should be the same. Thus, the average variability of periodontitis would be
the same for both monozygotic and dizygotic twins. However, the periodontal disease
variability was greater in dizygotic twins, indicating that there is a genetic aspect to
periodontitis. Approximately half of the variability in periodontitis is from inherited
traits [reviewed in (310)].
Because periodontitis is not inherited as a Mendelian disease, it appears that there
are not major genes involved in the initiation and progression of periodontitis and, more
than likely, gene polymorphisms of several genes may interact and contribute to
periodontitis (310). Numerous studies have investigated polymorphisms of various
genes, mostly related to inflammatory cytokine production, that include the interleukin-1
(IL-1) genes, tumor necrosis factor-a (TNF-a), vitamin D receptor, and cellular Fc
receptors in individuals with periodontitis. Evidence suggests that certain IL-1 genotypes
have an increased association with developing periodontitis [reviewed in (1, 263, 271)],
but there are also contradicting reports that indicate the IL-1 gene polymorphisms may
play a less significant role in periodontal disease progression (1). IL-1 promotes bone
resorption, stimulates production of prostaglandin E2, which also is a bone-resorbing
factor, and releases matrix metalloproteinases (MMPs) that degrade collagen (310). All
of these functions could be involved in periodontal tissue destruction. In general, it
appears that IL-1 polymorphism is a contributory, but non-essential risk factor, for
periodontal disease progression (271). Therefore, IL-1 genotype status may influence
the susceptibility and expression of periodontitis for many patients and since there is no
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single ‘periodontitis genotype’, consequently, there may be other genetic factors involved
(263). Investigation into TNF-a polymorphisms, a cytokine with similar biological
activities as IL-1, has also demonstrated an association with periodontal disease (310).
Because of the association of the vitamin D receptor gene polymorphisms and increased
risk for bone loss, its involvement in the alveolar bone loss of periodontal disease has
been studied. It appears that there is, in fact, a relationship between a less common allele
of the vitamin D receptor gene and localized aggressive periodontitis (1). The Fc portion
of antibodies is responsible for binding receptors present on immune cells and these Fc
receptors, especially IgG Fc receptors that are designated FcyRs and found on the cell
surface of macrophages, monocytes, and polymorphonuclear neutrophils, appear to be
involved in bacterial clearance and have been the subject of numerous periodontal
studies (263). It appears that IgG Fc receptor IIIp was associated with a resistance to
periodontitis (1, 263), while Fcyllla was associated with a significantly higher risk (1).
Fcyllip polymorphism affects the function of polymorphonuclear neutrophils and
influences their ability to efficiently use antibodies as opsonins, potentially reducing the
patient’s ability to clear bacterial infections (310). From these studies it is evident that
periodontal disease is an end result of the complex interactions of host factors, genetics,
and the environment (263) and further studies need to be performed to determine the
extent of the host’s genotype in periodontal disease.

B.2. The Menstrual Cycle and Pregnancy
Female sex steroid hormones are not necessary or sufficient to induce gingival
changes in themselves, but in the presence of bacterial plaque they may alter periodontal
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tissue responses (247). It has been reported that there are significant and observable
gingival inflammatory changes during the menstrual cycle, such as bleeding and swollen
gingiva, an increase in gingival inflammation (237) and gingival exudate (247) that peaks
just before ovulation concomitant with the highest levels of estradiol and progesterone,
and a minor increase in tooth mobility. In addition, it has been demonstrated that
progesterone reduces corpuscular flow rate allowing the build up of inflammatory cells,
increased vascular permeability, and increased vascular proliferation [reviewed in (247)].
Moreover, progesterone has been shown to increase the production of the inflammatory
mediator prostaglandin E2, to enhance the accumulation and chemotaxis of
polymorphonuclear leukocytes in the gingival sulcus, and modulate the production of
cytokines (247).
Not only are there gingival changes during the menstrual cycle, but also there are
hormone associated changes to the periodontium during pregnancy. The most significant
hormonal change is the increased production of estrogens and progesterone that rise over
the course of pregnancy and fall to non-pregnant levels within two to three days of
delivery (202). The rise and fall of gingival inflammation levels coincide with the rise of
estrogen and progesterone in the second month of pregnancy through the eighth month of
pregnancy (113, 247). Pregnancy gingivitis is very common and affects 30 to 100% of
pregnant women (247). From the few studies done on periodontal attachment loss during
pregnancy, it appears that the gingival inflammation does not progress to periodontitis
(202, 207). This could be from the reduction of MMPs, caused by increased levels of
progesterone, reducing the levels of inflammation-mediated collagen degradation (207).
Estrogens and progesterone have numerous effects during pregnancy that include effects
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on the vascular system, maintenance of the endometrium, preparation of the mammary
glands for milk production, increase of the basal metabolic rate, and modulation of the
immune system (202). Because the gingiva has receptors for estrogen and progesterone,
these hormones can have increased levels in gingival tissues causing changes in gingival
vasculature, the local immune system, cells of the periodontium (247) and possibly the
constituents of the bacterial biofilm. Progesterone is known to decrease IL-6 secretion in
human gingival fibroblasts, which may lower resistance to inflammatory insults (202).
However, the exact mechanism of hormone-related gingival inflammation is not yet
known, but it is clear that pregnancy does not cause gingivitis since a plaque-free tooth
surface with a healthy gingiva at the beginning of pregnancy shows no clinical signs of
inflammation with maintenance of good oral hygiene during pregnancy (202).
It is possible that the hormonal changes that occur during pregnancy in the
periodontal tissues could modify the microbial environment altering the number and
ratios of bacteria in dental plaque. For example the number of Gram-negative rods was
increased when the gingivitis was the worst and the gingiva bled most readily (202). The
ratio of anaerobic to aerobic bacteria increased significantly during the thirteenth through
sixteenth week of pregnancy and remained elevated until the third trimester, with only
Bacteroides intermedins numbers increasing. A possible explanation for this is that both
estrogen and progesterone can substitute for the essential growth factor vitamin K
providing a means for increased growth (113, 247). However, it has not been absolutely
established that the increased hormone levels during pregnancy cause an increase in
specific bacterial species in dental plaque (247).
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To protect the growing fetus, an immune response against the developing fetus
cannot develop, so the maternal immune system is slightly depressed compared to the
non-pregnant state. It appears that T cells are more sensitive to hormonal changes than B
cells, with the T helper cell numbers slightly decreasing along with modifications in their
actions (202), causing a suppression in the T cell response (113). T helper cells are a
major source of cytokines that are either pro-inflammatory, termed Th-1, or anti
inflammatory, termed Th-2, and in pregnancy immune responses are skewed to Th-2
response (202). In addition, cell mediated immunity is suppressed (113, 247) and
lymphocyte proliferation is impaired during pregnancy. These immune system changes
may account for the heightened gingival inflammatory response during pregnancy to the
same bacterial burden (113), but further studies are needed.

B.3. Diabetes Mellitus
Diabetes mellitus is one of the strongest systemic risk factors for periodontitis
(271). Diabetes is the most common of all endocrine disorders with type 2, characterized
by tissue insulin resistance and hyperinsulinemia (Table 1), being the most common form
(113). Type 1 diabetes usually results from the autoimmune destruction of the insulin
producing (3 cells of the pancreas and is usually diagnosed in young individuals (Table 1)
(247). The diabetic state causes systemic changes in important components of the
immune system relating to the periodontium, such as inadequate local immune response
to bacterial plaque assault, and alterations in the periodontal tissue physiology, consisting
of blood vessel changes, and changes in collagen metabolism (1). It is well documented
that persons with diabetes have a compromised ability to respond to bacterial infections,
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Table 1. Comparison of type 1 and type 2 diabetes. Taken from (247).
Type 1 diabetes

Type 2 diabetes

Age at onset

Generally < 30 years

Generally in adulthood (prevalence in
young is increasing)

Racial preference

White

Black, Hispanic, American Indian, Pacific Islanders

Presence of family history

Common

More common than type 1

Most common morphotype

Thin or normal stature

Obese

Onset of Clinical Disease

Abrupt

Slow

Pathophysiology

Autoimmune p-cell
destruction

Insulin resistance, impaired insulin secretion, increased
liver glucose production

Level of endogenous insulin
production

None

Decreased, normal, or elevated (depends on
stage of disease)

Susceptibility to ketoacidosis

High

Low

Common treatment regimens

Insulin, diet, exercise

Diet (weight loss), exercise, oral agents, insulin
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which may increase their risk for periodontitis (113), and have exaggerated inflammatory
responses compared to non-diabetics (1). Similar to non-diabetic individuals, there is
heterogeneity in both onset and progression of periodontitis in the diabetic population
(247). Insulin-dependent and non-insulin-dependent diabetics appear to have equal risk
for developing periodontitis (271). Diabetic individuals typically have greater attachment
loss, even after correcting for possible confounding factors (113) and a significantly
higher number of affected teeth (1) than non-diabetics. Individuals with poor metabolic
control had increased attachment loss as compared to well-controlled diabetics with
similar oral hygiene (113, 247), which may be caused by high GCF levels of IL-1 (3, a
potent bone resorptive cytokine (91). Thus, proper control of diabetes may be an
important variable in both the onset and progression of periodontal disease, with well
controlled patients having a similar risk as non-diabetic individuals (247). However, it
cannot be ruled out that in some diabetic individuals the risk for periodontitis may be
more related to other risk factors, such as poor oral hygiene and/or smoking, than to the
presence of diabetes (247).
Despite the strong association of diabetes and periodontitis, the mechanism in
which diabetes promotes periodontitis is not completely understood. Since the
periodontium is composed mainly of collagen, changes in collagen metabolism that occur
in diabetes may contribute to modulation of wound healing and to periodontitis initiation
and progression (247). Not only is collagen production decreased in diabetics, but also
newly formed collagen can be degraded by the elevated levels of collagenase in the
periodontium (247). It has been suggested that hyperglycemia progressively glycates
proteins, forming advanced glycation end products (AGE) (1), which increases the
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crosslinking of collagen, preventing its degradation (247). Since newly formed collagen
is degraded faster than the glycated collagen, the net effect is a predominance of older,
highly cross-linked collagen causing an increase in the basement membrane thickness of
capillary walls and possibly impairing the exchange of oxygen and metabolic waste
products (247). AGE accumulate faster in diabetics (247) and its receptor is present in
gingival tissues and is up-regulated in type 2 diabetics (181). AGE can also stimulate
phagocytes and the release of inflammatory cytokines that promote periodontal tissue
loss (1). Despite the systemic changes that occur with diabetes, it appears that there are
very few differences in the dental plaque bacteria of diabetics with periodontitis at all
levels of glycemic control and non-diabetics with periodontitis (247). However, there
seems to be changes in the immune response to bacteria in diabetic patients. The
polymorphonuclear leukocyte plays a dominant role in the maintenance of the healthy
periodontium against bacterial invaders. It is well established that in diabetes there is a
reduction in polymorphonuclear leukocyte chemotaxis, adherence, and phagocytosis and
this may result in significantly increased tissue destruction (247).

Furthermore, diabetic

patients possess a hyper-responsive monocyte/macrophage phenotype, in which
stimulation by bacterial antigens results in an exaggerated pro-inflammatory cytokine
production (247). It has also been found that diabetes alters the response to bacteria by
increasing fibroblast apoptosis and subsequently decreasing the ability to produce matrix
(229). At this time, it is not apparent which of the changes caused by diabetes has a more
significant role in the development of periodontitis. Nevertheless, the association
between diabetes and periodontitis is quite strong.

19

B.4. Smoking
Cigarette smoking has been recognized as a risk factor for periodontitis for many
years (271). Cigar and pipe smoking have been shown to have similar destructive effects
to periodontal health as cigarette smoking (1). It has been estimated that more than half
of the cases of adult periodontitis may be due to cigarette smoking (293). Smokers have
more mean attachment loss, deeper periodontal pockets, and more missing teeth than
non-smokers (293). Smokers have between a 2 and 7 fold increase in risk of having
periodontal tissue loss as compared to non-smokers [reviewed in (1)], even when the
level of plaque accumulations and gingival inflammation are not significantly different
(187). Interestingly, even though smokers have a significantly greater plaque index, the
average number of bleeding sites in smokers is less than non-smokers, suggesting that
gingival inflammatory symptoms appear to be suppressed in smokers (293). Heavy
smoking decreased gingival bleeding upon probing by almost 50% and was dose
dependent with heaviest smokers having the most reduction in gingival bleeding and
former smokers the least (80). There does appear to be a dose-effect relationship
between smoking and periodontitis, in that the individuals with the most smoking years
and higher cotinine levels (236), indicative of increased smoking, have the more severe
levels of periodontal disease, irrespective of other factors (1, 271). Despite the increased
levels of cotinine in GCF as compared to the saliva, there appears to be no correlation
with periodontal pocket cotinine levels and pocket depth, attachment loss, or tooth loss
(293). In addition, smoking from mid-adolescence through adulthood doubles the
likelihood of periodontitis occurring by the mid-twenties (293). Quitting smoking may
improve periodontal health (1). Furthermore, the periodontal health of former smokers is
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intermediate between current smokers and non-smokers and the progression of bone loss
is significantly retarded in individuals who stop smoking (293).
The nature of the interaction between smoking and specific tobacco components,
oral bacterial pathogens, and the host to increase periodontal disease severity and
progression is not well understood (310). One possible explanation of the increased
periodontitis rate is that the oxygen saturation of hemoglobin in the gingiva does differ
between smokers and non-smokers which can impair gingival microcirculation (1). The
higher proportion of small blood vessels and a lower proportion of large blood vessels in
the gingiva of smokers has been suggested to be caused by the suppression of the
inflammatory response in smokers (293). Furthermore, nicotine causes local
vasoconstriction which reduces blood flow, edema, and the clinical signs of inflammation
which may explain the decreased levels of inflammation and gingival bleeding seen in
smokers (187). In addition, smoking affects the immune system by modifying the
humoral and cellular immune systems and cytokine and adhesion molecule network (1).
It is also thought that smoking hinders the host’s ability to heal, so much so, that the
capability for repair is diminished to the equivalent level of a non-smoker 36 years older
(293), prolonging the insults sustained in periodontal tissue from dental pathogens.
Cigarette smoking affects colonization of subgingival species, including P.
gingivalis, allowing a higher bacterial load in current smokers than in previous smokers
or non-smokers (326). Smoking was found to be a determining factor for the
composition of the microbial flora and may select for certain bacterial species by
providing a favorable habitat for their growth and damaging the neutrophils that protect
the periodontium by the formation of AGE (293). In addition, it has been reported that
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there is a difference in the percent of sites colonized rather than in total counts or
proportions of species (293). However, conflicting results exist that do not demonstrate
any microbial difference between smokers and non-smokers (1, 293). It is not yet clear if
there are consistent differences in the bacterial population between smokers and nonsmokers.
Another possible means by which smoking increases the risk for periodontitis is
tobacco-derived chemicals directly damaging periodontal tissues. Nicotine inhibits the
attachment, growth, and chemotaxis (293) of periodontal ligament fibroblasts in vitro
causing atypical cell morphology and formation of vacuoles that are irreversible at high
nicotine concentrations (1). Cotinine was found to enhance the toxins from periodontal
pathogens and acrolein and acetaldehyde are cytotoxic to human gingival fibroblasts
(293). Further in vivo studies are needed to determine the extent smoking metabolites
increase periodontitis risk.
Since it has been shown that smokers also have other possibly harmful dental
habits, such as increased use of sugar in tea and coffee and increased alcohol
consumption, multiple factors may be involved in the association of smoking and
periodontitis (1). Studies suggest that the periodontal destruction that occurs from
smoking outweighs any genetic association with periodontitis since a twin with a life
long smoking habit has greater alveolar bone loss compared to the non-smoking twin (1).
In general, smoking is probably the single most significant modifiable risk factor for
periodontal disease (271).
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C. Complications of Periodontitis
C.l. Respiratory Diseases
It is becoming increasingly clear that the oral cavity can act as the site of origin
for dissemination of pathogenic organisms to distant body sites, especially in
immunocompromised individuals, such as patients with cancer, diabetes, rheumatoid
arthritis, or undergoing immunosuppressive treatment (217). Several means have been
suggested by which periodontitis may affect systemic health: shared disease risk factors,
subgingival plaque acting as a bacterial reservoir, the periodontium acting as a pool of
inflammatory mediators (217), and metastatic translocation of periodontal bacteria (118).
Upper respiratory passages are frequently inhabited by organisms derived from the oral,
nasal, and pharyngeal regions, but the lower respiratory tract is generally free of
contamination by means of host immune factors and mechanical clearance by coughing
or ciliary action (246). There are four possible routes by which microorganisms can
infect the lower respiratory tract: aspiration of oropharyngeal contents, inhalation of
infectious aerosols, spread of infection from neighboring sites, and/or hematogenous
spread from outside the lung (217). Chronic mechanical aspiration of small amounts of
saliva and oral particulate matter takes place in all human beings (343). Therefore, it
seems plausible that individuals with periodontitis and, consequently, a higher bacterial
burden would be more likely to aspirate bacterial-infected saliva more often increasing
the probability of initiating a respiratory infection. Oral bacteria can be found in the
upper airway (307, 343) and it has been demonstrated that P. gingivalis in dental plaque
was a significant risk factor for aspiration pneumonia (344). Recent literature indicates
that there is a relationship between periodontitis and respiratory illnesses, such as
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pneumonia and chronic pulmonary obstructive disease (COPD), but it needs to be more
firmly established through clinical trials (278).
Pneumonia is an infection of pulmonary parenchyma caused by a wide variety of
infectious agents, including bacteria, fungi, parasites, and viruses (217) and it is generally
classified into community-acquired or nosocomial (246). Pneumonia has been reported
to be caused by anaerobic bacteria and the oral cavity appears to be a logical reservoir of
these bacteria, as well as, the more common bacteria associated with pneumonia (118).
Community-acquired pneumonia is mainly derived from either the inhalation of
infectious aerosols or aspiration of normal oropharyngeal residents (307), while
nosocomial pneumonia is usually caused by aspiration of oropharyngeal Gram-negative
bacilli from the environment (307) and has a high morbidity and mortality rate (246).
The pathogenesis of pneumonia begins with the colonization of the oropharyngeal
surfaces by potential respiratory pathogens by bacterial adherence to host surfaces and
subsequent replication. Poor oral hygiene in the hospital or nursing home environment,
especially individuals who are in intensive care units, is common and as the
hospitalization length increases, so does the prevalence of these organisms in the oral
cavity and oropharynx (246). Bacteria are then aspirated from the upper airway into the
lower airway where bacteria adhere to the bronchial or alveolar epithelium (308). Since
it has been reported that increased oral hygiene in nursing home residents reduced the
number of bouts of pneumonia (391), these findings should be confirmed in larger
populations and possibly implemented in hospital and nursing home settings.
COPD includes chronic bronchitis, with obstruction of the small airways, and
emphysema, which is the result of enlargement of air spaces and loss of lung parenchyma
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(308). COPD was associated with poor periodontal health status as determined by
clinical or radiographic criteria in subjects in several studies [reviewed in (114)].
However, it has been reported that this increase occurs only in current smokers,
suggesting that there may be an interaction between severe periodontal disease and
smoking that incrementally increases the risk of COPD in current smokers (160).
Interestingly, COPD has several characteristics in common with periodontitis. COPD is
characterized by exacerbations or episodes in which there are objective signs of
worsening and the factors responsible for the initiation of episodes is not completely
known. The frequency of COPD exacerbations vary from individual to individual (307).
Furthermore, there is an exaggerated inflammatory response in the pathogenesis of both
diseases with the subsequent connective tissue destruction characteristic of both COPD
and periodontitis (114). Bacteria are an important component of respiratory disease, but
they alone are insufficient to cause disease; other factors that inhibit the normal lung
defense mechanisms need to be present, as well (278). In fact, there is a hypothesis that
the co-occurrence of COPD and periodontitis may be due to a common underlying host
susceptibility factor (114). Several mechanisms for the role of oral bacteria in the
pathogenesis of respiratory infection have been proposed by Scannapieco (307). He
suggests aspiration of oral pathogens into the lung could cause infection; periodontal
disease-associated enzymes in saliva may modify mucosal surfaces to promote adhesion
and colonization by respiratory pathogens, which are then aspirated into the lung (308);
periodontal disease-associated enzymes may destroy salivary pellicles on pathogenic
bacteria to hinder their clearance from the mucosal surface; and/or cytokines from
periodontal tissues may alter respiratory epithelium to promote infection. It seems clear
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that a greater bacterial burden in a particularly susceptible host may increase the risk for
certain community or nosocomial pneumonias and exacerbations of COPD (114), but
more studies to strengthen this association and to reveal the mechanisms involved need to
be performed.

C.2. Infective Endocarditis
Infective endocarditis, clinically the most common heart disease caused by oral
bacterial metastasis (118), is an infection of the heart caused by bacteria in the
bloodstream lodging on abnormal heart valves, damaged heart tissue (217), heart
malformations, and/or vascular prostheses. Definitive proof that oral bacteria can enter
the bloodstream and colonize the heart has been demonstrated. Fiehn, et. al. genetically
characterized the bacteria isolated from endocarditis patients’ blood stream and oral
cavity and found them to be identical (96). There have been numerous animal studies
that have demonstrated that dental extraction can cause histological evidence of
endocarditis under experimental conditions (217). However, in most cases it is difficult
to determine the event that triggered the endocarditis (118). Transient bacteremias are
well documented and may be caused by dental procedures, toothbrushing, and even
routine mastication [(113) and reviewed in (217)]. It has been proposed that early
bacteremia may prime the endothelial surface of the heart valves over many years and
promote early valve thickening, rendering the valves susceptible to late adherence and
colonization with bacteria. The later bacteremia may work over days or weeks and
allows bacterial adherence and colonization of the valve, resulting in endocarditis (217).
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Despite these findings the role of oral bacteria in subacute infective endocarditis is
controversial, as is the effectiveness of antibiotic prophylaxis in these cases (113).

C.3. Pregnancy Outcomes
Despite advances in maternal prenatal care and increased public awareness, the
incidence of preterm birth has not changed significantly over the last 40 years (273). The
traditional risk factors for preterm low-birth-weight deliveries are smoking, genetics,
alcohol use, lack of prenatal care, poor maternal nutrition, and urinary tract infection
(386). These risk factors are not present in approximately one fourth of preterm lowbirth-weight cases, suggesting that there are as yet undefined risk factors (246, 273) that
need to be appropriately targeted and managed (273). Subclinical infection may be an
important cause of premature labor. It is well established that maternal genitourinary
tract infections are associated with premature labor and low-birth-weight newborns
[reviewed in (120)], but the data are not consistent, indicating that the association may
depend on the specific infection and the presence of upper genital tract infection (174).
Preliminary data from the Oral Conditions and Pregnancy cohort study provides
evidence that maternal periodontal disease and progression are significant contributors to
risk of preterm delivery, low birth weight, and low weight for gestational age (273). This
study also found no significant differences in the prevalence of orange and red complex
members (see Chapter 1 section D.l. and Fig. 7) within the plaque of preterm mothers
compared to full term mothers at delivery (239). However, there was a trend for mothers
of full term infants to have higher IgG antibody titers to both orange and red complex
members than mothers who delivered early. Levels of fetal cord blood IgM directed
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against orange and red complex members, indicative of fetal exposure to an infectious
agent of maternal origin, was higher in pre-term babies, especially in mothers who had no
IgG response to red complex members. These results suggest that initiation or worsening
of periodontal status during pregnancy may increase the likelihood of preterm labor
without protective maternal IgG (239). It has been demonstrated that active periodontal
infection can be accelerated during pregnancy resulting in increased attachment loss
(221). Moreover, the pathogenic mechanism of periodontitis-associated prematurity
appears to use a blood-borne infectious pathway (239). Therefore, it is tempting to
speculate that bacteremia of periodontal pathogens is followed by a bacterial seeding of
the placenta, an organ that is relatively protected from the normal maternal immune
defenses (174). From these findings the proposed model of periodontitis and premature
labor involves the colonization of maternal periodontal pockets with orange complex
organisms and an antibody response. As the pockets deepen colonization of red members
occurs. In the presence of orange members only or a maternal antibody response to
orange and red members, there would be no significant increase in the rate of preterm
labor. However, in the presence of red complex colonization and/or the absence of
maternal IgG to red complex members, there would be an increase in the rate of
premature labor (239).
Jeffcoat and colleagues have confirmed that periodontal disease is present before
preterm birth and that the patients with the most severe periodontitis had the greatest risk
for preterm birth (174). In women who delivered prematurely there was a significant
increase in loss of periodontal tissue support with the highest prevalence of periodontitis
in the most premature deliveries and lowest birth weight infants (173). A chronic
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subcutaneous animal infection model with P. gingivalis resulted in increases in
prostaglandin E2 and TNF-ot and fetal growth restriction (273). In a follow up study it
was determined that the abnormal pregnancy outcomes resulting from a localized
infection are associated with P. gingivalis dissemination to the maternal liver and uterus,
maternal IgG immune responses in serum and amniotic fluid, and inflammatory
responses resulting in elevated serum TNF-a and decreased IL-10 levels. Taken together
these results establish that localized infections with P. gingivalis induce systemic
inflammatory responses (222).
The exact mechanism by which vaginal bacterial colonization may cause
premature rupture of membranes and preterm delivery is not known (246), but it
hypothesized that microbes themselves or microbial toxins enter the uterine cavity early
during pregnancy or possibly prior to pregnancy by the ascending route from the lower
genital tract or by the blood borne route from a non-genital focus (120). There does not
appear to be genital colonization of periodontal microbes in pregnant women with
periodontitis (273). Therefore, it has been suggested that periodontal infections could
serve as a reservoir for both Gram-negative anaerobic organisms and inflammatory
mediators (246) creating an additional risk factor by direct infection or by triggering the
host immune response causing inflammation and release of pro-inflammatory mediators,
like IL-1, TNF-a, and MMPs, which may cross the placenta and result in preterm
delivery and low birth weight (386). Maternal systemic infections can elicit a response
that results in inflammation of the matemal-fetal-placental unit, in which inflammatory
stimuli cause hyper-irritability of the smooth muscle of the uterus enhancing contractility
and cervical effacement and dilatation, and triggering preterm labor. Inflammation of the
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chorioamniotic membranes can result in premature rupture of membranes. Placental
damage caused by infection and inflammation can cause hemorrhage and necrosis that
results in poor fetal perfusion, fetal growth restriction, and distress (273). Pregnant
women with periodontitis and elevated amniotic fluid levels of prostaglandin E2, IL-6,
and IL-8 during weeks 15 to 20 of gestation are at a high risk for premature birth,
suggesting that periodontitis can induce a primary host response in the chorioamnion
leading to preterm birth (85). Pregnant women with threatened preterm labor had worse
periodontal conditions resulting in elevated levels of IL-8 and IL-1(3, which play a role in
early cervical dilatation (143).
Emerging studies have demonstrated that periodontal treatment during pregnancy
may reduce preterm births (273, 386). It has even been suggested the periodontal
treatment should be considered a necessary part of prenatal care (11). Inflammation of
the uterus and membranes represents a common effector mechanism that results in
preterm birth and clinical and/or subclinical infection remains a logical and highly
suspect candidate as a stimulus for increased inflammation (273). Further studies need to
be carried out to solidify the association of periodontitis and poor pregnancy outcomes
and to validate antibiotic treatment during pregnancy to lower the risk of preterm lowbirth-weight deliveries.

C.4. Atherosclerosis
Approximately 23 million adults in the United States have diagnosed
cardiovascular disease (356) and it is ranked number one in the number of deaths per year
(188, 379). The normal coronary artery has a trilaminar structure (219). The arterial wall
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is composed of an innermost layer of endothelial cells in contact with the blood (219)
resting on a thin basal lamina membrane; beneath this is the intima consisting mainly of
elastin and collagen fibers and some smooth muscle cells (331) scattered within the
intimal ECM (219) (Fig. 5). Below this is the media layer that consists of multiple layers
of smooth muscle cells, much more tightly packed than in the intima, embedded in a
matrix rich in elastin, as well as, collagen (219). Finally, the outer adventitia layer of
connective tissue, collagen, and elastic fibers embed the entire vessel within its
surroundings (331).
Atherosclerosis is a progressive, degenerative disease process, whose advanced
lesion is an atheroma, a dynamic plaque (317) consisting of lysed cells, cholesterol-ester
crystals, lipid-laden foam cells, and plasma proteins, such as fibrin and fibrinogen (113).
It is an inflammatory disease [reviewed in (76, 218, 219, 220, 295)] that can be divided
into three main stages: initiation, progression, and complication. If the inflammatory
response does not effectively neutralize or remove the offending agents, it can continue
indefinitely, and change from a protective to an injurious response (295). A hallmark
feature of atherosclerosis is endothelial dysfunction. Possible causes of endothelial
dysfunction leading to atherosclerosis include elevated and modified low density
lipoprotein (LDL); free radicals caused by cigarette smoking, hypertension, and diabetes
mellitus; genetic alterations; elevated plasma homocysteine concentrations; infectious
microorganisms; and combinations of these or other factors (295). Atherogenesis
initially involves leukocyte recruitment from the circulation by adhesion to the
endothelium through adhesion molecules, such as vascular cell adhesion molecule-1
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Figure 5. Schematic of the life history of an atheroma. The progression of atheroma formation
involves recruitment of inflammatory cells and lipids causing expansion of the artery outward.
The strength of the fibrous cap determines if thrombolytic events ensue. Thrombosis can lead to
acute myocardial infarction or a thrombus can be reabsorbed, but the healing process that follows
causes stenosis, restricting blood flow. Taken from (219).
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(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) (233), followed by
penetration through the endothelial layer and arterial basement membrane (227). Normal
endothelium does not support the binding of white blood cells, but an atherogenic diet
produces patches of arterial endothelial cells that express selective adhesion molecules
that bind various leukocytes (220). E-selectin and P-selectin mediate the transient
‘rolling’ of leukocytes along the endothelium and VCAM-1 and ICAM-1 stabilize the
attachment of leukocytes to the endothelium (233). Different forms of injury increase the
adhesiveness of the endothelium, with respect to leukocytes or platelets, and its
permeability, causing the endothelium to have pro-coagulant properties and form
vasoactive molecules (295). After adhesion and transmigration through the endothelial
layer and basement membrane, monocytes become macrophages, proliferate, and become
lipid-laden foam cells (227) and the artery enlarges outward to accommodate the
expansion of the intima (Fig. 5) (219). Smooth muscle cell migration and neointimal
formation are part of the main pathologic events during progression of atherosclerosis
(227). During the progression of atherosclerosis, lipid-laden smooth muscle cells and
macrophages (foam cells) accumulate along with T cells, releasing inflammatory
cytokines and degrading ECM constituents (227). The development of fatty streaks,
which are present in most people under the age of 30 and are asymptomatic, into more
advanced lesions and plaques is dependent on further inflammation (331). Under
persistent inflammatory conditions with other risk factors, such as high blood lipid levels,
the lipid core can grow, the ECM can be degraded by proteases released by activated
leukocytes, and synthesis of collagen is limited by pro-inflammatory cytokines, resulting
in the thinning of the fibrous cap (Fig. 5) (219). The cap keeps the highly thrombogenic
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contents of the lesion separate from the circulation (317). A small percentage of lesions,
often referred to as vulnerable plaques, may undergo transformation, that includes the
thinning of the cap, formation of a necrotic core, a heightened stage of inflammation, and
accumulation of free cholesterol, all resulting in lesional necrosis and plaque erosion or
rupture (338). The rupture of the plaque’s thin fibrous caps, usually occurs at the
shoulder regions of the lesion where macrophages are concentrated, resulting in the
contents of the lipid core coming in contact with blood clotting factors and, consequently,
thrombus formation (331) causing most of the acute manifestations of atherosclerosis,
such as myocardial infarction and stroke (227). If the thrombus is persistently blocking
blood flow an acute myocardial infarction can occur (Fig. 5) (219). A myocardial
infarction is the damaging or death of an area of the heart muscle resulting from a
reduced blood supply to the area (217). The thrombus can be reabsorbed and a wound
healing response is triggered that causes smooth muscle cell proliferation, migration, and
ECM synthesis, constricting the lumen of the vessel, decreasing blood flow, and leading
to ischemia (Fig. 5) (219).
An interesting line of research has revealed an association between endothelial
progenitor cells (EPC) and cardiovascular risk factors. Increased risk factors for
atherosclerosis is correlated with decreased levels of EPC as all known major risk factors
negatively influence the numbers of EPC, their migratory capacity, and/or their
clonogenic potential (379). EPC are important in the regeneration of damaged or
dysfunctional endothelium and it has been found that they are a better measure of
endothelial function than the conventional risk factors for atherosclerosis (379). The
traditional risk factors (Table 2) of atherosclerosis, such as hypertension,
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Table 2. Risk factors implicated in
atherogenesis and periodontal disease. Bold
type, mutual risk factor of atherosclerosis and
periodontitis; regular type, atherosclerosis risk
factor. Taken from (63).

Not modifiable

Modifiable

Gender
Lack of exercise
Age
Stress
Race
A 1c o h o 1 co n s u mp t i o n
Family history
Diet
Hypertension
Smoking
Diabetes mellitus
Infections
Body mass index
C-reactive protein
Homocysteine
Lipoprotein a
White blood cells
Fibrinogen
Total cholesterol
Low density lipoprotein
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hypercholesterolemia, and smoking do not account for all cases of cardiovascular disease
(63, 217). Atherosclerosis is considered a multifactorial disease and evidence is
increasing that supports the chronic inflammatory nature of atheroma formation which
may suggest that there is a contribution by infectious agents in atherogenesis (190).
Many studies have focused on the potential association with atherogenesis of
cytomegalovirus and Chlamydia pneumoniae [reviewed in (190)], which is present in
almost one half of the plaque samples studied, but the association has not been consistent
(218).
Because of the chronic, inflammatory nature of periodontitis, its large bacterial
burden, and increased incidence of bacteremia (246), its association with atherogenesis
has been investigated. Numerous studies have found that individuals with stroke,
myocardial infarction, or atherosclerosis had evidence of pre-existing bacterial infections
or poor periodontal health [reviewed in (76, 246)]. In fact, one or more periodontal
pathogens have been found in 42% of atheromas from periodontitis patients (217) and the
total periodontal pathogen burden was recently found to be considerably and significantly
higher in atherosclerotic patients than in controls (328). For periodontal disease to be a
risk factor for atherosclerosis, the presence of periodontal pathogens should be isolated
from serum or atheromatous plaques, induce the release of proinflammatory cytokines,
and animal models that demonstrate bacterial-induced atherogenesis should be available
(63). Recently, an animal model was developed to test the potential atherogenic effects
of P. gingivalis in normocholesterolemic and hypercholesterolemic pigs, which develop
coronary lesions that closely simulate human atherosclerosis (39). P. gingivalis has been
identified in atherosclerotic plaque in several studies (39, 49, 58, 97, 102, 138, 193, 194).
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Furthermore, in one study plaque samples were collected after a two-week washout
period to allow bacterial clearance from the blood, which suggests that P. gingivalis was
detected because of bacterial tissue invasion and not persistent bacteremia (39). P.
gingivalis was localized to the intima underlying the plaque in viable microcolonies (49)
at an approximate number of 1.9 x 105 viable cells in resected tissue (194). P. gingivalis
has been shown to induce foam cell formation and degrade fibrous capsule most likely
through activation of MMP-9 from macrophages, and enhance expression of monocyte
chemoattractant protein-1 (MCP-1), which could lead to the recruitment of inflammatory
cells (199). Furthermore, it has been recently reported that the mean carotid intimamedia thickness was increased in the presence of a group of periodontal pathogens that
included P. gingivalis and decreased with the removal of any one of the group members
(79). P. gingivalis can induce platelet aggregation while its proteases (see Chapter 1
section E.2.) can activate factor IX (149) and factor X, prothrombin, and protein C,
leading to thrombus formation (217). It is well established that chronic infections, such
as periodontitis, enhance the production of inflammatory cytokines that may hasten the
development of atheromas (220). P. gingivalis is a potent inducer of IL-lp, TNF-oc,
prostaglandin E2, and MMPs (128). Several reports of the apolipoprotein E-deficient
(ApoE) mouse model, in which mice become hypercholesterolemic and develop
atherosclerotic lesions similar to humans (295), demonstrate that P. gingivalis inoculation
caused more pronounced foam cell formation and atherosclerotic lesions (63). In fact,
invasive P. gingivalis accelerated atheroma formation and immunization against P.
gingivalis prevented both periodontal disease and atherosclerosis in the ApoE mouse
model (121) and the increase in plaque accumulation occurred early after P. gingivalis
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exposure (253). In addition, in the recently developed swine model P. gingivalis
increased the size of coronary and aortic lesions in both normocholesterolemic and
hypercholesterolemic pigs (39). Collectively, these results strengthen the association of
periodontitis and atherosclerosis and, in particular, the involvement of P. gingivalis.
However, more research needs to be done to explain perplexing and inconsistent results
in which no periodontal bacteria can be found in carotid samples (42).
Numerous explanations of the involvement of bacteria in atherogenesis have been
presented thus far. It has been proposed that in periodontitis the LPS from Gram
negative subgingival bacteria or bacteria that has entered into the circulation trigger the
production of high levels of cytokines that initiate or exacerbate the conditions associated
with atherosclerosis (118). Infectious agents might also influence atherogenesis in two
ways: directly by infection of vascular cells or indirectly by influencing cell function
(190). Endothelial cell infection would represent the first step in the alteration of the
vascular wall homeostasis. Lysis of endothelial cells or desquamation by direct or
indirect means, would allow leukocyte migration and establishment of inflammatory
activity within the vascular wall (190). It is hypothesized that some individuals may
respond to a microbial challenge with a hyper-inflammatory response because of the
host-microbial environment and individual variation in genes that regulate the T cell
(113) and the secretory capacity of monocytic cells causing release of high levels of
proinflammatory mediators such as prostaglandin E2, TNF-a, and IL-1(3 (217) in serum
and in GCF (25). Prospective epidemiological studies have found risk with increased
basal levels of cytokines, such as IL-6 and TNF-a (233), cell adhesion molecules, such as
soluble ICAM-1, platelet selectin (P-selectin), and endothelial selectin (E-selectin), and
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down stream acute-phase reactants such as C-reactive protein (CRP), fibrinogen, and
serum amyloid A (220). Moreover, increased levels of these adhesion molecules are
found in atherosclerotic lesions compared to normal arteries (233). It is also possible that
atherogenesis is triggered by an autoimmune response to host tissue heat shock proteins
(Hsp) that are highly similar to bacterial Hsp (217). Alternatively periodontitis could
trigger the release of CRP, which is a marker of inflammation, and form deposits on
injured blood vessels (128, 217). In periodontitis patients there is a significantly elevated
level of CRP that decreases significantly after periodontal therapy (128). The potential
relationships between periodontitis and atherosclerosis are summarized in figure 6.
Overall, it appears that the association between periodontitis and atherosclerosis is
becoming much stronger, but the bacterial involvement in the aggravation of the
inflammatory response and the alteration of cellular functions need to be further studied.

D. Oral Pathogens and Their Involvement in Periodontal Disease
D.l. Identification of Oral Pathogens
Despite the more than 500 bacterial species present in the oral cavity (279) only
several species have been identified in subgingival plaque and closely associated with
periodontitis. These include P. gingivalis, Tannerella forsythia (formerly Bacteroides
forsythus and Tannerella forsythensis (153)), Actinobacillus actinomycetemcomitans,
Prevotella intermedia, Campylobbacter rectus, Eubacterium nodatum, Treponema
denticola, Streptococcus intermedia, Prevotella nigrescens, Peptostreptococcus micros.
Fusobacterium nucleatum, Eikenella corrodens, and non-classified spirochetes (100).
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Figure 7. Microbial complexes in subgingival biofilms. This illustrates the related communities of
dental plaque species. The red complex has the strongest association with periodontitis and tends to
associate with orange complex members. The yellow, green, and purple complex members usually
colonize the subgingival area first, providing a hospitable environment for orange members followed by
the red complex members. Modified from (128).
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They have been classified by community ordination into color groups based on
relatedness and association with periodontal disease (Fig. 7). The red complex consists
of P. gingivalis, T. denticola, and T. forsythia and has the strongest association with
gingival pocket depth and bleeding upon probing, both clinical signs of periodontal
disease (325). The red complex is almost always found in association with the members
of the orange complex, F. nucleatum subspecies, P. intermedia, P. nigrescens, P. micros,
C. rectus, C. showae, C. gracilis, E. nodatum, and S. contellatus. Furthermore, with
increasing numbers of orange complex members there is increasing numbers of red
cluster members suggesting that orange complex colonization occurs prior to red
complex colonization (325). It has been reported that there is an ecological succession of
colonization within the oral cavity. The yellow, green and purple complex proliferate
first, then the orange complex, and finally the red complex (326). P. gingivalis can
interact with other bacterial species in the periodontal pocket and therefore plays an
important role in the maintenance of the subgingival biofilm (128). The colonization of
the soft tissues with supragingival plaque is essential to the colonization of the
periodontal pocket and disease progression. The current paradigm of the microbial
etiology of periodontitis implicates numerically minor Gram-negative anaerobic
components of the biofilm, such as P. gingivalis, T forsythia, and T. denticola, as the
primary etiologic agents (198). However, recent evidence demonstrates that there may be
as yet undiscovered bacteria that are associated with periodontitis, as well as, bacteria
that previously have not been linked to periodontitis (197). It is unclear whether these
newly identified and more numerous species play a more important role in pathogenesis
than the less numerous previously implicated species (198). These results suggest that

44

the development of periodontitis involves a disruption in the microbial ecology of the
entire dentition rather than at localized disease sites and a shift in the relative proportions
of major bacteria (198).

D.2. The Role of the Dental Biofilm in Periodontal Disease
There are several obstacles that the bacteria must overcome in order to survive
and replicate in the oral cavity. They must resist mechanical displacement and inhibitory
factors in saliva and gingival crevicular flow, the sloughing off of epithelial cells,
antibodies preventing bacterial attachment, and neutrophil phagocytosis. If the bacteria
invade the underlying connective tissue, the bacteria must then evade host immune cells
including B and T cells, lymphocytes, neutrophils, and macrophages (187). Biofilms are
single or multiple communities of microorganisms within a glycocalyx attached to a solid
surface. A biofilm provides several advantages to its inhabitants [reviewed in (326)].
Nutrients are more concentrated on surfaces than in solution, allowing better bacterial
growth. Nutrients are able to pass to deeper layers of the biofilm through channels.
Biofilm organisms are protected from competing organisms, parasites, host defense
mechanisms, such as phagocytosis (128), and antibiotics. Species within biofilms appear
to have two forms: a planktonic state to allow bacteria to spread to new locations and a
sessile state to facilitate multiplication and provide protection (326). The growth of the
biofilm occurs primarily through cell division of adherent bacteria and the regular
removal of dental plaque interferes with its maturation and subsequent colonization of red
complex members that cause periodontitis (226)
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Supragingival biofilm, or plaque, is not constrained and is in constant contact with
saliva, while the subgingival plaque is confined within the periodontal pocket (385). The
initiation, development, and adaptation of dental plaque to changing environmental
conditions are all governed by a dynamic equilibrium between the oral microbiota and
environmental factors that affect its survival (226). The dental plaque has a surprising
degree of order and organization in its structure. Prior to bacterial colonization a pellicle
composed primarily of salivary proteins forms on the tooth surface providing a surface to
which early colonizing bacteria can adhere (226). Generally, subgingival plaque has a
region of Gram-negative and/or motile species located adjacent to the epithelial lining of
the periodontal pocket and a band of Gram-positive rods and cocci tightly adhere to the
tooth enamel or root surface (224, 226). In pockets of 4 to 6 mm, T. denticola resides in
the surface layer of the plaque, while P. gingivalis is in the layer beneath (326). The
bacteria present in the subgingival plaque are important in the progression of periodontal
disease; however, the supragingival plaque plays a very important role, as well. The
supragingival plaque has higher numbers of green and purple complex species, but it also
contains red and orange complex species that act as a reservoir to initiate colonization of
the periodontal pocket (385). Moreover, the colonization of the supragingival plaque by
red complex species appears to be a prerequisite to subgingival colonization and an
important reservoir for infection or re-infection (326). The most significant consequence
of biofilm formation is the continual release of bacteria cell surface components into the
oral cavity (128). Microorganisms that form dental plaque and cause gingivitis probably
do so by releasing bacterial products that induce tissue inflammation (187).
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D.3. The Role of P. gingivalis in Periodontitis
P. gingivalis is a non-motile, Gram-negative anaerobic coccobacillus (204) that is
non-spomlating, black-pigmented, and colonizes either the gingival sulcus or the
periodontal pocket (350). It is asaccharolytic and, thus, depends on nitrogenous
substrates for energy, mainly in the form of peptides. It requires iron for growth which it
fulfills through the use of hemin (protoporphyrin IX) (206). Using sensitive
deoxyribonucleic acid (DNA) and antibody tests it has been determined that P. gingivalis
is a normal inhabitant of the oral cavity and has been isolated from newborns within a
few days of birth [(245, 127) and reviewed in (126, 204)]. However, it is not common or
in high numbers in most human subjects, even those with gingivitis (134), but it is
isolated in higher numbers from individuals with periodontitis (326). P. gingivalis has
consistently been associated with periodontitis [(62, 127) and reviewed in (134, 204)] and
it is essential for disease activity (206). Mean counts of P. gingivalis are higher at sites
that display measures of inflammation (326). The implantation of P. gingivalis into
primates initiated periodontal bone loss (152). Furthermore, it has been reported that
periodontal pockets that contain P. gingivalis alone or in combination with the other red
complex members demonstrated the deepest pocket depths (325) and P. gingivalis can be
a prognostic factor for further periodontal disease progression (236). Hosts differ in their
susceptibility threshold to P. gingivalis (324), which is an opportunistic bacteria (206)
that accompanies a shift in the oral flora, promoting its establishment [reviewed in (204,
322)]. In addition, P. gingivalis has been isolated from saliva and from the surface of
soft tissues of the oral cavity, indicating that it may have habitats other than the
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periodontal pocket (326). The proteases of P. gingivalis (see Chapter 1 section E.2.) are
thought to be involved in the tissue destruction that occurs in periodontitis.

E. Virulence Factors of P. gingivalis
E.l. Lipopolysaccharide, Fimbriae, and Hemagglutinins
Virulence factors are bacterial constituents or metabolites capable of either
causing disruption of homeostatic or protective host mechanisms or causing the
progression or initiation of the disease (66). To successfully colonize and obtain
nutrients in the hostile environment of the periodontal pocket, P. gingivalis has a large
repertoire of tools. The three that have received the most attention are the fimbriae and
hemaggluttinins, for bacterial adherence to host tissues [reviewed in (154, 206)], and the
proteases (see Chapter 1 section E.2), which are used to provide a source of carbon and
nitrogen from peptides for bacterial nutrition. All three, as well as EPS, can contribute to
its virulence (204).
The EPS of Gram-negative bacteria consists of the lipid A moiety embedded in
the outer membrane; a core polysaccharide at the outer membrane surface; and the
polysaccharide O-antigen, which extends from the outer membrane into the environment,
all covalently linked together (244). Rhamnose, mannose, galactose, and glucose are the
major neutral sugars and glucosamine (154, 244) and galactosamine are the amino sugars
present in P. gingivalis EPS (154). EPS can penetrate periodontal tissue and expose
nearly all cell types to this potent inflammatory mediator (17). P. gingivalis EPS has
somewhat unusual characteristics in eliciting host responses. It is not as potent an
activator of human monocytes, endothelial cells do not express E-selectin in response to
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P. gingivalis LPS which inhibits leukocyte attachment, and it is a natural antagonist of
human endothelial cells by interfering with mitogen-activated protein (MAP) kinase
activation (17). Collectively, these results indicate that P. gingivalis LPS may obstruct
the host’s ability to locate adequate numbers of leukocytes near the dental plaque and
block the host’s endothelial and epithelial cell’s response toward other bacteria (17),
initiating periodontal disease and its progression. P. gingivalis LPS has been shown to
stimulate bone resorption, inhibit bone collagen formation, induce IL-1, and inhibit
gingival fibroblast proliferation (244). Endotoxic activity is confined to the lipid A
portion and the immunological activity is the result of the O-antigen (154). Throughout
the literature there are conflicting reports of the biological effects of P. gingivalis LPS.
However, the majority of evidence implicates P. gingivalis LPS lipid A as capable of
stimulating the host inflammatory response indirectly via the induction of host cytokines
(154).
Fimbriae have been classified into two types: type specific, which are involved in
the interaction with other bacteria and mammalian cells and surface adherence, and Fpili, which are involved in bacterial conjugation (154). Fimbriae consist of monomeric
fimbrillin subunits constructed into heat-stable, thin filaments (244) arranged in a
peritrichous fashion over the P. gingivalis cell surface (154). Protein sequence analysis
has indicated that P. gingivalis fimbriae are not homologous to other fimbrial proteins
and may define their own class of Gram-negative fimbriae (206). Genetic studies have
suggested that the considerable variation offlmA, the gene that encodes the fimbrillin
subunit, among different P. gingivalis strains is the result of mutations and genetic
exchange among strains (154). Fimbriae appear to be a major adherence-mediating
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determinant (206) and, consequently, knockout mutants offimA have a significantly
poorer ability to bind and invade host cells (154). Type specific fimbriae of P. gingivalis
allow its attachment to oral epithelial cells, Gram-positive bacteria (244), hydroxyapatite
(154), salivary proteins, fibrinogen, fibronectin, and lactoferrin (206), but not red blood
cells, indicating cell type specificity (154). Moreover, P. gingivalis fimbriae mediate
adherence to the root surface at the bottom of periodontal pockets (270). Thus, P.
gingivalis fimbriae support bacterial colonization of the periodontal pocket enabling
biofilm formation (261). Interestingly, even though P. gingivalis strains W83 and W50
have few fimbriae, indicative of poorer adhesion ability, they are highly virulent in a
mouse model (154). It has been demonstrated that periodontitis patients have
significantly higher antibody titers in serum and in saliva to P. gingivalis fimbriae than
dentally healthy control subjects, indicating the antigenic nature of fimbriae (154).
Besides mediating attachment, it is becoming evident that fimbriae are involved in
bacterial invasion of host cells (6, 78, 205, 389, 390) and fimbriae are also involved in
chemotaxis and cytokine induction (206). A recent report indicates that P. gingivalis
invasion of human aortic endothelial cells and the up-regulation of the cytokine IL-1(3;
the chemokines, MCP-1 and IL-8; and the cell adhesion molecules (CAMs) I-CAM-1, VCAM-1, and E-selectin were dependent on the presence of the major fimbriae (340). In
addition, a reports suggest that part of the tissue destruction that occurs in periodontitis
may be mediated by fimbrial interaction with integrins and the ECM (261) or activation
of integrins via a Toll-like receptor-2 (TLR-2) and phosphoinositide 3-kinase (PI3-K)
pathway (139).
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It is well established that hemagglutinin proteins are virulence factors for a
number of bacterial species and it is reasonable to assume that hemagglutinins of P.
gingivalis are involved in its virulence, as well (136). P. gingivalis expresses several
hemagglutinin genes, hagA, hagB, hagC, and hagD (215), as individual entities or
complexed with its gingipains (136, 206). Similar to fimbriae, hemagglutinins mediate P.
gingivalis adhesion to receptors on host cells (206). Hemagglutinins are expressed on the
bacterial cell surface in association with fimbriae or with non-fimbrial surface
components (136). Hemagglutinin antibodies can be isolated from periodontitis patients
(206). A distinguishing characteristic of P. gingivalis is its ability to hemagglutinate
erythrocytes (244), which is a likely source of the hemin required for growth (136).
Because of the association of P. gingivalis protease and hemagglutinin activities, these
proteins may have multiple roles in its virulence.

E.2. Gingipains
The gingipains from P. gingivalis are the best described proteases and virulence
factors of this oral pathogen. They are responsible for 85% of the general proteolytic
activity and 100% of the “trypsin-like” activity (283). There are two types of gingipains,
arginine-specific, encoded by the gene rgpA and rgpB (Fig. 8), and lysine-specific,
encoded by kgp (Fig. 9). rgpA codes for three isoforms: mature HRgpA is approximately
110 kD and is a non-covalent association of a catalytic domain and several hemagglutinin
domains, RgpA(cat) which is the approximately 50 kD catalytic domain, and mt-RgpA(cat),
which is a 50 to 70 kD membrane associated form [reviewed in (74, 282)] heavily
modified with various amounts and types of LPS (74) (Fig. 8). rgpB encodes for two
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proteases RgpB and mt-RgpB, which are about 48 kD and 70 to 90 kD, respectively (Fig.
8). kgp encodes for a single protease that is similar to HRgpA in that it is a covalent
association of a catalytic domain and hemagglutinin domains (282) (Fig. 9). RgpA and
RgpB are essentially identical at the N-terminal region, while the C-terminal region is
significantly different (31). The rgpA and rgpB genes share 72%, 93%, and 40% identity
within their profragment, catalytic, and C-terminal extension domains, respectively (282),
and 90% amino acid sequence identity with their active sites being identical except for
four amino acid substitutions (4). In addition, sequencing studies of clinical strains of P.
gingivalis have revealed that rgpA is more conserved than rgpB, in which 5 different
genotypes were found in the region of the active center (26). The kgp and rgpA gene
products from P. gingivalis W50 share 23%, 22%, and 70% identity in their profragment,
catalytic, and hemagglutinin/adhesin domains, respectively (282). The catalytic domain
of Kgp shares 26% overall sequence identity and 40% sequence similarity to the catalytic
domain of RgpB, while they possess significantly different amino acids in the SI pocket,
they have a high similarity in residues of the S2 and S3 pockets (31).
Not only are the gingipains important in nutrition for P. gingivalis, but also they
have numerous other effects on host systems, some of which are: dysregulation of
clotting and fibrinolytic pathways, activation of kallikrein/kinin pathway, activation of
MMPs (400), modulation of host cytokine networks [reviewed in (164, 282)],
dysregulation of the complement cascade, degradation of immunoglobulins and iron
transporting proteins, and alteration of neutrophil antimicrobial activity (350).
Gingipains have also been found to activate proteinase-activated receptors (PARs), which
elicit a host inflammatory response that may be involved in periodontitis (155) and
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atherosclerosis (156). HRgpA, Kgp, and RgpB all cleaved CD14, the main receptor for
bacterial cell surface components, such as LPS, and up-regulate LPS-induced TNF-a
production to evade the host’s immune system (335). The level of hemin present in
culture media modulated gingipain activity, suggesting that heme acquisition is a
dominant function of the gingipains (272). The gingipains appear to be involved in the
colonization of the gingiva (348). Moreover, Fletcher, et. ah, have shown that gingipains
are involved in virulence in the mouse model (101).

F. Gingipains are Members of the Protease Clan CD
F.l. Clan CD Members
Comparisons of the primary structure of the gingipains do not reveal any
similarity to known proteins or proteases (284). However, bioinformatic studies of the
active site of legumain (family Cl3), a cysteine endopeptidase originally found only in
plants, was found to be very similar to several other families of cysteine proteases:
clostripain (family Cll), from Clostridium histolyticum, caspases (family Cl4), separase
(family 50) (284), a protease required for sister chromatid separation during anaphase
(353), and gingipains (family C25) and, therefore, they have been grouped into the
cysteine protease clan CD (52). They all have a conserved catalytic motif of His-Glyspacer-Ala-Cys with a block of hydrophobic amino acids preceding each of the catalytic
residues, which suggests that they may have similar enzymological properties and
functions (52). A second common feature is a substrate specificity dominated by the
interactions of the SI subsite recognizing the specific PI residue, which is asparagines
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(legumain), lysine (Kgp), arginine (Rgp, clostripain, and separase), or aspartic acid
(caspases) (22, 52, 284).

F.2. Similarity of Caspases and Gingipains
These similarities have been further established by the crystal structure of RgpB.
Each of the RgpB catalytic domain subunits contain a caspase folding motif that
corresponds to a heterodimer of caspases (284). Active caspases are composed of a
heterodimer comprising a large subunit that contains the catalytic cysteine residue, and a
smaller subunit that contains determinants that govern substrate specificity (404). It was
found that the structure of RgpB resembles a ‘crooked one-root tooth’, with the catalytic
domain being the crown and topologically similar to caspase-1 and -3, while the root has
an immunoglobulin-like fold (88). The purpose of the Ig-like domain is unclear,
although it may help bind to protein substrates or dock to endogenous proteins, other
bacteria, or host cell surfaces (74). It also appears that Rgp is activated in a similar
manner as the caspases (252). To further illustrate the similarities between caspases and
gingipains, natural caspase inhibitors have been found to modulate gingipain activity.
p35, a baculovirus anti-apoptotic protein that is a broad spectrum inhibitor of caspases-1,
-3, -6, -7, -8, and -10 (50), and a point mutant of cowpox viral cytokine-response
modifier A (CrmA), which normally inhibits caspases-1, -4, -5, -8, -9, and -10 (50)
effectively abrogated the activity of Kgp (323). In addition, we have shown that peptide
caspase inhibitors abrogate the activity of Kgp [Chapter 3 and (319)], further
strengthening the similarity between caspases and gingipains.
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G. P. gingivalis Adherence and Invasion of Host Cells
Microscopic in vivo studies of periodontitis tissues have revealed the
characteristic penetration of a variety of bacterial species, including P. gingivalis, in the
gingival epithelium, which may suggest that an intracellular location may be another
ecological niche for P. gingivalis [(137) and reviewed in (205)]. Furthermore, it has
recently been demonstrated that P. gingivalis can also reach the underlying connective
tissue in the periodontium (7, 18) and may do so paracellularly or intracellularly (18).
The transcellular route consists of bacteria crossing the epithelial barrier by entering the
cells through the apical surface and exiting through the basolateral surface, while the
paracellular route consists of bacteria crossing the epithelial barrier by going between
individual epithelial cells through the tight and adherens junctions (Fig. 10) (18). Mainly
three different mammalian cells have been used in P. gingivalis invasion studies: KB
cells, gingival epithelial cells (GEC), and vascular endothelial cells. The mechanisms of
bacterial invasion vary among bacterial species, even among strains of the same species,
and are host cell type specific (205). KB cell and GEC invasion are similar. Engulfment
of P. gingivalis by KB cells occurs by receptor-mediated endocytosis and bacteria are
both free within the cytoplasm and in membrane-bound vacuoles in the perinuclear space
(205). P. gingivalis invades GEC remarkably fast. Within 15 minutes P. gingivalis
localizes freely inside the cell in the perinuclear area (205). P. gingivalis fimbriae bind
integrin (31 and induce tyrosine phosphorylation of paxillin (389) and cellular
redistribution of paxillin and focal adhesion kinase (FAK) (390). Actin microfilament
and microtubule restructuring, bacterial DNA, ribonucleic acid (RNA), and protein
synthesis (203), as well as, release of calcium are all required for invasion (205).
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Figure 10. Schematic diagram depicting routes of bacterial invasion to the deeper tissues of the
periodontium. The transcellular route consists of bacteria crossing the epithelial barrier by entering the cells
through the apical surface and exiting through the basolateral surface. The paracellular route consists of bacteria
crossing the epithelial barrier by going between individual epithelial cells through the tight and adherens
junctions. Modified from (18).

In addition, gingipains are involved in invasion (203), but the mechanism is unclear.
The gingipains could be exposing cryptitopes in epithelial cell receptors (6, 78) or
enhancing fimbrial binding (78). Invasion does not induce GEC apoptosis and P.
gingivalis remains viable (389, 390). P. gingivalis can also modulate GEC signaling. It
can target members of the MAP kinase pathway, extracellular signal-regulated kinase
(ERK) 1/2, and c-Jun N-terminal kinase (JNK) (205, 373), which may be required for
invasion (373).

Mutant P. gingivalis that does not have fimbriae are still able to invade,

but at a much lower level, suggesting that the existence of fimbriae-dependent and
fimbriae-independent pathways may partially explain the differences in invasion
pathways in host cell types (390).
It has been established that P. gingivalis adheres in discrete locations along the
endothelial cell membrane, possibly by gingipain adhesin binding to integrin pi (314),
and can invade and replicate inside of endothelial cells (78, 83). Similar to GEC,
fimbriae are required for invasion, but there are other adhesive molecules required for
maximum invasion and microfilament and microtubule rearrangements to occur (205). In
endothelial cells only live P. gingivalis caused an increase in TLR-2, -3, -4, -6, and -9
expression that was mediated by a heat-resistant outer membrane component (392).
However, in endothelial cells P. gingivalis traffics to the late autophagosome and
prevents its acquisition of cathepsin L and its development into an autolysosome (84). P.
gingivalis may use this invasion strategy because induction of autophagy increases the
pool of amino acids for metabolic purposes or to inhibit host protein synthesis, increasing
survivability (83).
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Bacterial invasion could pose a more subtle but equally damaging threat to the
host (205). Intracellular P. gingivalis could be a reservoir for infection or for
immunomodulating components (78). P. gingivalis-induced diseases may be from a
disruption in the balance of cell pathways that P. gingivalis modulates while residing
intracellularly (390). The ability of P. gingivalis to modulate host cell pathways could
have an impact on host cell gene expression that may interfere with the cell’s ability to
defend against increasing bacterial cell numbers and infection (205). Cell invasion of the
highly vascularized gingiva may be a means by which P. gingivalis gains access to the
bloodstream and establishes metastatic infections or affects endothelial cells of the heart
vasculature (205). P. gingivalis-mduczd changes in endothelial cells may show a variety
of atherogenic properties including increased procoagulant activity, secretion of
vasoactive and inflammatory mediators, and expression of adhesion molecules (78) [see
Chapter 1 section C.4].

H. Apoptosis
It is typically thought that cells can die in one of two ways: by necrosis or by
apoptosis, but this functional opposition is becoming less clear (186, 195) since both
apoptosis and necrosis can be caused by the same pathophysiological exposures, can be
prevented by anti-apoptotic mechanisms, and can be transformed from one form to the
other (329). Necrosis is the death of cells through external damage, usually mediated via
destruction of the plasma membrane or the biochemical supports of its integrity (382).
Necrosis is a rapid (382), passive, accidental (98) form of cell death that results from
acute cellular injury that is beyond repair (367) and results in inflammation (264) from
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the release of cytoplasmic components into the surrounding tissue spaces (382).
Apoptosis is an asynchronous (382), active, programmed (98) process of controlled
autodigestion of the cell (264). However, it is becoming apparent that the intensity of the
insult to the cell (212, 214) and the levels of certain intracellular molecules, such as
adenosine triphosphate (ATP) (186, 212, 402), determine if apoptosis or necrosis ensues
(212). Maintenance of a certain level of ATP is required for execution of apoptotic
programs; if the amount of ATP drops below some critical level, this can either switch
apoptotic cell death to necrotic or may trigger necrosis by itself (286). Furthermore, cell
death appears to be a continuum between apoptosis and necrosis with other modes of cell
death with overlapping characteristics in between. The characteristics of apoptosis and
necrosis are compared in table 3. Necrosis is characterized by cellular swelling, rupture
of the plasma membrane, disruption of cellular organelles, including the mitochondria,
and the chromatin is irregularly clumped (304).
Apoptosis comes from the Greek word that means the falling of leaves from a tree
or petals from a flower (98, 264), which denotes the natural removal of components
without damage to the organism as a whole (98). Apoptosis is a physiological form of
cell death that has a characteristic morphology and set of associated biochemical events,
that include cell shrinkage, chromatin condensation, chromosomal DNA cleavage,
cellular membrane blebbing, and extracellular phosphatidyl serine exposure (380), in
order to clear damaged or infected cells from the body without eliciting an immune
response because of the containment of cellular constituents by an intact membrane and
the subsequent engulfment of apoptotic bodies (402). Apoptosis is critical in sculpting
the embryo, maintaining tissue homeostasis, shaping the immune repertoire, and
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Table 3. Apoptosis versus necrosis. Modified from (195, 264).
Apoptosis

Primary necrosis

Physiological or pathological
(subnecrotic damage)

Accidental

Susceptibility tightly regulated

Unregulated or poorly regulated

Scattered distribution

Contiguous cells

Chromatin condensation (pyknosis)
Large crescentic chromatin

Small crescentic chromatin

Nuclear fragmentation (karyorrhexis)
Nucleosomal DNA fragments
(approximately 180 bp) creating DNA
ladder pattern

DNA smear

Decreased cell volume

Increased cell volume (oncosis)

Intact organelles

Swollen organelles

No mitochondrial swelling

Swollen mitochondria

Plasma membranes near-to-intact until
late (loss of membrane asymmetry
before loss of membrane integrity)

Plasma membrane destroyed early

Phagocytic fate (if not removed
necrosis secondary to apoptosis
ensues)

Cellular contents released

No leakage of cell content; little or no
inflammation

Extensive inflammation
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terminating immune responses and its disturbed regulation underlies many diseases,
including cancer, autoimmunity, and degenerative disorders (68). Therefore, its apparent
involvement in some infectious processes is rather curious and has received much
attention (98). Apoptosis can be divided into three stages: initiation, effector, and
degradation. In the initiation phase the apoptotic stimuli triggers activation of the central
molecular machinery of apoptosis. In the effector phase the apoptotic machinery is fully
activated causing changes in the nucleus. In the degradation phase the hallmark
characteristics of apoptosis are observed (304). There are two main pathways of
apoptosis (Fig. 11): the intrinsic pathway, in which death is triggered from the
mitochondria and the extrinsic, initiated by receptor-ligand binding on the cell surface,
with both pathways activating a cascade of caspases that converge on caspase-3.
The cysteine aspartyl proteases, termed caspases [reviewed in (64)], are the
initiators and effectors of the apoptotic program, however, they also have functions that
are vital to living cells [reviewed in (196)]. Caspases have the same basic structure: a
prodomain located at the amino-terminal portion, a large subunit of approximately 20 kD
located in the middle of the molecule, and a carboxy terminal small subunit of
approximately 10 kD (257). Enzyme activation occurs by proteolytic cleavage between
domains and association of the large and small subunits forming a heterodimer (257).
The caspases all contain an active site pentapeptide sequence of QACXG, where X is R,
Q, or G; an active site cysteine and a distant histidine are involved in catalysis; and an
absolute requirement for aspartic acid in the substrate PI position (404). The caspases
can be divided into groups based on their physiologic roles. One group is the caspases
that are centrally involved in apoptosis (caspases-2, -3, -6, -7, -8, -9, and -10) and the
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Figure 11. The intrinsic and extrinsic pathways of apoptosis. The intrinsic
pathway of apoptosis involves a trigger, such as DNA damage, that ultimately
activates caspase-9 via the mitochondria. Caspase-9 then activates caspase-3 which
then cleaves apoptotic substrates inducing the biochemical and morphological
characteristics of apoptosis. The extrinsic pathway involves a death ligand, such as
Fas ligand, that binds to a death receptor on the cell surface, causing the recruitment of
caspase-8 and its autoactivation. Caspase-8 then activates caspase-3, which cleaves
apoptotic substrates as in the intrinsic pathway. Taken from (146).
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other group is the caspases related to caspase-1 (caspase-1, -4, -5, -13, and -14), whose
primary role appears to be in cytokine processing during inflammatory responses (98).
The initiator caspases are caspases-2, -8, -9, and -10, while the effector caspases-3, -6,
and -7 execute the cleavages of cellular proteins to bring about the characteristic
biochemical and morphological features of apoptosis (98, 380), such as exposure of
phosphatidylserine on the cell surface, cell shrinkage, nuclear condensation, DNA
cleavage, and membrane blebbing (312). The initiator caspases have long prodomains
that mediate binding to adaptor molecules, via caspase recruitment domains (CARD) or
death effector domains (DED), causing oligomerization, self-cleavage, and enzyme
activation that activates downstream effector caspases (98). The effector caspases have
short prodomains that are unlikely to mediate protein-protein interactions (50) and that
are activated by internal cleavage to form heterotetramers of two large subunits and two
small subunits (98). The caspases can also be divided into groups based on their
substrate specificity. Caspase-1, -4, and -5 recognize the consensus amino acid sequence
WEHD; caspase-2, -3, and -7 preferentially cleave at the amino acid sequence DEXD,
where X is V, T, or H; and the last group is caspase-6, -8, -9, and -10 which recognize the
(L/V)EXD amino acid sequence with all groups cleaving at the aspartic acid (50). This
highly specific cleavage allows caspases to cleave only a limited number of proteins,
often in the interdomain regions of proteins, leading to protein activation or inactivation
(50) contributing to the demise of the cell through disassembly of structural components,
DNA cleavage, and inhibition of DNA repair (380). Caspase cleavage of cellular
substrates is specialized, as evidenced by the presence of uncleaved caspase sequences
(345).
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The intrinsic pathway (Fig. 11) signals apoptosis via the mitochondria with
activation of caspase-9. This pathway is the more ancient pathway; it is triggered by
diverse intracellular stresses, such as cytokine deprivation and genotoxic damage; and it
is regulated by the B-cell lymphoma 2 (Bcl-2) family of proteins (68), many of which are
localized in the outer mitochondrial membrane (195). DNA damage caused by
ultraviolet radiation, X-irradiation, growth factor withdrawal, and chemotherapeutic
drugs (312), increases the stability and, consequently, the level of p53, causing an
increase in the level of Bcl-2-associated protein x (Bax) (380). Bax undergoes a
conformational change allowing its integration and oligomerization in the outer leaflet of
the mitochondrial membrane and is believed to provoke or contribute to the
mitochondrial membrane permeabilization and release of proapoptotic proteins (68)
cytochrome c, apoptosis-inducing factor (AIF), and second mitochondria-derived
activator of caspases/direct inhibitor of apoptotic protein binding protein with low
isoionic point (Smac/DIABLO) (312). Activation of mitochondrial permeability
transition destroys the normal permeability of the mitochondria and disrupts normal
mitochondrial function by uncoupling oxidative phosphorylation (360). Therefore,
oxidation of metabolites by oxygen still occurs with electron flux, but this flux is no
longer coupled to proton pumping and consequently, the production of ATP is abolished
(360). Furthermore, electrons can escape from the electron transport chain and form
reactive oxygen species (ROS) (360). Cytochrome c normally is localized to the
intermembrane space of mitochondria, where it becomes covalently attached to heme
(291, 360) and where it participates in oxidative phosphorylation, but after apoptotic
stimulus there is an interval of time between the death stimulus and cytochrome c release
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into the cytosol that can vary from cell to cell, but it is released from all the mitochondria
in a cell within five minutes of apoptosis initiation (122) and always prior to
phosphatidylserine exposure and the loss of plasma membrane integrity (404). The
CARD in apoptosis protease-activating factor-1 (Apaf-1) and the prodomain of caspase-9
interact and in the presence of cytochrome c and ATP form a complex designated as the
apoptosome causing the autoactivation of caspase-9 which in turn activates downstream
caspases, such as caspase-3 and -7 (404). This pathway is inhibited by Bcl-2 and Bcl-2
like protein 1 long (Bc1-xl). These proteins are localized to the outer mitochondrial
membrane where they can suppress apoptosis by blocking the formation of the
apoptosome and the activation of caspase-9 either by blocking cytochrome c release
and/or binding Apaf-1 (404). AIF translocates in response to apoptotic stimuli (360), in a
Bcl-2-controlled fashion, from the mitochondria through the cytosol to the nucleus and
induces chromatin condensation (232, 336) and DNA fragmentation (402) by the rapid
activation of nuclear endonucleases (195). It can also stimulate the proteolytic activation
of caspase-3 (195). Smac/DIABLO promotes apoptosis by binding and inactivating
inhibitor of apoptosis proteins (IAP), which bind to procaspases and activated caspases
blocking their processing and their activity (404).
Apoptosis can also be triggered by stimuli from outside the cell in a pathway
designated the extrinsic pathway (Fig. 11), a more recently evolved pathway (68). The
most clearly defined of the extrinsic pathways is the CD95 ligand (CD95L) death
receptor pathway. CD95L is predominantly expressed on activated lymphocytes, natural
killer cells, erythroblasts, immune privileged tissues and on some tumors (404). It is
released in soluble form after cleavage from its membrane site by metalloproteinases
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before binding CD95 (312). CD95 is ubiquitously expressed in various tissues (50).
CD95L binding to its ligand CD95 on the cell surface causes trimerization of CD95 and
the recruitment of the adaptor molecule Fas-associated death domain (FADD) through
interaction of the death domain (DD) in CD95 and FADD (86, 347). Subsequently, the
DED in FADD interacts with DED in procaspase-8 recruiting it to this complex, termed
the death-inducing signaling complex (DISC) (312, 347), which allows the autocleavage
of caspase-8 to its activated state (86). Caspase-8 then activates caspase-3 and other
downstream caspases resulting in the cleavage of structural and regulatory intracellular
proteins and the dismantling of the cell (312). It also cleaves Bcl-2 homology domain
type 3 (BH3) interacting domain death agonist (Bid) to its truncated form (tBid) which
translocates to the mitochondria (404) releasing cytochrome c (312) and allowing cross
talk to occur between the extrinsic and intrinsic pathways (146). When FADD-like IL-1
converting enzyme inhibitory protein (FLIP), an enzymatically inactive homologue of
caspase-8 because of its lack of the active site cysteine (50, 404), binds through its DEDs
to FADD in place of procaspase-8 or binds procaspase-8 itself, the death signal is
aborted, inhibiting the extrinsic pathway, and leading to cell survival (312, 347).
Cell death can be assayed by numerous methods, but not all methods are able to
definitively identify only apoptotic cells. Since the onset of apoptosis is characterized by
shrinkage of the cell and the nucleus as well as condensation of nuclear chromatin into
sharply delineated masses that become marginated against the nuclear membranes (304),
these features can be visualized by either light, fluorescence, or electron microscopy and
differentiated from necrosis. Electron microscopy is considered the gold standard of
apoptotic determination (361) and the nuclear morphology is the most accurate indicator
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of apoptosis (382). Endogenous DNases cut the internucleosomal regions into doublestranded fragments of 180-200 base pairs, creating the biochemical hallmark of apoptosis
(304). When these fragments are subjected to electrophoresis they migrate into a
distinctive laddering pattern that differs dramatically from necrosis in which a multitude
of DNA fragments are formed that smear indistinctly during electrophoresis (264). The
basis of another method of apoptotic cell determination is based on the structure of the
cell membrane. The increased calcium levels that are triggered in early apoptosis inhibit
a translocase that generates and maintains the localization of phosphatidylserine in
membrane leaflets facing the cytosol and activate a scramblase that distributes
phosphatidylserine symmetrically over the inner and outer leaflets (361). The exposed
phosphatidylserine residues allow for the recognition and elimination of apoptotic cells
by their healthy neighbors, before the membrane breaks up and cytosol or organelles spill
into the intercellular space and elicit inflammatory reactions (195). Annexin V does not
cross the plasma membrane and binds phosphatidylserine avidly (361), allowing it to be
used as a detection method for early apoptotic cells. In combination with propidium
iodide, it can be used to distinguish apoptotic from necrotic cells. Mitochondria undergo
drastic changes accompanied by de-energization of the inner membrane, swelling, and
permeabilization (286). This leakiness of the mitochondrial outer membrane resulting in
the release of cytochrome c into the cytosol is different from the overall loss of
membrane potential of the entire mitochondrion that is measured by vital dyes (382).
Mitochondrial permeability transition represents an abrupt increase of permeability of the
mitochondrial inner membrane to solutes of molecular mass less than about 1500 Da and
causes membrane depolarization, uncoupling of oxidative phosphorylation, release of
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intramitochondrial ions and metabolic intermediates, and large amplitude mitochondrial
swelling (213). It releases proteins that are usually confined to the mitochondrial
compartment (195) that can induce cell death. It is involved in both apoptosis and
necrosis (151, 186, 213, 304). The release of cytochrome c occurs immediately from
necrotic cells and within 2 h of the cell death trigger from apoptotic cells (175).
Therefore, methods that only detect changes in mitochondrial membrane integrity or
potential or the release of cytochrome c are not specific for apoptosis. Apoptosis can also
be differentiated from necrosis by degradation of certain cellular proteins to specific sized
cleavage products. For example, during apoptosis caspases specifically cleave
poly(ADP-ribose) polymerase (PARP) and Topoisomerase I (Topo I) into 85 kD and 70
kD products, respectively. However, in necrosis PARP is cleaved into a 50 kD product
and Topo I into 70 kD and 45 kD products (47). Table 4 describes some common
methods used to detect dying cells and whether apoptotic cells can be distinguished from
necrotic cells. For accurate determination of apoptosis, a positive result from several
methods should be obtained (312).

H.l. Anoikis
A special type of apoptosis can be triggered by cellular detachment that causes
loss of integrin signaling [see Chapter 1 section K.l] or inappropriate cell-matrix contacts
(103, 394). The term anoikis (an-o-EE-kis) from the Greek meaning the state of being
without a home was coined by Frisch and Francis to describe this subset of apoptosis
(103). All of the features that characterize apoptosis, such as nuclear fragmentation and
membrane blebbing, are observed in anoikis (358). However, the changes in nuclear
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Table 4. Detection of apoptotic cells. Modified from (312).

Distinguishes
Apoptosis from
Necrosis

Method

Description

Microscopy

Hoffman modulation contrast to
visualize apoptotic blebs;
immunofluorescent
visualization of nuclear
morphology; electron
microscopic visualization of
chromatin

Yes

Dye exclusion

Exclusion of dyes (Trypan blue,
propidium iodide, etc.) by intact
cell membrane of apoptotic
cells

Yes

Gel electrophoresis to detect
DNA fragmentation in apoptotic
cells

DNA ladders (200 - 5000 bp
fragments): visualized after
staining gels with fluorescent or
chromogenic reagents

Yes

TUNEL methods

In situ-end labeling of free 3’
ends of DNA fragments by
using fluorescent or
chromogenic agents

No

AD P/ATP ratio

The change in ADP/ATP ratios
is used to differentiate
apoptosis from necrosis

Yes

Annexin V binding

In vitro detection of membrane
phosphatidylserine with
annexin V; measurement is
combined with dye exclusion
test to rule out necrosis

Yes

Changes in membrane
potential: release of
cytochrome c from
mitochondria and activation of
caspase-9

Assessed with voltage-sensitive
dyes, immunologic methods for
cytochrome c detection and/or
functional assays for caspase-9
activation

Yes

Cleavage of cellular caspase
substrates

Immunochemistry and/or
western blot detection of
proteolytic cleavage products

Yes

Caspase activity assay

Functional or immunologic
methods

Yes
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morphology are not always indicative of apoptosis induction, especially in detachment
induced apoptosis (241). Similar to the morphological changes, many of the signal
transduction pathways triggered by matrix detachment are very similar to those in
apoptosis, implying that integrins regulate critical components of the apoptotic machinery
(394). Since broad spectrum caspase inhibitors block anoikis (129), anoikis appears to be
caspase-dependent like ‘classical’ apoptosis. Anoikis has been described in numerous
cell types, including epithelial cells (103), endothelial cells (249, 289), keratinocytes,
thyroid cells, fibroblasts, and osteoblasts (394). Anoikis is important in the physiological
processes of controlling the cell number in the skin (281) and digestive tract (135),
morphogenesis of the mammary gland (35), and development of the mouse embryo (69).
It provides a mechanism for highly localized elimination of unneeded or improperly
targeted cells during development, irrespective of the hormonal environment (249).
Therefore, anoikis is considered to play an essential role in the development and
organization of normal tissues through its inhibitory effects on unfavorable cellular
proliferation at inappropriate locations (162) and is subsequently an important process for
neoplastic cells to overcome in order to metastasize. Furthermore, it may have a role in
cardiovascular disease (251) [see Chapter 1 section J.2.].
It is likely that there will not be a single pathway for triggering anoikis in a cell
since the characterization of focal adhesion proteins reveals that multiple pathways
connect adhesion to the suppression of apoptosis (358) and specific integrins have
differing abilities to rescue cells from anoikis (394). Furthermore, cell spreading and cell
geometry contribute to regulating cell viability, both of which are downstream of
integrins (332). In fact, endothelial cell spreading is essential to suppress apoptosis
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(241). The apoptotic cell death that is induced specifically through the disruption of cell
shape is called amorphosis from the Greek word amorphos for Tack of shape’ or
‘misshapen’ (241). The specific apoptotic pathway triggered in a cell most likely reflects
the dominant apoptosis pathway in that cell type (333), consequently, most likely there is
probably not a single pathway for induction of anoikis (129). Because of this, the
signaling pathways of anoikis have yet to be clearly defined, but there currently are
several key mediators, besides the integrins, that have been determined, such as some
Bcl-2 family members, numerous protein kinases and phosphatases, and members of the
death receptor complex.
As previously mentioned, Bcl-2 family members are involved in the regulation of
permeability of the outer mitochondrial membrane which can either maintain cell
survival or promote cell death. Cell adhesion regulates cell survival by altering the
signaling balance of pro-apoptotic and anti-apoptotic Bcl-2 members (241). Frisch and
Francis determined that Bcl-2 conferred resistance to anoikis (103). In addition, upregulation of Bcl-2 by endothelial adhesion (129) or overexpression of Bcl-2 or Bc1-Xl
prevented cell death by anoikis or amorphosis (241). It has also been observed that
mammary epithelial cells deficient in Bax alone are more resistant to anoikis (358).
Furthermore, detachment-induced Bax translocation and cytochrome c release which
were both caspase-dependent and could be blocked at an early stage by v-Ha-ras Harvey
rat sarcoma viral oncogene homolog (Ras) and protein kinase B/v-akt murine thymoma
viral oncogene homolog 1 (PKB/Akt) and blocked downstream of cytochrome c release
by v-raf-1 murine leukemia viral oncogene homolog (Raf) (300). In addition, Bax
translocation to the mitochondria occurred within 15 minutes of cellular detachment, in
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the absence of active caspases, with cytochrome c release occurring several hours later
and caspase-3 activation following several hours after cytochrome c release (368). Bax
translocates mostly as an inactive monomer and its clustering coincides with the
activation of all Bax molecules, mitochondrial membrane permeability, and apoptosis
commitment (357). The overexpression of Bcl-2 antagonist of cell death (Bad) sensitizes
cells to detachment (358). It is selectively activated by cellular detachment, through the
loss of Akt activity on Bad, allowing the buildup and translocation of unphosphorylated
Bad to the mitochondria to inactivate anti-apoptotic Bcl-2 proteins (162). Consequently,
overexpression of Akt can suppress anoikis (241). Interestingly, detachment-induced
upregulation of Bcl-2 interacting mediator of cell death (Bim) requires a lack of integrin
(31 engagement (292), among other things, and it has been demonstrated that individual
integrins can modulate Bcl-2 levels in several cell types (394). However, it has also been
reported that thyroid epithelial cells undergo apoptosis through a p5 3-dependent pathway
that does not involve regulation of p53 and Bcl-2 family members, but relies on the
phosphorylation of proteins other than p53 and Bcl-2 when integrin-mediated adhesion to
the ECM is denied (365). Moreover, endothelial detachment and loss of FAK signaling,
possibly through the action of phosphatase and tensin homolog (PTEN), a target of p53
transactivation (129), both induce p53-dependent apoptosis (241).
Numerous kinase and phosphatase signaling molecules have been implicated in
anoikis as major regulators [reviewed in (104)]. Three of the main pathways being
studied are the Jun N-terminal kinase (INK) pathway, the mitogen-activated protein
kinase (MAPK) pathway, and the PKB/Akt pathway. FAK acts as a bridge protein
linking growth factor receptor and integrin stimulated signaling pathways and is
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potentially able to modulate anoikis because it is connected to signaling pathways
involving the cytoskeleton and transcriptional activity in the nucleus (257). Integrinmatrix interactions lead to the autophosphorylation of FAK which is thought to act as an
integrin signal transducer and Frisch and colleagues identified FAK as being involved in
anoikis signaling (106). They also suggested that interference with FAK causes cell
rounding which may be sufficient to cause apoptosis (106). Furthermore, FAK and
pl30Cas, a signaling adaptor protein that interacts with many signaling proteins, are
cleaved early and rapidly in anoikis by caspases, calpain, and other proteases and the
pl30Cas cleavage product promotes apoptosis in detached cells (376). Treatment of
cardiomyocytes with cathepsin G, a serine protease, caused a progressive and rapid cell
detachment, cleavage of FAK and Akt, and activation of caspase-3 (302). While FAK
can associate with an array of integrins, integrin-linked kinase (ILK), a serine/threonine
protein kinase has a strong preference for the cytoplasmic domains of integrin-pl, -|32,
and -(33 and directly phosphorylates PKB/Akt (129). Both FAK and ILK if
overexpressed in detached cells will rescue cells from apoptosis and loss of their function
in attached cells induces apoptosis (129). JNK is rapidly and strongly induced by
suspension of confluent cells (105). Bcl-2 can inhibit anoikis through the inhibition of
the JNK pathway and caspase-7 activation (105). In exploration of the members of
caspase-dependent JNK pathway involved in anoikis, Frisch and colleagues identified
mitogen-activated protein kinase kinase kinase-1 (MEKK-1) as a caspase-7 substrate that
is cleaved to remove an inhibitory N-terminal domain promoting anoikis and further
caspase activation (44). Moreover, cleavage resistant MEKK-1 protected cells from
anoikis for at least 24 hours (44). p-catenin can rescue cells from anoikis in a pathway
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that involves MAPK (378). The proteolytic removal of the pleckstrin homology domain
of PKB/Akt by caspases contributes to detachment-induced apoptosis and may be part of
a post-commitment amplification step in anoikis (16). In addition, constitutive Akt2
activation is sufficient to protect cells from anoikis (108), in addition, Aktl protects
endothelial cells from anoikis (109). Cdc42 and Racl, Rho family guanosine
triphosphatases (GTPases), have been shown to regulate anoikis possibly by two
independent pathways; one mediated by Akt and the other mediated by actin
reorganization (57).
It is also possible that anoikis is triggered through a death receptor pathway (300).
It has been shown that the bulk of anoikis is endothelial cells is mediated by the Fas/FasL
interaction (10). This same study found that FasL is up-regulated while Flip is downregulated in detached cells prior to anoikis via the MAPK/ERK pathway (10). In
addition, an investigation into the cardioprotective effects of eicosapentaenoic acid also
found that decreased levels of Flip sensitized endothelial cells to anoikis (337). A recent
study demonstrated that detached cells expressed FasL and underwent a rapid anoikis,
despite ERK and Akt being fully activated (167), implying another signaling cascade is
used in their cell system. Another study investigated the involvement of FADD in
anoikis. Autoproteolytic cleavage of caspase-8 was an initiating event that involved
FADD, but not other death receptors, and overexpression of Bcl-2 and Bc1-Xl could
protect cells from anoikis (301). Detachment was required for caspase activation that
followed the death receptor/caspase-8 model and a cytochrome c/caspase-9 secondary
pathway in DU-145 cells treated with methylseleninic acid (176). It has also been
proposed that the p-cytoplasmic tails of unligated integrins recruit caspase-8 and possibly
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another protein (332) to the cell membrane and trigger cell death, termed ‘integrin
mediated death’, which is separate from anoikis (334). Moreover, integrin ligation with
substrate ECM triggers critical secondary events that generally inhibit the induction of
apoptosis (332). In support of the caspase-9 pathway being triggered in anoikis, a study
of cells aggregated on cellulose underwent apoptosis with caspase-9 followed by caspase3 activation and without caspase-8 activation (116). Collectively, the induction of
anoikis or amorphosis depends on the loss of survival signals produced by attachment or
spreading, combined with the specific induction of death regulators by detachment or
cytoskeletal disruption (241) or the withdrawal of survival stimuli (129).

H.2. Caspase-Independent Apoptosis
It has been shown in numerous reports that caspase inhibition does not always
prevent the death of a compromised cell (33, 230) and may even accelerate (267) or
enhance it (171, 211, 242, 265). Furthermore, caspase inhibition fails to block apoptotic
cell death in cells treated with AIF, Bax, and proteases, such as calpain, the proteasome,
and serine proteases (131) and against environmental stress, pathogenic insults, and
developmental cell death (43). This implies that despite effective caspase inhibition the
cell is still destined to die from factors other than caspases (33). It would be dangerous
for the cell to rely on a single protease family for the clearance of unwanted cells (172).
Therefore, simultaneous induction of both caspase-dependent and -independent pathways
seems to be common (171,211) with caspase activation being the preferred method, but
in its absence or failure there are other ways to cause cell death (231). Furthermore,
caspase-dependent and -independent pathways may operate together (232), therefore,
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methods that estimate apoptosis by measuring only caspase activation may underestimate
the total of apoptotic cells (166).
A variety of cell death programs may be triggered in distinct circumstances (131)
and apoptosis represents only one mode of programmed cell death (196) (Fig. 12).
Classically defined apoptotic morphology can be achieved either by activation of
caspases or through the mediation of other families of proteases and the exact cytological
features may vary slightly among these various forms of apoptosis (131). In general, the
mode of cell death and its morphological manifestations is dependent on the death
inducer and cell type (73), energy metabolism and level, signaling pathway, stimulus, and
environment (402). It becomes more and more apparent that intermediate forms of
apoptosis and necrosis occur and that a stereotyped outcome of either apoptosis or
necrosis cannot always be expected (402). It has been proposed to redefine apoptosis as
caspase-mediated cell death with the activation of caspases-2, -3, -6, -7, -8, -9, and -10
and the morphological features of cytoplasmic and nuclear condensation, chromatin
cleavage, formation of apoptotic bodies, maintenance of an intact plasma membrane, and
phosphatidylserine exposure (98). Furthermore, it has been proposed to classify the type
of cell death based upon nuclear morphology: (i) classic apoptosis characterized by
chromatin condensed to compact almost geometric figures, (ii) apoptosis-like with less
compact, lumpy chromatin masses, and (iii) necrosis-like that occurs either in the absence
of chromatin condensation or at best with chromatin clustering to form loose speckles
(172, 211). Apoptosis-like cell death can display any degree and combination of other
apoptotic features including phosphatidylserine exposure, the most sensitive apoptotic
marker to caspase inhibition (73), cytoplasmic shrinkage, zeiosis, formation of apoptotic
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Figure 12. Caspase-independent signaling pathways leading to mitochondrial
membrane permeabilization. Disruption of the cytoskeleton triggers the release of Bim
and Bmf which signal to Bax and Bak. Granzymes released from cytotoxic T lymphocytes
(CTLs) and natural killer (NK) cells can be taken up by the action of perforin on the target
cell allowing the entrance of granzyme B, which cleaves and activates Bid, consequently,
activating pore-forming proteins Bax and/or Bak. Tumor necrosis factor (TNF) and TNFrelated apoptosis-inducing ligand (TRAIL), as well as, various oxidants, detergents and
chemotherapeutic drugs, can induce the release of active cathepsins from lysosomes that can
also cleave Bid. TNF and TRAIL can induce an increase in ROS, which can cause direct
damage to mitochondria and/or lysosomes. DNA damage induced by radiation or
chemotherapeutic drugs induces a p53-mediated transcription of genes encoding Bax, Noxa
or p53 up-regulated modulator of apoptosis (PUMA), as well as, proteins involved in ROS
generation. Endoplasmic reticulum (ER) stress results in the release of Ca2+, which can
cause direct mitochondrial damage or activate Bax by calpain-mediated cleavage.
Depending on the stimulus, the cell type and the metabolic status of the cell, mitochondrial
membrane permeabilization leads to either caspase-mediated apoptosis or caspaseindependent programmed cell death (PCD). Taken from (171, 242, 94).
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bodies, and caspase activation (172, 211). The morphological appearance of cell death
and, therefore, its mode may not be linked to a single commitment step, but may be the
fulmination of several pathways that determine the shape of dying cells (267).
Furthermore, there is probably no single universal mechanism or pathway for caspaseindependent apoptotic signaling (352). The most likely purpose of caspase-independent
apoptosis is the same as for apoptosis, which is to safely remove dead cells without
triggering inflammation, in instances where the caspases are absent or nonfunctional.
Deficient caspase activity could occur from mutation, as is common in cancer cells,
especially lung cancer (242), energy depletion, nitrative stress, oxidative stress (45, 70),
other activated proteases or viral proteins that inhibit caspases (211). The most probable
reason for the inability of caspase inhibitors to rescue dying cells is that mitochondrial
outer membrane permeabilization (MOMP) could not be prevented and MOMP appears
to be the key determining event and the point of no return in cell death (196).
Consequently, when mitochondrial permeability transition occurs in a few mitochondria,
autophagy is activated, leading to lysosomal degradation of the affected organelles and
cessation of the signals that stimulate autophagy (131). When a larger number of
mitochondria are permeabilized apoptosis occurs, probably due to the larger number of
concentration of molecules such as cytochrome c and AIF in the cytoplasm (131).
Finally, when virtually all of the mitochondria in the cell are affected, mitochondrial
permeability transition promotes necrosis, attributed to the uncoupling of oxidative
phosphorylation and accelerated ATP hydrolysis by mitochondrial ATPase (131).
Similar to classic apoptosis, alternative death programs may be mediated by other
cysteine proteases or non-cysteine proteases that are switched on by death receptors or
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mitochondrial alterations (211). Interestingly, it has been demonstrated that several
different substrate specific proteases loaded into the cell cytoplasm can trigger apoptosis,
suggesting that activation of intracellular proteases during cell death by any molecular
pathway could give rise to apoptotic morphology and DNA fragmentation (381). Many
non-caspase proteases can activate caspases (231) and can cleave some of the same
substrates as caspases, suggesting they mimic the cellular effects of caspases (211) or
undermine primary cell structure (231). In addition, they can provide other apoptotic
signaling pathways and propagation of proteolytic cascades (352).
Granzyme A and B are serine proteases that are released by cytotoxic T
lymphocytes (CTL) and natural killer (NK) cells. These proteases enter target cells
through pores created by perforin, which is also released by CTL and NK cells (242).
They predominantly induce the activation of Bid which enables MOMP and cytochrome
c release (329). Moreover, granzyme B is more efficient at Bid cleavage than caspase-8
(352). Granzyme A is a typical mediator of caspase-independent apoptotic pathways
(329) and probably is a backup system if granzyme B is inhibited (352). It is a trypsin
like protease that cleaves its substrates at arginine and lysine residues (171, 242) and has
been shown to cleave a DNase that produces DNA single strand breaks (29).
Furthermore, Granzyme A cleaves lamins A, B, and C, disrupting the nuclear lamina
(395), degrades histone HI, and cleaves the tails of the core histones, allowing DNases
access to the chromatin (396). Granzyme B cleaves its substrates after aspartate residues
and can directly activate caspases, but in the presence of caspase inhibitors granzyme B
induces a slower necrosis-like cell death (171, 242). It has been shown by several reports
that Bcl-2 can completely block the granzyme pathway (352).
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Cathepsins are cysteine (cathepsins B, C, L, H, K, S, and O), aspartate (cathepsins
D, E, and F), and serine (cathepsin G) (242, 329) proteases that were thought to only
function in disposal of proteins in the lysosomal compartment and degradation of
secreted ECM (171). However, they have been found to play roles in bone remodeling,
hair follicle morphogenesis, antigen presentation, and in cell death (171). Similar to the
extent of mitochondrial damage determining the mode of cell death, partial lysosomal
permeabilization triggers apoptosis, while massive lysosomal damage and release of
proteases induces necrosis (130). Like the caspases, cathepsins are synthesized as
inactive zymogens, with activation involving proteolytic processing in a cascade-like
fashion like the caspases (178). Cathepsins translocate from the lysosomal lumen to the
cytosol in response to a wide variety of death stimuli and similar to caspase-8 can cleave
and activate Bid, mediate MOMP, and induce apoptosis-like morphology (172).
Therefore, lysosomal proteases appear to be able to initiate apoptosis (130). They have
been shown to be active outside of lysosomes [reviewed in (352)]. Cathepsins B, L, and
D are the most abundant proteases in lysosomes (130) and have been the most strongly
associated with cell death (242). For example, cathepsin B released into the cytosol by a
cell death trigger can damage the mitochondrial membrane releasing ROS that can further
signal caspase-independent cell death, preventable by serine protease inhibitor 2A
(Spi2A) (228). A recent report indicated that cathepsin B mediated caspase-independent
cell death induced by chemotherapeutic drugs and even suggested that cathepsin B may
stimulate its own release (40). Cathepsin B seems to play a key role in Bid cleavage
(130). In addition, the activation of cathepsin D is a part of caspase-independent
apoptosis triggered by oxidative stress (329), staurosporine, death receptor-activation,
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and growth factor deprivation [reviewed in (130)]. Taken together, the unifying method
of apoptosis induction for cathepsins appears to be cleavage of Bid at Arg65 or Arg71 for
cathepsin H (130) and subsequent cytochrome c release and caspase-9 activation (352).
Calpains are cysteine proteases that reside in the cytosol in inactive zymogen
forms and require an increase in the intracellular calcium level for activation (242). They
bind and require calcium for optimal activity (178). It is thought that they play an
important role in cytoskeletal reorganization and muscle protein degradation (329). They
can function upstream or downstream of the caspases and can even signal cell death in
the absence of active caspases (171). Calpains and caspases frequently synergize in
apoptosis, especially in neuronal cells (329). They are known to cleave Bax (242) and
can cleave fodrin, a cytoskeletal protein, upstream of caspases, which eventually disrupts
the cytoskeleton and allows the persistent membrane blebbing seen in caspaseindependent apoptosis (33, 374). Recently, it has been shown that calpains are involved
in caspase-independent cell death in light-induced retinal degeneration in vivo (82). In
addition, calpain activation in radiation-induced apoptosis has been demonstrated to
occur in the absence of caspase activity (374).
High temperature requirement protein A2 (HtrA2/Omi) is a ubiquitously
expressed mitochondrial intermembrane space serine protease that shares sequence and
structural homology to Escherichia coli HtrA/DegP, a protease at normal temperature
(360) and a chaperone protein that activates at elevated temperatures to clean up damaged
and misfolded proteins [reviewed in (303)]. HtrA2/Omi is released from mitochondria
into the cytosol and triggers cell death via its serine protease activity in the absence of
caspase activity (171, 232, 242, 303) or it can facilitate caspase activation by
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counteracting lAPs (171, 242, 303) and promoting caspase activation. HtrA2/Omi
involvement in cell death may be cell type specific, but it has been shown in neutrophils
that its serine protease activity is involved in TNF-a-induced caspase-independent cell
death and most likely not involved in classical apoptosis (32). In addition, HtrA2/Omi
may mediate cell death through its serine protease activity from within the mitochondria
by inactivation of antioxidant enzymes (32).
AIF is a phylogenetically ancient (303) flavoprotein, indicating it can stably bind
flavin-adenine dinucleotide (FAD) (43). It is believed to play a central role in the
regulation of caspase-independent cell death (71). It translocates to the nucleus after
being released from mitochondria where it induces caspase-independent formation of
large chromatin fragments (171). It may recruit an endonuclease (43, 71), increasing the
susceptibility of DNA to nucleases through its interaction with DNA, or AIF may have
some hidden nuclease activity (43). Interestingly, AIF could be essential for cell survival
or protection from cell death induced by oxidative stress via its nicotinamide-adenine
dinucleotide (NADH) oxidase activity acting as a free radical scavenger (232, 303). It
triggers death either directly, through interaction with DNA, or indirectly, through ROS
(232). In several reports inhibition of both caspases and AIF are required to prevent
apoptotic features such as chromatin condensation (43).
Endonuclease G (EndoG) is mainly associated with DNA repair or mitochondrial
DNA duplication (232).

It was originally discovered as a protein that induces caspase-

independent DNA fragmentation in purified nuclei [reviewed in (303)]. It has sequence
non-specific DNase activity on uncommon kinked DNA and RNase activity that is
needed for mitochondrial DNA replication (232). Apoptosis inducers signal EndoG to
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translocate from the mitochondria to the nucleus where it extensively degrades nuclear
DNA into oligonucleosomal fragments (232). It does not require functioning caspases
for its activation (232), but may require the cooperativity of exonucleases and DNase I to
produce DNA fragments (303).
Not only have proteases been implicated in caspase-independent cell death, but
also other molecules are involved in cell death in the absence of caspases. For instance,
doxycycline, a tetracycline analog, induces caspase-independent apoptosis that involves
the release of both EndoG and AIF (275). An analog of vitamin K induces caspaseindependent apoptosis in hepatocellular carcinoma cells (92). It appears that TNF-a is
able to induce two modes of cell death in polymorphonuclear neutrophils that is
determined by the availability of downstream caspases: classical apoptosis if the caspases
are present or a nonclassical caspase-independent death that lacks most of the
characteristic apoptotic features and involves mitochondrial ROS (240). Similar
engagement of two cell death modes has also been demonstrated in HT29
adenocarcinoma cells (383).

In addition, hydroquinone induces distinct mechanisms of

cell death, either caspase-dependent or -independent, in different leukemia cell types
(166). A recent report suggested that caspase-3 may mediate cell death dependent on the
death stimuli and the cell type, while hydrogen peroxide induces a caspase independent
cell death regardless of cell type (185). The promyelocytic leukemia protein PML caused
rat embryo fibroblasts to round up, display cytoplasmic shrinkage, and detach from the
culture surface within three hours in the absence of active caspase-3, as evidenced by the
absence of PARP or lamin B cleavage (288). Furthermore, PML-induced death is the
first identification of a death pathway mediated by an endogenous gene product that does
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not activate caspases and may represent a central unsuspected pathway with PML as a
pivotal checkpoint (288).

The C-terminal moiety of human immunodeficiency virus-1

(HIV-1) induces apoptosis via mitochondrial membrane permeabilization that does not
require caspases or AIF and can be inhibited by Bcl-2 and viral mitochondrial inhibitor of
apoptosis (vMIA), a viral apoptosis inhibitor that is specifically targeted to the
mitochondria (297). Recent reports demonstrate that radiation-induced cell death in
hippocampal neurons involves the expression of Bax by up-regulated p53 levels, not
caspase activation (179) and downregulation of survivin resulted in caspase-independent
cell death in neuroblastoma cells (316) revealing possible caspase-independent pathway
members.

I. Effects of P. gingivalis on Host Cell Survival
1.1. Purpose of Pathogen-Induced Effects on Host Cell Survival
Invasive bacteria directly inducing apoptosis in host cells was first demonstrated
by Zychlinsky and colleagues by Shigella felxneri causing macrophage cell death in vitro
and in vivo (255). Numerous microbes are known to affect host cell survival; some
trigger apoptosis while others provide increased cell survival in host cells [reviewed in
(111, 112, 123, 259, 377)]. As an example, Yersinia enterocolitica and Y. pestis and
pseudotuberculosis express two proteins Yersinia outer protein P (YopP) in Y.
enterocolitica and J (YopJ) in the latter species. YopP/J can inhibit survival pathways,
which may balance pro-apoptotic signaling pathways, resulting in cell death, and can
directly activate pro-apoptotic signaling molecules (123). Pathogens can modulate cell
death pathways through numerous mechanisms, such as, engagement of specific host
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receptors by bacterial ligands, activation of second messenger pathways by a bacterial
effector, direct interaction of pathogen effector molecules with the host cell death
pathways, the alteration of host membrane permeability by pore-forming toxins, and the
inhibition of host protein synthesis by bacterial toxins (377). Overall, there appears to be
two general mechanisms for Gram-negative pathogen-induced cell death. In the first,
effector proteins delivered by a Type III secretion system activate caspase-1 producing
both features of apoptosis and necrosis. In the second mechanism, activation of TLR-4
by LPS triggers apoptosis (132).
Apoptosis induced in any host cell type by bacteria acting external to the cell is
likely to be a pathogenic mechanism for promoting invasiveness (65). It would be
beneficial to the bacteria to induce apoptosis of the host cell in order to evade the immune
system by eliminating key defense cells like lymphocytes, monocytes, and neutrophils
(377), however, cell death may also be a protective mechanism signaled by the host cell
to induce inflammation through caspase-1 activation (111, 112), clear the pathogen, and
limit intracellular replication (65). For example, apoptosis of lung epithelial cells upon
infection with Pseudomonas aeruginosa constitutes a pivotal part of host defense against
P. aeruginosa infections. However, this apoptosis crucially contributes to the host
defense against the bacteria (123). It is also possible that apoptosis contributes to the
spread of intracellular bacteria, as appears to be the case for Salmonella-mdL\xcQdi
apoptosis of macrophages (112, 256) through successive rounds of intracellular growth,
apoptosis, and phagocytosis of infected apoptotic bodies, perpetuating the infection and
ensuring cell to cell spread (132). In addition, apoptosis may play a role in bacterial
trafficking into a niche permissive for intracellular replication (112), as in the case of
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Shigella flexneri, which kills macrophages by apoptosis and thereby gains access to Peyer
patches, permitting the bacteria to spread and to infect enterocytes from the basolateral
side (123). Collectively, these findings suggest that there is no universal function for
pathogen regulated cell death (259).
Host cells infected by some pathogens may actually have increased cell survival
that aids in pathogenesis. Inhibiting host cell apoptosis would provide a safe haven for an
intracellular pathogen (377) and help to maintain the metabolic activity of the infected
cell (112). For example, inhibiting host cell death facilitates the intracellular
development of Toxoplasma gondii, which increases parasitemia and may lead to an
enhanced inflammatory response to the parasite resulting in host mortality (234).
Experimental evidence suggests that T. gondii inhibits apoptosis of host cells by different
mechanisms, both direct inhibition of infected cells and indirect mechanisms, to protect
both infected and uninfected host cells (234). Direct mechanisms interfere with caspase
cascade activation, increase levels of anti-apoptotic Bcl-2 family members, increase
lAPs, and decrease levels of PARP that may inhibit apoptosis in a caspase-independent
fashion (234). Remarkably, a single viable parasite was sufficient to block apoptosis of
the host cell and this inhibition was reversed when the parasite was killed (234). Some
pathogens signal both cell death and cell survival. For example, Mycobacterium
tuberculosis induces apoptosis in macrophages via a TNF-a and caspase-1 dependent
pathway, but also protects cells from apoptosis via NF-kB and neutralization of TNFa pro-apoptotic activity (112). Chronic infection with Helicobacter pylori is associated
with gastric cancer suggesting that this bacterium would induce apoptosis resistance in
gastric cells. However, it induces apoptosis in the majority of gastric cells, but a small
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percentage of cells are resistant to H. pylori-md\xcQ& apoptosis, as well as, other apoptotic
stimuli (321). The bacterial-related factors responsible for this effect are unclear. In
addition, Chlamydia induces resistance to apoptosis during the initial stages of infection
and then later induces apoptosis in host cells (377), indicating that intracellular bacteria
can fine tune the balance between anti- and pro-apoptotic activities at discrete stages of
infection (112), facilitating the spread of infection.

1.2. P. gingivalis-lnAuctd Apoptosis
Because of the close proximity between oral pathogens and host cells in the
gingiva, the interplay of P. gingivalis and the various cell types present in the gingival
crevice has been under intense scrutiny. It is becoming increasingly clear that host cell
responses to pathogenic bacteria can involve either elevated apoptosis or suppression of
cell death (262). The body of evidence reveals that P. gingivalis induces apoptosis in
only some cell types. The components involved in P. gmgzva/zT-induced apoptosis are
still being defined. Investigations using whole P. gingivalis found that apoptosis is
induced in fibroblasts and that it is modulated by TNF-oc (124). Immortalized normal
human keratinocytes infected with P. gingivalis rapidly exhibit significant levels of
apoptosis (150).
In order to ascertain the active constituent in P. gingivalis that induces apoptosis,
many investigations have not used whole P. gingivalis, but instead have used different
fractions of the bacterium or its culture fluid. Heat-stable molecules secreted in the
culture medium of P. gingivalis induced apoptosis in peripheral blood mononuclear cells
(115). In addition, further studies in T-cells demonstrated the activation of caspase-3 by
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P. gingivalis culture fluid was not inhibited by protease inhibitors (140). Myocardial
cells treated with P. gingivalis culture supernatant became apoptotic and had increased
levels of Bad, calcineurin, a calmodulin-dependent serine/threonine phosphatase that is
mediator of cardiomyocyte hypertrophy and apoptosis, and the calcineurin downstream
effector nuclear factor of activated T cells-3 (NFAT-3), which suggests that calcineurin
dephosphorylates NFAT-3 and Bad, causing myocyte hypertrophy and triggering
apoptosis (209). In addition, in this same system it was demonstrated that P. gingivalis
culture supernatant induced DNA fragmentation and activation of caspases-3, -8, and -9.
These effects could be blocked by inhibitors of p38 and ERK, but enhanced by a JNK
inhibitor (210), suggesting P. gingivalis signals through p38 and ERK to initiate
apoptosis and that the JNK pathway may counteract this signaling.
One of the metabolites in P. gingivalis culture supernatant is butyric acid which
induced apoptosis in two different B lymphoma cell lines that was sensitive to
calmodulin inhibition (200) and induced a caspase-8 and -9 dependent apoptosis in Tcells that is independent of Fas (201). Another feature of the culture supernatant is that it
can contain P. gingivalis cell membrane. T-cells also die via apoptosis when treated with
P. gingivalis membrane (117). P. gingivalis EPS induced apoptosis in the thymus,
spleen, and lymph nodes in an in vivo mouse model (168). Culture supernatant can also
contain vesicles that contain both cell membrane and gingipains. In human epithelial
cells treated with microspheres coated with P. gingivalis vesicles, a portion of the cells
detached and displayed apoptotic morphology within 6 h, but detachment and cell death
was not demonstrated with longer treatment or with gingipain-deficient mutants (165).
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The relationship between gingipains and apoptosis has also been intensely studied
for more than a decade. The first reports investigated the cytotoxicity of gingipains on
different epithelial cell lines and found that culture supernatants with gingipain activity
caused the cells to round up and detach from the monolayer with some apoptotic
morphology in some of the cell lines tested (315). Cultured human gingival fibroblasts
also rounded up, detached, and lost cell viability when exposed to outer membrane
vesicles that possessed gingipain activity (258). Low levels of cytotoxicity were induced
in peripheral blood mononuclear cells by the gingipains (335). As the gingipains became
more clearly defined, cytotoxicity experiments also became more refined. Gingival
fibroblasts and epithelial cells treated with culture supernatants in the presence and
absence of leupeptin, which inhibits Rgp activity, revealed that both Rgp and Kgp
activity are responsible for cell detachment (177). More specific tests for apoptotic cells
established that culture supernatants with gingipain activity were responsible for human
gingival fibroblast detachment and apoptosis (370). Our group has also shown that
gingipain active extracts induce epithelial cell detachment and apoptosis (55). Using
extracts of wild type P. gingivalis, in the presence and absence of Rgp and/or Kgp
inhibitors, along with Rgp and/or Kgp mutants reported that both gingipains, especially
Rgp, was responsible for cell detachment and the loss of viability in human gingival
fibroblasts (14) and endothelial cells (15). The results of our work presented in chapters
2 and 3 extend these results by using purified gingipains to further elucidate the
individual roles of the gingipains in cell detachment, CAM cleavage, and apoptosis (318,
319).
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1.3. P. gingivalis-lnduced Resistance to Apoptosis
Despite the numerous reports of the ability of P. gingivalis whole cells, culture
supernatants, membranes, and gingipains to induce apoptosis, there is also data indicating
that P. gingivalis inhibits apoptosis in some cell types. Furthermore, there is evidence
that P. gingivalis infection may initiate divergent survival and death pathways (60). The
delay or interruption of apoptosis may enable the bacterium to shift from intracellular
multiplication to intercellular dissemination (388). P. gingivalis fimbriae inhibited
growth factor deprivation-induced apoptosis via ERK-dependent expression of p21 in a
human monocytic cell line (277). In addition, it has been demonstrated that P. gingivalis
EPS can prevent apoptosis of neutrophils derived from a human promyelocytic cell line,
which may prolong an acute inflammatory response which results in an increased
potential for tissue destruction (260). Experimental results suggested that the first
response to P. gingivalis infection in gingival epithelial cells was apoptosis; however,
over time P. gingivalis initiated anti-apoptotic signaling via increased levels of Bcl-2 and
decreased levels of Bax that canceled the cells’ death response and was even able to
promote cell survival in the presence of the apoptotic inducer camptothecin (262).
Furthermore, inhibition of the PI3-K/Akt pathway abolished the P. gingivalis-'m&xxcQd
protection from apoptosis (387). Interestingly, these studies demonstrated that apoptosis
was induced first since a reversible phosphatidylserine exposure triggered by P.
gingivalis invasion could be inhibited by z-VAD-FMK (387), suggesting that caspases
are activated but the anti-apoptotic signaling predominates. These investigators proposed
that P. gingivalis inhibited mitochondrial-dependent apoptosis in gingival epithelial cells
in order to maintain its intracellular lifestyle long enough to allow the successful spread
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of the bacteria to adjacent cells (388) and deeper host tissues (7, 387). In contrast,
another report found that heat killed P. gingivalis induced caspase-3 and -8 activation and
apoptosis in gingival epithelial cells through FasL-mediated apoptosis that was mediated
by nuclear factor kB (NF-kB) and TLR-2 (41). These investigators suggested that NFkB

activation was likely to be both anti-apoptotic and pro-apoptotic, depending on the

stimulus and the specific cell type involved (41). Evidence is emerging that P. gingivalis
can modulate several different monocytic cell survival mechanisms in order to evade host
defenses such as, signal transducer and activator of transcription 6 (STAT6), which
permits nitric oxide synthesis in macrophages; interferon-dependent positive-acting
transcription factor (STAT1), which is essential in caspase-independent cell death of
activated macrophages; double stranded RNA (dsRNA) -activated protein kinase
(PRKR), which may be important in the anti-apoptotic signaling by P. gingivalis;
calreticulin precursor (CALR), which binds complement Clq modulating the host
immune response, and gene associated with retinoid-interferon induced mortality
(GRIM 19) (401). GRIM 19 appears to be a nuclear protein that is expressed in response
to interferon and retinoic acid, induces cell death (9), and is involved in pathogen
recognition and invasion (21). Moreover, in epithelial cells P. gingivalis modulated 25
apoptosis-associated genes linked to p53 and the mitochondrial pathway of apoptosis
(137). Considering the many diverse signaling pathways engaged in apoptosis, it is not
surprising that some bacteria inhibit or delay apoptosis while others induce it (387).
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J. Involvement of Apoptosis in Disease Pathology
J.l. Periodontitis
Apoptosis can be viewed as a guardian of proper functioning and appropriate cells
and tissues. If it is unregulated or misappropriated, excessive apoptosis could promote
cellular and tissue damage leading to disease. It has been suggested that in periodontitis
pro-apoptotic signals, such as direct toxic effects of bacterial products from the near-by
plaque, at times, overwhelm the usual anti-apoptotic functional signals that maintain
periodontal vessels (403). Apoptotic cells are present in periodontal lesions (110, 191,
305, 349) along with an increased number of p53 positive cells (110, 349) and a decrease
in Bcl-2 positive cells (305, 349), both important apoptosis-regulating molecules. Cells
with DNA breaks were detected in junctional epithelium, infiltrated connective tissue,
secular epithelium, and orogingival epithelium (349). Moreover, periodontitis-associated
tissue, including cells of the orogingival epithelium, basal cell layer, and the underlying
connective tissue, was characterized by a strongly increased activation of caspase-3 and 7 and cleavage of PARP (20). Collectively, these results indicate that apoptosis has some
involvement in periodontitis the extent of which is beginning to be defined.

J.2. Cardiovascular Disease
Apoptotic morphology has been noted for many years in descriptions of
atherosclerosis and many studies have identified increased apoptosis of vascular cells in
atherosclerotic plaques compared with normal vessels (51, 58, 142, 287, 331).
Furthermore, loss of vascular cells via apoptosis has been detected in heart failure,
ischemic heart disease, and atherosclerosis (145, 238, 361). Apoptosis occurs in all cells
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of the atherosclerotic plaque, becoming increasingly frequent and important as the plaque
grows, the lipid core develops, the cap ruptures, and thrombosis occurs (331) which
suggests apoptosis may be an integral process in the changes occurring during early
coronary atherosclerosis (142, 296). Apoptotic cell death is now recognized as a
functional manifestation of tissue injury (296).
Endothelial cells form the inner lining of all blood vessels and function in
maintenance of vascular tone and anticoagulant properties of vessels (331), as well as,
mitogenesis, angiogenesis, vascular permeability, and fluid balance (90). Traditional
hypotheses of atherogenesis suggest that vascular endothelial cell injury and/or
endothelial dysfunction is an early (90, 296) and critical event for the development of
atherosclerosis and may be responsible for plaque rupture (331). Continual damage of
the vascular endothelium results in endothelial dysfunction characterized by reduced
nitric oxide (NO) bioavailability and by a progressive loss of endothelial cells (379).
Disappearance of endothelial cells could play a role in the initiation of atherosclerosis,
whereas smooth muscle cell apoptosis is claimed to play a predominant role in
atherothrombotic complications (251) by the loss of viable smooth muscle cells that
produce collagen stabilizing the fibrous cap (13). Therefore, apoptosis of endothelial
cells is a crucial step in atherosclerosis (309) and apoptosis of smooth muscle cells is
detrimental for plaque stability (189). If the endothelial monolayer has to be repaired, the
dysfunctional endothelial cells will be unable to provide sufficient atheroprotective
activity (331), such as decreased levels of NO (90), which is protective for normal arterial
wall (189). Furthermore, endothelial dysfunction provides a link between diseases, such
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as, hypertension, chronic renal failure, or diabetes and the high risk for cardiovascular
events that patients with these conditions exhibit (90).
Different pathways may be responsible for inducing apoptosis in different disease
states, at different stages of the disease, or in different cell types within the
atherosclerotic plaque (331). Increased endothelial apoptosis may be due to a variety of
systemic factors, such as, inflammatory mediators (218), increased levels of glucose,
oxidative stress, angiotensin II, and oxidized low-density lipoprotein [reviewed in (331)].
There may also be the involvement of local factors such as, the loss of cell-cell or cellmatrix adhesion, loss of growth factors via cell death of growth factor producing cells,
increased levels of NO that decrease Bcl-2 levels and increase the levels of Bax, and
death receptor signaling [reviewed in (331)], such as Fas, which has been identified in as
many as two-thirds of the cells in the fibrous cap in human atherosclerotic lesions (145).
However, there does not seem to be an association between serum levels of soluble Fas
and atherosclerosis (362). Other apoptosis-related molecules, such as Bcl-2, Bc1-Xl, and
Bax, have been documented in atherosclerotic lesions (145). In addition, monocyte
adhesion to endothelial fibronectin via the GDI 1/CD18 integrins initiates a perpetuating
and amplifying cascade of increasing lipid accumulation, changes in oxidative state of the
endothelial cell, and modulation of CAM expression which culminates in increased
endothelial cell apoptosis (331). Endothelial apoptosis regulates vascular smooth muscle
cell apoptosis since endothelial cell products promote vascular smooth muscle cell
survival (331).
Apoptosis appears to be involved in initiating atherosclerosis, but it is also
involved in lesion growth and its thrombogenic characteristics. In the central core of

96

atherosclerotic lesions, lipid loading and apoptosis of macrophages may interfere with
efficient removal of apoptotic remnants, leading to accumulation of cell debris in the
central core (145). Macrophages in atherosclerotic lesions have a decreased ability to
phagocytize apoptotic cells which may be due to cytoplasmic overload of indigestible
material, oxidative stress, and competitive inhibition of oxidized red blood cells, oxidized
LDL, and apoptotic cells for the same receptors on macrophages (311). In addition,
vascular cell apoptosis causes phosphatidylserine exposure on the membrane surface,
which enhances tissue factor activity, loss of anticoagulant components of the membrane,
can promote thrombin generation in vivo (145), and produces circulating microparticles,
which act as potent procoagulant substrates locally and systemically and account for the
large proportion of the pro-coagulant activity of the plaque (331).
Anoikis has also been implicated in pathological processes (251). Anoikis of
vascular cells can be induced by pericellular proteolysis of molecules involved in
integrin-matrix interactions, can shed membrane-bound proteins leading to their
solubilization, can release latent proteins bound to the ECM leading to their activation,
and can act on large adhesive glycoproteins leading to their fragmentation and to the
subsequent solubilization of these fragments (251). These proteases can be of bacterial
origin (251). Endothelial cell anoikis induces a significant rise in the levels of ROS
which decreases the bioavailability of NO and contributes to the oxidation of LDL, which
plays a critical role in atherosclerosis (216). It appears that the effects of ROS are
dependent on the amount of ROS generated, the site, and the overall antioxidant balance
(216). NO can be both anti-apoptotic and pro-apoptotic, but generally low concentrations
of NO are anti-apoptotic (296, 317) while high concentrations are pro-apoptotic (317).
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Recently, a new intriguing theory has been proposed that explains why
atherosclerosis occurs in the locations it does and why unsaturated fatty acids trigger
apoptosis in organs that depend on fatty acids for energy, like the heart which has the
highest need for fatty acids. Most of the fatty acids are transported by lipoproteins and
eventually have to pass the endothelium causing the coronary arteries to be exposed to
the highest fatty acid transfer rate (309). Protein phosphatase 2C (PP2C) is activated by
unsaturated fatty acids and triggers the pro-apoptotic function of Bad (309). Very low
(VLDL) and LDL fatty acids increase PP2C activation resulting in nearly complete
apoptosis of endothelial cells (159), while high density lipoprotein (HDL) induces the
activation of Akt, which phosphorylates Bad preventing apoptosis (269, 309).
Collectively, these results form an explanation for the location of atherosclerotic lesions
and the roles that ‘good lipids’, HDL, and ‘bad lipids’, VLDL and LDL, play in
atherosclerosis pathogenesis. Furthermore, this theory explains the increased levels of
atherosclerosis in diabetic patients, because of their organs’ increased reliance on fatty
acids as an energy source because of their intracellular glucose deficit (309).
Oxidized LDL induces apoptosis in cultured endothelial cells (145). In cells of
the atherosclerotic lesion, free cholesterol accumulates in the endoplasmic reticulum
membrane, which is normally cholesterol poor and highly fluid, and induces the
endoplasmic reticulum stress signal transduction pathway, known as the unfolded protein
response (UPR), that eventually leads to apoptosis via both Fas and mitochondrial
pathways (338). Not only can free cholesterol cause ER stress and trigger the UPR in
endothelial cells, but also hyperhomocysteinemia (HHcy) can induce the UPR,
contributing to endothelial cell apoptosis (363). Homocysteine induces detachment and
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apoptotic cell death in endothelial cells through UPR activation. It appears that
homocysteine induces T cell death associated gene 51 (TDAG51) which impairs cell
adhesion and contributes to the development of atherosclerosis in ApoE-deficient mice
on a high HHcy diet (13). TDAG51 colocalizes with FAK and induces cell shape
changes that are independent of caspase activation and prior to the initiation of the cell
death program (13) further supporting induction of anoikis by homocysteine.
Interestingly, it was recently reported that eicosapentaenoic acid, a
polyunsaturated fatty acid from fish oil which has been established to lower
cardiovascular events, restored the level of cFLIP and suppressed caspase-8 activation,
partially through Akt signaling, to protect endothelial cells from anoikis (337).
Remarkably, eicosapentaenoic acid significantly protected endothelial cells even when
the treatment was applied to detached cells (337). In addition, a recent evidence
demonstrated a decrease in apoptotic cells and increased plaque stabilization with a
change from a high-cholesterol to low-cholesterol diet (141), strengthening the
relationships between fatty acids, apoptosis, and atherosclerosis.

K. The Effects of Gingipains on Cell Adhesion Molecules
K.l. Cell Adhesion Molecules
There are four major families of CAMs: cadherins, integrins, immunoglobulin
gene superfamily members, and selectins. They are expressed on endothelial cells and
mediate cell-cell interaction, cell-matrix interactions, and cell signals for growth,
differentiation, and apoptosis [reviewed in (285)]. Cadherins are single pass
transmembrane proteins characterized by the presence of extracellular cadherin repeats
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and dimerization through the extracellular domain mediating homophilic adhesion in
trans (48). Cadherins, calcium dependent adhesion molecules, are concentrated at cell
cell junctions and coincide with cortical actin bundles in an association that is essential
for its cell binding action (341). Endothelial cells express two major cadherins neural
(N)-cadherin and vascular endothelial (VE)-cadherin (48). N-cadherin is distributed over
the whole endothelial cell membrane (77) and has recently been found to localize to
endothelial cell-cell junctions, as well (235). VE-cadherin is located at cell-cell contacts
(266) and is specific for endothelial cells of almost all types of vessels and is a target of
agents that increase vascular permeability (77). In fact, VE-cadherin is one of the first
markers expressed by endothelial progenitor cells when they become committed to the
endothelial lineage, however, N-cadherin is also plays an essential role in vessel
morphogenesis, possibly through regulating the levels of VE-cadherin (48, 235). It has
been suggested that VE-cadherin promotes homotypic interactions with endothelial cells
and N-cadherin may be responsible for the anchorage of endothelial cells to other cell
types (77) (Fig. 13). Interestingly, it has been reported that these two cadherins compete
for their clustering at intercellular junctions in the same cell (77). The extracellular
domain of VE-cadherin, which is particularly sensitive to proteolysis (24), contains five
homologous repeats and its intracellular domain is functionally separated into two parts:
the juxtamembrane domain, which is proximal to the membrane, and the catenin-binding
domain, which is located at the distal end (371). VE-cadherin acts as a seal at
intercellular junctions (77), associating through its cytoplasmic tail with (3-catenin, acatenin, y-catenin (plakoglobin), pl20, and the actin cytoskeleton (48, 77, 119) (Fig. 14).
It has been demonstrated that the complex members can regulate each other. VE-
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Pericytes, Smooth muscle cells, Glial cells

Figure 13. Endothelial N-cadherin and VE-cadherin localization and functions. N-cadherin is
mainly found at the contact sites between endothelial and mural cells where it supports heterotypic cell
cell adhesion. VE-cadherin is localized at the adherens junctions between adjacent endothelial cells,
where it mediates the indicated functions. Modified from (48).
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Fig. 14. Schematic representation of VE-cadherin intracellular protein complex.
VE-cadherin binds to |3-catenin, plakoglobin, and pi20 through its cytoplasmic tail.
Plakoglobin and (3-catenin link a-catenin which promotes the anchorage of the
complex to the actin cytoskeleton, possibly directly or through other adaptor proteins.
Wingless/integration site-1 (Wnt) growth factors through binding to frizzled receptors
activate disheveled, which in turn inhibits the glycogen synthase kinase-3(3 (GSK-3).
In the absence of Wnt activation, GSK-3 with the cooperation of adenomatous
polyposis coli (APC) and axin/conductin induces p-catenin phosphorylation (indicated
as P- in the figure). Phosphorylated p-catenin is rapidly ubiquinated and cleaved by
the proteasome. Inhibition of GSK-3, p-catenin is stabilized in the cytoplasm and can
translocate to the nucleus where it binds transcription factors of the high mobility
group (HMG) such as T cell factor (Tcf) and lymphoid enhancer factor (Lef). Also, Pcatenin can associate with presenilin and possibly play a role in modulating apoptosis.
Modified from (77).
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cadherin expression was regulated by the expression of pi 20 and its expression had a
major impact on the permeability of the endothelial barrier (169). In endothelial cells and
vascular smooth muscle cells abolishing N-cadherin decreased the levels of (3-catenin and
induced apoptosis, by modulating phosphorylation of Akt and Bad, even in the presence
of cell-matrix contact, indicating that cell-cell contacts affect survival signaling (192). In
addition, it was recently demonstrated that N-cadherin post-transcriptionally controlled
the expression of VE-cadherin in both mouse and human endothelial cells (235).
Moreover, decreased levels of N-cadherin caused decreased levels of VE-cadherin, pi 20,
and P-catenin and increased levels of integrin pi (235). Regulation of N-cadherin
transcript levels by cell adhesion were due to integrin p 1 -mediated adhesion through
increased nuclear Twistl, a transcription factor that is up-regulated in breast and prostate
cancers (3).
Modulation of cadherin expression affects cell adhesion and survival. VEcadherin -/- endothelial cells tend to detach from one another (48). Moreover, inhibition
of its function produced more damage to the endothelial monolayer in vivo compared to
in vitro (24). Proteolysis of VE-cadherin at cell-cell junctions damages the integrity of
the endothelial monolayer by producing gaps between cells since the remnant VEcadherin fragments at the cell surface probably cannot self-associate (147). These gaps
provide a passage for cellular migration to deeper tissues, as in neutrophil transmigration
(147), or bacterial access to deeper tissues through this paracellular route (Fig. 10). It has
been demonstrated that polymorphonuclear leukocytes can detach endothelial cells
through the proteolysis of VE-cadherin and loss of cell/matrix interactions (251).
Decreased levels of N-cadherin, and not VE-cadherin, caused significant growth arrest in
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endothelial cells (235). Disruption of N-cadherin contacts significantly increased
vascular smooth muscle cell apoptosis, whereas, over-expression of N-cadherin increased
both cell survival and cell-cell contacts (119). Blockage of N-cadherin has been shown
to induce anoikis, as well (129). In vascular smooth muscle cells, N-cadherin adhesion
activates Akt and inactivates pro-apoptotic Bad (119). A peptide containing the
homophilic cell adhesion recognition sequence His-Ala-Val, which targets N-cadherin,
and not VE-cadherin, has been shown to perturb the molecular organization of adherens
junctions and induce apoptosis that is dependent on cell density in endothelial cells that
can be rescued by basic fibroblast growth factor (bFGF), which suggests the involvement
of FGF receptor signaling (93). The cell density dependence of this apoptosis raises the
possibility that cell-matrix and cell-cell adhesions are differentially involved in the
generation of survival signals at low and high cell densities, respectively (93). It should
be noted that as a part of physiological processes some cell adhesion molecules are
cleaved. (3-catenin is cleaved during polymorphonuclear cell adhesion to endothelial
cells (254) and during apoptosis (99), by caspases-3, -6, and -8 (37, 148, 359). Ncadherin (99), y-catenin (99), FAK (99, 148), and pl30Cas can also be cleaved by caspases
during apoptosis (19), as well as, tensin, paxillin (99, 332), and talin, which associate
with integrins, and the cleavage products of these proteins can be pro-apoptotic
themselves (332). However, the role of (3-catenin in apoptosis appears to be cell-type
specific (119).
One way that VE-cadherin may signal is by retaining (3-catenin at the cell
membrane preventing it from translocating to the nucleus and acting as a transcription
factor (48, 119). Another possibility is that both VE-cadherin and N-cadherin can
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associate with growth factor receptors and modulate their intracellular signaling and
affect cell survival (48, 119). In addition, because of the cadherin complex binding the
actin cytoskeleton, apoptosis inhibition is achieved by the prevention of actin
reorganization, a requirement of apoptosis progression (119). It is also likely that
cadherin function changes in different cell types depending on the cadherin repertoire of
the cell (48).
Integrins have been identified as a family of cell surface receptors that recognize
extracellular matrices (341). Integrins and their ligands play key roles in development,
immune responses, leukocyte traffic, hemostasis, and cancer and are at the heart of many
human genetic, auto-immune, and other diseases (161). Integrins are heterodimeric
molecules consisting of non-covalently bound a and (3 subunits and divided into families
based on the commonality of the (3 subunit (Fig. 15). There are eight (3 subunits and 18 a
subunits which assemble into 24 known integrins with specific, non-redundant functions
(161). Integrin (31 is expressed at the cell membrane of basal cells of the gingival
epithelium, throughout the cells of the junctional epithelium, and in cells of the
connective tissue, including endothelial cells (157). Seven integrins are currently known
to be expressed on endothelial cells (ai(3i, aiPi, asPi, asPi, a6pi, avP3, and avPs) (299).
Furthermore, integrin pi is consistently expressed in endothelial cells of all vessel types,
irrespective of size and tissue site (248) on both the basal (substratum-attached) and
apical (free) side of cultured endothelial cells (67). pi integrins appear to mediate cell
adhesion to ECM proteins, such as collagen, laminin, and fibronectin (285). The
prototypical members of the immunoglobulin superfamily, V-CAM and I-CAM can serve
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Figure 15. The integrin receptor family. Integrins are ap heterodimers with
associations as depicted. Eight (3 subunits can assort with 18a subunits to form 24
distinct integrins. These can be considered in several subfamilies based on
evolutionary relationships (coloring of a subunits), ligand specificity, and restricted
expression on white blood cells (161). It should be noted the prevalence of integrins
that contain the (31 subunit.
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as ligands for integrins (285). Focal adhesions are mainly composed of integrins and
transmit forces and biochemical signals between cells and the ECM (384). In addition,
blocking integrin function could disrupt the junctional connection leading to permeation
of macromolecules across endothelial monolayers (384).
Integrins play a major role in cell survival signaling. Integrins are intimately tied
to one of the most basic elements of the cell, the actin cytoskeleton, and thus impact life
and death pathways through many different mechanisms (332). It is now very well
established that integrin-mediated signals are necessary in normal cells to block
apoptosis, via PI3K and Akt, and to stimulate cell cycle progression, via ERK and cyclin
D1 (161). As with the cadherins, many integrin-stimulated pathways are closely coupled
with growth factors and integrins frequently activate or inhibit each other (161).
Modulation of integrin (31 expression disrupted focal adhesions and the actin
cytoskeleton which occurred prior to detachment, implicating focal adhesion perturbation
as a cause of detachment, not a consequence of detachment (274). Further studies
confirmed that the integrin (31 subunit caused cellular detachment while evidence of
apoptosis, such as activation of caspase-8 and -3 and suppression of survival pathways,
occurred between 6 to 24 h after detachment (144). Ligation of integrin (31 protects
fibroblasts from apoptosis through increased levels of phosphorylated Akt (346).
Moreover, integrin (31 is able to activate an anti-anoikis pathway signaling through She,
FAK, Ras, PI3K, and Akt that increases the levels of Bcl-2 (243). All (31 integrins are
able to stimulate FAK (372) through its phosphorylation, which is a key element of
integrin signaling (223).
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A relatively new theory suggests that integrins may be a subtype of dependence
receptors. In general, dependence receptors mediate positive signaling in the presence of
a ligand and negative signaling, leading to cell death, in the absence of an appropriate
signal (332). The most extreme case of ligand-deprivation occurs after complete loss of
cell contact with the substrate resulting in apoptosis/anoikis (332). Integrin ligation
initiates several parallel, but interconnected, signaling cascades with anoikis occurring in
a manner dependent on the dominant apoptotic cascade in a particular cell type (332).
Thus, integrins can be viewed to function as a rheostat, sensing both the composition and
relative rigidity of the local ECM and transmitting appropriate signals to the cell,
affecting the cell’s ability to suppress or escalate pro-apoptotic signaling events (332).
Cadherins and integrins can modulate each other, as well. N-cadherin can
promote endothelial cell proliferation possibly by modulating the levels of integrin (31
(48). Integrin ligation can trigger disassembly of VE-cadherin-containing adherens
junctions, predominantly through the perturbation of the y-catenin (plakoglobin) linkage
of VE-cadherin to the actin-based cytoskeleton and is Src-dependent (371).
Cadherins have also been implicated in atherosclerosis. VE-cadherin is expressed
in atherosclerotic lesions and the levels of soluble VE-cadherin correlate with the extent
of coronary atherosclerosis independently of other risk factors, indicating the shedding of
VE-cadherin occurs in atherosclerotic plaques (119). N-cadherin-mediated cell-cell
contacts down-regulate vascular smooth muscle proliferation, which is key aspect of
atherosclerosis, via (3-catenin intracellular signaling (119). Collectively, these results
emphasize the importance of cadherins and integrins in cell survival and the potential
injury that can be caused by agents that affect their organization and/or signaling.
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K.2. Gingipain-Induced Degradation of CAMs
Proteolytic cleavage plays an important role in regulating signaling proteins and
signal transduction (376). Because of the degradation of proteins of cell-cell junctional
complexes, P. gingivalis may be able to invade and spread in deeper structures via a
paracellular pathway (182). In various pathological contexts, molecules capable of
inducing integrin disengagement and proteases able to degrade adhesive glycoproteins
could play a predominant role (251). Therefore, the gingipain-induced degradation of
CAMs could be implicated in disease pathogenesis.
Gingipains have been shown to cleave cell adhesion molecules in different cell
types. In Madin-Darby canine kidney (MDCK) cells, an epithelial model system for
bacterial pathogen interaction, P. gingivalis bacteria of a threshold concentration were
found to disrupt the epithelial barrier by protease cleavage of E-cadherin, occludin, and
integrin (31 (182). Interestingly, this study found that the basolateral side of MDCK cells
was more sensitive to P. gingivalis and cells easily detached from the culture surface
(182). Kgp was the most effective of the gingipains in hydrolyzing E-cadherin in the
adherens junctions of MDCK epithelial cells (183).
Immortalized human oral keratinocyte cell lines display an interesting interaction
when treated with P. gingivalis that would most likely aid its evasion of the host immune
system in the gingival pocket. P. gingivalis induces an initial up-regulation of ICAM-1
messenger RNA (mRNA), but there is also a down-regulation of ICAM-1 at the protein
level, most likely because of protease degradation (158). A later study established the
protease involvement of ICAM-1 degradation in different oral epithelial cell lines.
HRgpA and RgpB were found to be more effective than Kgp at cleaving ICAM-1 (339).
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This study also demonstrated that integrin (31, integrin ot2, and integrin a5 were not
cleaved by HRgpA (339). Up-regulation of CAMs has also been found in other cell
types. Increased protein expression of ICAM-1, as well as, E-cadherin was also
demonstrated in endothelial cells (366) and increased expression of ICAM-1, vascular
cell adhesion molecule-1 (VCAM-1), and very late antigen-4 (VLA-4), also known as
integrin a4pl, was exhibited in gingival epithelial cells (369). In addition, ICAM-1,
VCAM-1, E- and P-selectin protein expression were all shown to be up-regulated when
human umbilical vein endothelial cells (HUVEC) were co-cultured with P. gingivalis
(184), suggesting that these proteins are not degraded by gingipains. In other
immortalized human oral keratinocytes, gingipains were found to cleave cell-cell contacts
(P-catenin, y-catenin, and pi20), focal contacts (paxillin and oc3 integrin), p4 integrin in
hemidesmosomes, signaling molecules (FAK, Src, and pl30Cas), and the epidermal
growth factor (EOF) receptor (150). However, E-cadherin, PI3-K, or extracellular signalregulated kinases 1 and 2 (ERK-1 and -2) were not cleaved (150). Our group has also
shown that gingipains cleave N-cadherin and integrin pi, but not vasodilator-stimulated
phosphoprotein (VASP), a substrate for cyclic adenosine monophosphate (cAMP)- and
cyclic guanosine monophosphate (cGMP)-dependent kinases, and paxillin in KB
epithelial cells (55).
HRgpA was 12 times more effective than RgpA in cleaving integrin a5pl on
human gingival fibroblasts, while otvP3 was unaffected (314). This study also
established that the adhesion domain of HRgpA facilitates the protease’s binding with
integrin pi (314). However, in human gingival fibroblasts Rgp was implicated in the
cleavage of integrin subunits a2, pi, and P3, but not integrin subunits a5 and av (14).
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In HUVEC, RgpA and Kgp degrade CD99, a CAM that has been implicated in
multifactorial cellular events, within 15 minutes of exposure, producing prominent
contraction and progressive intercellular gap formation in the endothelial monolayer
(393). These investigators also demonstrated that endothelial leukocyte adhesion
molecule-1 (ELAM-1 also known as E-selectin), VCAM-1, and ICAM-1 were not
degraded by the gingipains tested (393). They surmised that these effects may contribute
to the successful colonization of P. gingivalis by limiting the host inflammatory response
(393).
The work presented here in subsequent chapters establishes that gingipains induce
cell detachment, cleavage of N-cadherin, VE-cadherin, and degradation of integrin (31,
and apoptosis in endothelial cells [See Chapter 2 and (318)]. In addition, the following
results show that different combinations of the gingipains work together to detach cells,
cleave N-cadherin, VE-cadherin, and degrade integrin (31 and induce cell death by both
caspase-dependent and -independent pathways. [See Chapter 3 and (319)]. Taken
together, these results indicate that gingipains do modulate expression of CAMs and are
able to cleave them. However, it would appear that these effects and even which
gingipains are the most effective may be cell type dependent. Despite this cell type
dependency, these results implicate a role for gingipains in the pathogenesis of
periodontitis and cardiovascular disease.

L. Hypothesis
Since the condition of the oral cavity is a mirror to the overall health status, as
suggested by the Surgeon General’s Oral Health Report (355), elucidating the role that
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gingipain-induced tissue destruction has in periodontitis and systemic illnesses, such as
atherosclerosis, would also be invaluable in overall health improvement. Before such
systemic mechanisms can be understood, the mechanism(s) of localized destruction in the
periodontium, a highly vascularized tissue, must be determined. Our general hypothesis
is that the gingipains cleave specific host cell adhesion molecules causing loss of
tissue integrity and tissue damage. We discovered that bovine coronary artery
endothelial cells (BCAEC) treated with gingipain-active samples rapidly lost cell
adhesion and died via apoptosis in the presence and absence of a general caspase
inhibitor. The kinetics of cell detachment paralleled the cleavage of N-cadherin and VEcadherin, whereas degradation of integrin (31 was rapid and preceded cell detachment.
Our preliminary data suggest that the different gingipains have varying and synergistic
roles in CAM cleavage, cell detachment, and apoptosis. The gingipain(s) involved in
periodontal tissue destruction could be used as targets for therapeutic agents to eradicate
periodontitis. Discerning the mechanism(s) of gingipain-induced apoptosis would also
allow for other specific treatment modalities in the management of periodontitis.
Furthermore, understanding the role(s) that the individual gingipains have in periodontal
tissue damage would establish a model for cellular destruction in other tissues, such as
the cardiovascular system. Since oral health reflects the general health, as suggested by
the Surgeon General, the results from the proposed experiments would also provide a
means to improve the overall health of a large percentage of the American public. In
order to ascertain the mechanism(s) involved in tissue destruction by the different
gingipains the following specific aims were proposed:
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L.l. Specific Aim 1
Identify the gingipain(s) responsible for cell detachment, the cleavage of
adhesion molecules, and apoptosis in endothelial cells. We established in the work
presented here in Chapters 2 and 3 (318, 319) that samples containing a mixture of
gingipains induced BCAEC detachment, cleaved N-cadherin, VE-cadherin, and degraded
integrin |31. Gingipain-active samples also induced apoptosis. Experiments designed to
isolate the individual roles of the gingipains in CAM cleavage, cell detachment, and
apoptosis were performed. Since we have shown that Kgp can be inhibited by peptide
caspase inhibitors, we performed experiments in the presence and absence of caspaseinhibitors to investigate the role of Kgp in cell adhesion disruption and apoptosis.
Likewise, we treated BCAEC with leupeptin, which inhibits Rgp, to define the roles of
HRgpA and RgpB. Experiments in endothelial cells with purified HRgpA, RgpB, and
Kgp were also performed to confirm the results from the inhibitor studies.
Despite the relatedness and similarities of the gingipains, our results demonstrate
that the gingipains have differing roles in endothelial cell adhesion molecule cleavage,
cell detachment, and apoptosis. Kgp and HRgpA quickly detached BCAEC and all the
gingipains were able to cleave CAMs to varying degrees, with Kgp being primarily
responsible for the rapid degradation of integrin |31. Only HRgpA and Rgp induced
apoptosis and this apoptosis can be caspase-independent.

L.2. Specific Aim 2
Define the mechanism of gingipain-induced endothelial cell apoptosis. It is
possible for the gingipains to induce apoptosis in two ways. First, the gingipains cleave
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cell adhesion molecules causing endothelial cell detachment and initiating anoikis. The
other possibility is direct activation of the apoptotic program. Interestingly, it has been
shown that RgpB has topological similarity to caspases-1 and -3 (88) and we
demonstrated that Kgp can be inhibited by peptide caspase inhibitors. These results raise
the possibility that RgpB and possibly other gingipains may have caspase-like activity
and induce apoptosis through cleavage of proteins involved in cell death. The results
presented here suggest that both anoikis and direct initiation of apoptosis may be
activated by gingipains. In the presence of active caspases, gingipains cleave CAMs
producing cell detachment resulting in a detachment-induced cell death. Because
gingipains can induce apoptosis when caspases are inactivated, it is possible that during
gingipain-induced anoikis the gingipains are also concurrently initiating a caspaseindependent apoptosis.
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molecule cleavage and apoptosis in endothelial cells

SHAUN M. SHEETS1, JAN POTEMPA2, JAMES TRAVIS2, CARLOS A.
CASIANO3, AND HANSEL M. FLETCHER3

1. Graduate student who oversaw and completed all experiments and wrote the
manuscript.
2. Collaborator that provided purified gingipains as reagents for an experiment.
3. Student’s mentors and co-chairmen of the research committee that provided
research guidance and critically reviewed the manuscript.

Infection and Immunity. 2005. 73(3): 1543-1552.

115

Gingipains from Porphyromonas gingivalis W83 induce cell adhesion
molecule cleavage and apoptosis in endothelial cells

SHAUN M. SHEETS1*, JAN POTEMPA2-*, JAMES TRAVIS3, CARLOS A.
CASIANO1’4, AND HANSEL M. FLETCHER1

Department of Biochemistry and Microbiology, School of Medicine, Loma Linda
University, Loma Linda, California1, the Department of Microbiology, Faculty of
Biotechnology, Jagiellonian University, Krakow, Poland2, the Department of
Biochemistry, University of Georgia, Athens, Georgia3, and the Center for
Molecular Biology and Gene Therapy, Loma Linda University, Loma Linda,
California4

Running Title: Gingipain-induced endothelial cell apoptosis

Corresponding author*: Shaun M. Sheets
Department of Biochemistry and Microbiology,
Mailing address:
School of Medicine, Loma Linda University,
Loma Linda, CA 92350
(909)558-4472
Phone:
(909)558-4035
Fax:
ssheets04b@som.llu.edu
Email:

116

A. Abstract
The presence of Porphyromonas gingivalis in the periodontal pocket and the high
levels of gingipain activity detected in gingival crevicular fluid could implicate a role for
gingipains in the destruction of the highly vascular periodontal tissue. To explore the
effects of these proteases on endothelial cells, we exposed bovine coronary artery
endothelial cells (BCAEC) and human microvascular endothelial cells (HMVEC) to
gingipain-active extracellular protein preparations and/or purified gingipains from P.
gingivalis. Treated cells exhibited a rapid loss of cell adhesion properties that was
followed by apoptotic cell death. Cleavage of N- and VE-cadherin and integrin (31 was
observed in immunoblots of cell lysates. There was a direct correlation between the
kinetics of cleavage of N- and VE-cadherin and loss of cell adhesion properties. Loss of
cell adhesion, as well as N- and VE-cadherin and integrin (31 cleavage, could be inhibited
or significantly delayed by preincubation of P. gingivalis W83 gingipain-active
extracellular extracts with the cysteine protease inhibitor TLCK. Furthermore, purified
gingipains also induced endothelial cell detachment and apoptosis. Apoptosis-associated
events, including Annexin-V positivity, caspase-3 activation, and cleavage of the caspase
substrates poly(ADP-ribose) polymerase (PARP) and Topoisomerase I (Topo I) were
observed in endothelial cells after detachment. All of the effects observed were correlated
with the different levels of cysteine-dependent proteolytic activity of the extracts tested.
Taken together, these results indicate that gingipains from P. gingivalis can alter cell
adhesion molecules and induce endothelial cell death, which could have implications for
the pathogenicity of this organism.
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B. Introduction
Porphyromonas gingivalis is an asaccharolytic, black-pigmented, Gram-negative
anaerobe that is strongly associated with chronic periodontitis (13), a chronic
inflammatory condition affecting tooth supporting tissues that ultimately results in tooth
loss, and may be involved in systemic illnesses, such as atherosclerosis [reviewed in
references (28, 44)]. P. gingivalis is well known for its cysteine proteases, designated
gingipains, of two different specificities that are both extracellular and membrane bound.
The rgpA gene encodes the arginine-specific proteases HRgpA, RgpA(cat), and mt-RgpA,
while rgpB encodes RgpB and mt-RgpB. The lysine-specific protease Kgp is encoded by
the kgp gene (55). Not only are the gingipains important in nutrition for P. gingivalis, but
also they have numerous other effects on host systems, including dysregulation of
clotting and fibrinolytic pathways, activation of kallikrein/kinin pathway, and modulation
of host cytokine networks [reviewed in reference (41)]. It also has been established that
gingipains can activate matrix metalloproteinases (MMPs) [(18, 16, 31, 41) and reviewed
in references (55, 41)]. MMPs can cleave numerous cell surface proteins such as
cytokine precursors, growth factors, cytokine receptors, and cell adhesion molecules,
including cadherins, causing their shedding from the cell surface in a regular manner (3,
7, 19, 25, 26, 33, 48). However, the involvement of gingipains in periodontal tissue
destruction is not clearly understood.
Studies of gingival crevicular fluid (GCF) have shown that it is a mixture of
numerous proteases of both host and bacterial origin [reviewed in reference (55)]. The
host-derived activity of both neutrophil elastase and MMPs, especially collagenase, has
been shown to correlate with periodontal tissue destruction in vivo. Gingipain activity
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can be measured during disease progression in GCF and its quantification can be used to
predict attachment loss (20). It has been demonstrated that gingipains can cleave
laminin, fibronectin, and collagen in vitro', however, this by itself does not seem to be
sufficient to cause the destruction of the periodontal connective tissue. Because
gingipains can activate host MMPs, the gingipains may be indirectly mediating the
observed tissue destruction (55). Alternatively, the gingipains may harm cells of the
periodontal pocket, thereby, directly causing tissue damage.
Apoptosis, or programmed cell death, is a physiological form of cell death that
has a characteristic morphology and set of associated biochemical events. Apoptotic
cells are present in periodontal lesions (24, 67, 40, 59) along with an increased number of
p53 positive cells (24, 67) and a decrease in Bcl-2 positive cells (59, 67), both important
apoptosis-regulating molecules. It is well documented that proteases from P. gingivalis
can induce cell death in different cell types in vitro, including fibroblasts, epithelial cells,
and endothelial cells (5, 69, 51, 62, 37, 30). In addition, we have previously shown that
gingipain-active extracts can induce apoptosis in KB epithelial cells (12). In this same
study, we determined that prior to cell death the cell adhesion molecules (CAMs) Neural
(N)-cadherin and integrin p 1 were cleaved and that KB cells lost adhesion to the culture
surface. This is consistent with several reports demonstrating the ability of gingipains to
cleave numerous CAMs in various cell types (4, 34, 39, 65). Since gingipains induce
CAM cleavage and cell detachment, a special type of apoptosis may be induced by
gingipains, called anoikis. It is triggered by cellular detachment and loss of integrin
signaling and has not yet been fully characterized (22). Anoikis has been implicated in
pathological processes, such as cardiovascular disease (50).

119

Our previous report demonstrated that gingipain-active extracts from P. gingivalis
W83 induced cell detachment and apoptosis in KB epithelial cells (12). Furthermore,
extracts from strain FLL32, a recA defective mutant with significantly reduced gingipain
activity (1), and a W83 extract pretreated with TLCK, a cysteine protease inhibitor shown
to inhibit both Rgp and Kgp activity (21, 54), exhibited no significant cell rounding and
detachment (12). Because of the degradation of proteins of epithelial cell-cell junctional
complexes, P. gingivalis may be able to invade and spread in deeper structures via a
paracellular pathway (38). The periodontal pocket is a highly vascularized tissue in close
proximity to the bacterial biofilm (15) that is separated from endothelial cells by one to
two epithelial cells and a negligible layer of extracellular matrix (71). It has been
suggested that in periodontitis, pro-apoptotic signals, such as direct toxic effects of
bacterial products from the nearby plaque, at times, overwhelm the usual anti-apoptotic
functional signals that maintain periodontal vessels (71). Because of the close proximity
of epithelial cells and endothelial cells in the periodontal pocket, the damage of
endothelial cells in periodontitis lesions (71), and the apoptosis that occurs in
periodontitis (24, 67, 40, 59), we investigated if the gingipains would also induce loss of
adhesion properties in two different types of endothelial cells, BCAEC and HMVEC. In
patients with aggressive periodontal disease, total gingipain activity present in GCF
ranged from 47.5 to 407.3 pU/pl (20). We demonstrate here that gingipain-active
extracts with a similar enzyme activity as GCF of aggressive periodontal lesions, induce
apoptosis in both BCAEC and HMVEC. Prior to apoptosis, endothelial cells detached
from the culture surface and N-cadherin, Vascular Endothelial (VE)-cadherin, and
integrin (31 were cleaved, suggesting that gingipains may induce cell death via anoikis.
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C. Materials and Methods
C.l. P. gingivalis strains and culture conditions
P. gingivalis strains W83 and FLL32, a recyt-defective mutant with reduced
proteolytic activity that is non-virulent in a mouse model (1), were grown in brain heart
infusion (BHI) broth (Difco Laboratories, Detroit, MI) supplemented with 0.5% yeast
extract (Difco Laboratories, Detroit, MI), hemin (5 pg/ml), vitamin K (0.5 pg/ml), and
cysteine (0.1%) (all from Sigma-Aldrich, St. Louis, MO). All cultures were incubated at
37°C in an anaerobic chamber (Coy Manufacturing, Ann Arbor, MI) in 10% LL, 10%
C02, and 80% N2.

C.2. Gingipain extract preparation and protease assay
P. gingivalis W83 and FLL32 were grown as previously described (12). Bacterial
cultures were centrifuged (12,000 x g, 45 min, 4°C) to remove cells, and then filtered
through a 0.45 pm filter (Millipore, Bellerica, MA). The extracellular culture fluid was
acetone precipitated at -20°C in a 60:40 ratio of acetone (Fisher Scientific, Tustin, CA) to
cell-free media, with constant stirring. This precipitate was centrifuged (12,000 x g, 30
min, 4°C) and the pellet was resuspended in 150 mM NaCl (VWR Scientific, Brisbane,
CA), 20 mM Bis-Tris (Sigma-Aldrich, St. Louis, MO), 5 mM CaCl2 (VWR Scientific,
Brisbane, CA). The resuspended pellets were dialyzed at 4°C in Spectrapor 12-14,000
MWCO dialysis tubing versus 4 L of the same buffer with Aldrithiol-4 (Sigma-Aldrich,
St. Louis, MO), to stabilize the gingipains, overnight with 3 more changes of dialysis
buffer without Aldrithiol-4. After dialysis, the sample was centrifuged (34,000 x g7 1 h,
4°C) and the resulting supernatant was concentrated in a pressurized stirring concentrator

121

(Millipore, Bellerica, MA) with a 10,000 MWCO membrane at 4°C. This concentrated
gingipain-active extract was clarified by centrifugation (192,000 x g, 1 h, 4°C) and stored
in aliquots at -80°C.
To determine gingipain activity, 5 pi (for Rgp) and 15 pi (for Kgp) of
concentrated extract were preincubated in a final volume of 150 pi Activated Assay
Buffer pH 7.6, containing 0.2 M Tris-HCl, 0.1 M NaCl, and 9 mM L-cysteine. The
reaction was initiated by the addition of 50 pi of 4 mM N-alpha-benzoyl-DL-arginine-pnitroanilide (BAPNA) (Sigma, St. Louis, MO), for Rgp activity, or Ac-Lys-p-nitroanilide
(ALNA) (Bachem, King of Prussia, PA), for Kgp activity, was added to the
150pl reaction and the rate of enzymatic substrate hydrolysis was read in a microplate
reader (Bio-Rad, Hercules, CA) at 405 nm using its kinetic measurement software
program. One unit of gingipain activity is defined as the amount of enzyme releasing 1
pmol p-nitroanilide per minute as calculated based on maximum velocity and the
extinction coefficient of p-nitroanilide of 9200 at 405 nm. In each sample used in this
paper, gingipain activity was calculated based on the average of three measurements of
the maximum velocity of the enzymatic reaction of specific substrate turnover and
converted to units of gingipain activity.

C.3. Purification of gingipains from P. gingivalis strain HG66
HRgpA, Kgp, and RgpB were purified from the strain HG66 culture fluid as
described previously (54, 56). Briefly, Kgp and HRgpA were purified using gel filtration
and arginine-sepharose chromatography, while RgpB was purified using a combination
of gel filtration and anion-exchange chromatography on Mono Q (56). In this way,
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approximately 5 mg of each gingipain from 1 L of bacterial culture was obtained in
homogenous form as determined by SDS-PAGE.

C.4. Eukaryotic cell culture and gingipain treatments
BCAEC and HMVEC were cultured according to the manufacturer’s
specifications and using their reagents (Cambrex, Walkersville, MD). Briefly, BCAEC
(or HMVEC) were thawed and seeded at a density of 2500 cells/cm2 (5000 cells/cm2 for
HMVEC) in Falcon T-75 flasks in 15 ml EGM-MV media (EGM-2 MV for HMVEC).
The media was changed on the cells every other day and doubled in volume when the
cells were approximately 50% confluent. Cells, from passages 6 through 9, were tested
for viability prior to seeding in appropriate tissue culture dishes and allowed to reach near
confluency before gingipain treatment. Culture media was removed from culture dishes
and replaced with fresh media containing 5 mM L-cysteine, to activate the gingipains.
Gingipain-active extracellular extracts or purified gingipains were added to the
endothelial cells and allowed to incubate for the indicated times at 37°C in 5% CO2.
Cells were also treated with 200 pg/ml of P. gingivalis FLL32 extract (equivalent to 0.73
Units of Rgp activity/ml media and 0.49 Units of Kgp activity/ml media) as a negative
control for gingipain activity and to exclude any other bacterial factors. To inhibit
gingipain activity, purified gingipains or 200 pg/ml of W83 extracts were pretreated for
at least 30 min on ice with 10 mM TLCK (Sigma, St. Louis, MO) and then added to the
cells. Untreated cells did not have P. gingivalis extracts added to the cysteine-containing
media.
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C.5. Caspase-3 (DEVDase) activity assay
BCAEC were seeded in 250 \x\ media in black, clear-bottom 96-well tissue culture
plates and treated as described above with gingipain extracts in 100 pi media. Four pM
staurosporine (Str) was used as a positive control. Treatment was allowed to continue for
the indicated times and caspase-3 activity was determined by cleavage of the fluorescent
substrate Ac-DEVD-AMC (Alexis Biochemicals, San Diego, CA) according to Carrasco
and colleagues (8). One-step caspase-3/7 assay buffer (50 pi) containing DTT, AcDEVD-AMC, and PMSF was added to the wells and then incubated at 37°C, 5% CO2 for
1 h. The plate was then read at excitation and emission wavelengths of 380 and 460 nm,
respectively, in a BIO-TEK Instruments FLx800 Microplate Fluorescence Reader
(Winooski, Vermont). To calculate fold increase in DEVDase activity the average
relative fluorescence intensity of three treated wells was divided by the average relative
fluorescence intensity of 3 untreated wells. Standard error of the mean was calculated
from 7 independent trials and significance was determined using the two tailed, nonpaired Student’s t test.

C.6. Quantification of apoptosis in BCAEC by flow cytometry
Endothelial cells were seeded in duplicate into 60 mm dishes and treated with P.
gingivalis W83 extract as described above. After the indicated incubations, the cells
were removed by pipette from both dishes, placed in a 15 ml tube, and centrifuged for 5
min at 2500 rpm in a clinical centrifuge. The supernatant was removed and the cell pellet
was resuspended in 2 to 4 ml of 1 x Binding Buffer (Annexin V-FITC Apoptosis
Detection Kit I, BD Biosciences Pharmingen™, San Diego, CA). 100 pi of cells was
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incubated for 15 min at room temperature in the dark with 5 pi of Annexin V-FITC
and/or 5 pi propidium iodide (PI) (both from the Apoptosis Detection Kit). For each time
point A total of 10,000 unlabeled cells, PI only stained cells, Annexin-V only stained
cells, and Annexin-V and PI stained cells were counted on a BD FACScalibur flow
cytometer (BD Biosciences, San Jose, CA) using the CellQuest software. The percentage
of Annexin-V positive cells was calculated from the quadrants as follows: Percent
Annexin-V positive cells = (Upper Right + Lower Right in Annexin-V & PI stained cells)
- (Upper Left + Upper Right + Lower Right from unstained cells) - (Upper Right +
Lower Right from PI only stained cells) - (Upper Left from Annexin-V only stained
cells). Standard error of the mean was calculated from 4 independent trials.

C.7. Preparation of BCAEC lysates for SDS-PAGE
Attached BCAEC were washed once with Dulbecco’s PBS (DPBS) and directly
lysed in the plate with cell lysis buffer (100 mM Tris-HCl pH 6.8, 4% SDS, 10%
glycerol) containing complete protease inhibitor cocktail (Roche Applied Science,
Indianapolis, IN). Floating cells were collected by centrifugation and washed with DPBS
plus complete protease inhibitor cocktail and combined with the lysed, attached cells.
Lysates were heated to 95°C for 5 min and stored at -80°C until required. Prior to
determination of the protein concentration (Bio-Rad DC Protein Assay, Bio-Rad,
Hercules, CA), lysates were sonicated to shear DNA.
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C.8. SDS-PAGE and Western blot analysis
Total protein in NuPAGE™ sample buffer and reducing agent were heated at
72°C for 10 min and separated on NuPAGE™ 4-12% Bis-Tris gels at 200 V for 60 min
according to supplier’s instructions (Invitrogen, Carlsbad, CA). Gels were transferred to
Optitran® nitrocellulose (Schleicher & Schuell, Keene, NH) in NuPAGE™ XCell blot
module at 30 V for 1 to 2 h according to manufacturer’s instructions. Nitrocellulose
membranes were incubated with blocking buffer (20 mM Tris-HCl pH 7.4, 150 mM
NaCl, 0.05% Tween-20, and 2% non-fat powdered milk) for 30 min with shaking.
Membranes were probed with an appropriate dilution of primary antibody in blocking
buffer for 1.5 h in a humidity chamber without shaking and washed for 5 min in blocking
buffer with shaking. Membranes were incubated for 30 min with appropriate HRP
conjugated secondary antibodies diluted in blocking buffer in a humidity chamber
without shaking. Membranes were washed with shaking in lx PBS (Sigma-Aldrich, St.
Louis, MO) with 0.1% Tween-20 five times for five minutes each. A 1:1 dilution of
Western Lightning™ Chemiluminescence Plus (Perkin Elmer Life Sciences, Boston,
MA) reagents was added to the membrane and incubated for 3 min with shaking. Excess
substrate was blotted from the membrane prior to exposing the membrane to film.
The primary antibodies used in these experiments were N-cadherin clone 32 and
integrin pi clone 18 (BD Biosciences, San Diego, CA), VE-cadherin clone C-19 (Santa
Cruz Biotechnology, Santa Cruz, CA), PART clone C2-10 (R & D Systems, Minneapolis,
MN), and a highly specific human autoantibody to Topoisomerase I (generous gift from
Eng M. Tan, The Scripps Research Institute, La Jolla, CA).
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C.9. Immunoprecipitation and cleavage of cadherins
BCAEC were seeded as described above in 60 mm dishes and allowed to grow to
confluency. Dishes were placed on ice and were washed once in cold 1 x DPBS after
removing the media. 1 ml of cold Native RIPA buffer [50 mM Tris pH 7.4, 150 mM
NaCl, 1% IGEPAL CA-360 (equivalent to Triton X-100), and 0.25% sodium
deoxycholate] was added to the dishes and allowed to incubate for 10 to 20 min on ice.
Lysed cells were collected by scraping, placed in microfuge tubes, and centrifuged at 4°C
for 10 min. The supernatants of ten 60 mm dishes were combined and placed into 15 ml
screw-cap tubes. 400 pi of a 50% slurry of Protein G-Agarose beads (Roche Applied
Science, Indianapolis, IN) was added to 10 ml of lysed BCAEC and allowed to rotate at
4°C for 2.5 h. The beads were collected by centrifugation in a clinical centrifuge for 1
min and the supernatants were transferred to new tubes. To the precleared supernatants,
25 pg of N-cadherin antibody or VE-cadherin antibody was added and allowed to rotate
at 4°C for 2 h. 400 pi of a 50% slurry of Protein G-Agarose beads was added and
allowed to rotate at 4°C overnight. After centrifugation, the supernatants were removed
and the beads were washed with Native RIPA buffer and placed in a microfuge tube. The
beads were centrifuged at 6000 x g for 1 min and then washed two times for 20 min with
rotation at 4°C in Native RIPA buffer. The beads were then washed two times in
Activated Assay Buffer (see above). The beads were finally resuspended in 400 pi
Activated Assay Buffer.
For in vitro cleavage of immunoprecipitated N-cadherin and VE-cadherin, 25 pi
of the resuspended bead mix was mixed with 0.125 pg of W83 extract (equivalent to 0.19
Units of Rgp activity and 0.01 Units of Kgp activity) with and without TLCK
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pretreatment, and 0.125 pg FLL32 extract (0.0037 Units of Rgp activity and 0.0025 Units
of Kgp activity) and incubated at 37°C for the indicated times. Control samples were
incubated for the duration of the time course (20 min). After incubation, 10 mM TLCK
and sample buffer were added to the reaction tube to a final volume of 50 pi and the tube
was immediately placed at -20°C. Half of the sample volume was separated by SDSPAGE and immunoblotted versus N-cadherin and VE-cadherin as described above. For
the VE-cadherin immunoblot, a secondary antibody designed to react only with the native
rabbit antibody (True Blot, eBioscience, San Diego, CA) was used.

D. Results
D.l. Endothelial cells lose adhesion properties after treatment with gingipain-active
extracts
Endothelial cells rounded and detached from the culture surface and from each
other in the presence of active gingipains and did not detach with TLCK-inactivated
gingipains or extracts from P. gingivalis FLL32 (Fig. 16). A time course of gingipain
treatment of BC AEC shows the beginning of detachment at 2 h, nearly complete
detachment at 6 h, and apoptosis occurring by 24 h with no evidence of necrotic cells
during these treatments (Fig. 16). In contrast, BCAEC treated with extracts from FLL32
and W83 pretreated with TLCK to inhibit gingipain activity, displayed minimal
detachment and cell death by 24 h. HMVEC responded similarly to treatment with
gingipain-active extracts, but seemed to be more sensitive than BCAEC as evidenced by
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activity/ml media) and FLL32 (0.73 Units of Rgp activity/ml media and 0.49 Units of Kgp activity/ml media) in
the presence of 5 mM L-cysteine for the indicated times. Arrows indicate cells with apoptotic morphology.
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Figure 17. Loss of adhesion and apoptosis in HMVEC treated with P. gingivalis
extracts. HMVEC were treated with 200 pg/ml extracellular proteins from strains
W83 (113 Units of Rgp activity/ml media and 12.4 Units of Kgp activity/ml media)
and FLL32 (0.73 Units of Rgp activity/ml media and 0.49 Units of Kgp activity/ml
media) in the presence of 5 mM L-cysteine for the indicated times. Extracellular
extracts from W83 were pre-incubated on ice with 10 mM TLCK to inhibit both Rgp
and Kgp activity before cell treatment. Arrows indicate cells with apoptotic
morphology.
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the higher levels of cells with apoptotic morphology present by 6 h (Fig. 17). TLCK was
not able to completely prevent the detachment and apoptosis induced by the gingipainactive extract treatment in HMVEC. It is possible that TLCK may be more toxic to
HMVEC or that these cells were more stressed during the culturing process. Since both
cell lines displayed similar morphological responses to gingipain-active extract treatment
and BCAEC were healthier throughout culturing procedures, we chose BCAEC for
subsequent experiments. Taken together, these results suggest that the gingipains are
responsible for inducing the morphological changes exhibited by both BCAEC and
HMVEC.

D.2. Gingipain-active extracts induce caspase-3 activation and Annexin-V positivity
in BCAEC
When cells are no longer attached to the extracellular matrix and integrinmediated survival signals are lost, the cell can be committed to die via anoikis (22, 68).
We have shown that apoptotic cell death in KB cells is induced by the proteolytic activity
present in the P. gingivalis extracellular extracts and that their detachment precedes cell
death (12). To verify that the gingipains induce apoptosis in endothelial cells, we
measured the increase of DEVDase (caspase-3) activity fluorometrically (Fig. 18A) in
BCAEC treated with P. gingivalis gingipain-active extracts. Measuring the activity of
caspase-3 is normally used to assess the induction of apoptosis, irrespective of the
apoptotic pathway activated. As a positive control BCAEC were treated with 4 pM
staurosporine (Str), a classic inducer of apoptosis. As expected with Str, caspase-3 was
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Figure 18. Treatment of BCAEC with gingipain-active extracts induces activation of DEVDase activity and
Annexin-V positivity. (A) BCAEC were treated with 4 pM Str or 200 pg/ml extracts from W83 (113 Units of Rgp
activity/ml media and 12.4 Units of activity/ml media, 76.2 Units of Rgp activity/ml media and 5.2 Units of activity/ml
media, or 230 Units of Rgp activity/ml media and 19.4 Units of Kgp activity/ml media) and FLL32 (0.73 Units of Rgp
activity/ml media and 0.49 Units of Kgp activity/ml media) for the indicated times and then assayed for cleavage of the
fluorescent caspase-3 substrate Ac-DEVD-AMC. Error bars indicate standard error of the mean with * p<0.0005 and **
p<0.0004. (B) BCAEC were treated with 200 pg/ml W83 (230 Units of Rgp activity/ml media and 19.4 Units of Kgp
activity/ml media). Beginning at 6 h when endothelial cells detached, cells were collected and stained with Annexin-V
and/or PI. Stained cells were then counted by a BD FACSCalibur flow cytometer using the CellQuest software. Error bars
indicate standard error of the mean.
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activated quickly with maximal levels occurring between 12 and 15 h. In W83 extract
treatments there was a significant increase in DEVDase activity compared to FLL32
extract treatments (p<0.005 for 6 h and 9 h and p<0.0004 for 12 h, 15 h, and 18 h of W83
extract treatment). There was no significant difference between early time points of
TLCK pretreatment of W83 extract and FLL32 extract treatment (6 h and 9 h p>0.12,
data not shown). Moreover, TLCK-inhibition of gingipain activity significantly inhibited
caspase-3 activation at 6 h compared to W83 treatment at 6h (p<0.04, data not shown).
These results confirmed that gingipains induce an apoptotic morphology and caspase-3
activation characteristic of apoptosis in BCAEC. The levels of apoptosis after
detachment induced by W83 gingipain-active extracts were quantified by flow cytometry.
There was an increase in the percentage of Annexin-V positive cells from approximately
20% at 6 h to nearly 50% at 24 h (Fig. 18B). There was no evidence that gingipain
extract treatment induced primary necrosis (Pl-positive-only cells) in BCAEC during the
24 h time course (data not shown). Collectively, our results indicate that gingipain-active
extracts induce endothelial cell detachment and apoptosis.

D.3. Gingipain-active extracts induce cleavage of PARP and Topo I
Endothelial cell lysates were monitored by western blotting for cleavage of PARP
and Topo I. The cleavage products of these proteins that occur during cell death can be
used to distinguish between apoptosis and necrosis. During apoptosis, caspases
specifically cleave PARP and Topo I into 85 kD and 70 kD products, respectively.
However, in necrosis PARP is cleaved into a 50 kD product and Topo I into 70 kD and
45 kD products (9). In cell lysates from BCAEC treated with extract from W83 for 24 h,
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PARP was cleaved into its signature 85 kD apoptotic fragment with no 50 kD necrotic
fragment and Topo I was cleaved into its apoptotic 70 kD product (Fig. 19). These
cleavages were significantly inhibited by reducing the levels of gingipain activity.
However, cells treated with extracts of FLL32 and extracts of W83 pretreated with
TLCK, which have minimal gingipain activity and do not induce high levels of apoptosis,
still showed some cleavage of PARP and Topo I. These results suggest that the residual
amount of gingipain activity may be enough to induce low levels of apoptosis and limited
caspase substrate cleavage.

D.4. Gingipain-active extracts induce cleavage of N-cadherin, VE-cadherin, and
integrin pi
Cells treated with gingipain-active extracts detach quickly from the culture
surface, suggesting the cleavage of CAMs. This would be consistent with other studies
showing that gingipains can cleave different CAMs in several cell types (5, 69, 51, 62,
37, 30). Therefore, we expected gingipain-induced CAM cleavage in endothelial cells,
which was confirmed by western blot analysis of BCAEC lysates with different antiCAM antibodies (Fig. 20). N-cadherin was cleaved into several fragments ranging from
62 to 65 kD and into a single 30 kD product (Fig. 20A). Cleavage of N-cadherin did not
occur in the presence of inactivated gingipains or with FLL32 extract treatment. Only
extracts from W83 caused the disappearance of full length N-cadherin in HMVEC (data
not shown), further establishing that theses two endothelial cell types react similarly to
treatment with gingipain-active extracts. In addition, VE-cadherin in BCAEC is also
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Figure 19. Treatment of BCAEC with gingipain-active extracts induces cleavage of caspase substrates.
20 pg of protein from BCAEC treated, in the presence of 5 mM L-cysteine, with W83 extract (70 Units Rgp
activity/ml media and 5.3 units Kgp activity/ml media) were separated by SDS-PAGE and immunoblotted
with a monoclonal antibody to PARE (R & D Systems, Minneapolis, MN) and a highly specific human
autoantibody to Topoisomerase I (9). Arrows indicate cleavage products. Un, untreated.

Figure 20. Cleavage of N-cadherin, VE-cadherin, and integrin pi by gingipain-active extracts from strain W83. 10 pg of
protein from BCAEC treated, in the presence of 5 mM L-cysteine, for the indicated times with W83 extracts (70 Units Rgp
activity/ml media and 5.3 units Kgp activity/ml media), TLCK-treated W83 and FLL32 extracts (0.73 Units of Rgp activity/ml
media and 0.49 Units of Kgp activity/ml media) were separated by SDS-PAGE and immunoblotted with a monoclonal antibody to
(A) N-cadherin or (B) a polyclonal antibody to VE-cadherin. (C) BCAEC treated with 200 pg/ml W83 extract (230 Units of Rgp
activity/ml media and 19.4 Units of Kgp activity/ml media), FLL32 extract (0.73 Units of Rgp activity/ml media and 0.49 Units of
Kgp activity/ml media), and W83 extract pretreated with 10 mM TLCK were harvested, after treatment for the indicated times, and
20 pg was separated by SDS-PAGE. Membranes were reacted with a monoclonal antibody to integrin pi. Arrows indicate cleavage
products. Un, untreated.
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cleaved by gingipain-active extracts from P. gingivalis W83 into 4 predominant
fragments (Fig. 20B). It is noteworthy that VE-cadherin was cleaved prior to N-cadherin
in as little as 2 h after treatment. Surprisingly, TLCK pretreatment of W83 extracts was
not able to completely inhibit VE-cadherin cleavage. VE-cadherin in the presence of
TLCK was cleaved into two products one of which was also present in W83 treated cells.
Endothelial cells express several different members of the integrin p 1 family
along with avp3 and otvpS (58). Because of the predominance of integrin pi on
endothelial cells, we investigated the effects of the gingipains on this cell adhesion
molecule. Integrin p 1 appeared to be degraded even more rapidly and completely than
VE-cadherin. By two hours there was no longer any full length integrin P1 detectable by
western blotting, while the full length protein remained in cells treated with FLL32 and
TLCK-inactivated W83 extracts (data not shown). The amount of full length integrin pi
was decreased at 15 min with near total disappearance at 30 min (Fig. 20C).
Remarkably, complete integrin p 1 degradation occurred considerably before the
beginning of cell detachment at 2 h (Fig. 16). Treatment of BCAEC with either FLL32
extracts or W83 extracts pretreated with TLCK did not result in integrin pi degradation
(Fig. 20C). These data show that gingipain-active extracts have significant multiple
effects on endothelial cell adhesion to other cells and to the extracellular matrix, and
potentially on cell survival signaling, which may lead to detachment-induced apoptosis.

D.5. Gingipain-active extracts can directly cleave N-cadherin and VE-cadherin
To determine if the cleavages of N-cadherin and VE-cadherin resulted from direct
action of the gingipains, we performed the cleavage in a cell free system devoid of
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endothelial cell factors. N-cadherin and VE-cadherin were immunoprecipitated from
untreated BCAEC and then treated with extracts from W83, W83 pretreated with TLCK,
and FLL32. Treatment with W83 extracts showed complete disappearance of the full
length N-cadherin band within 20 min and significant decrease of the VE-cadherin band
in the same amount of time (Fig. 21). As expected, there was little change in the intensity
of either cadherin band after treatment with inactivated gingipains or FLL32 extract.
These results strongly suggest that the gingipains can directly cleave CAMs.

D.6. Purified gingipains induce loss of adhesion in BCAEC
BCAEC were treated with purified HRgpA, Kgp, and RgpB to further
demonstrate that the gingipains directly induce cell detachment and to ascertain which
gingipain(s) may be responsible for the observed effects. All three gingipains caused the
detachment of BCAEC that could be prevented by pretreatment with TLCK (Fig. 22).
Interestingly, BCAEC treated with Kgp detached first (data not shown) but over the
duration of the time course most of the cells reattached to the culture substrate and
continued to grow. Cells treated with RgpB showed a delay in detachment as compared
to cells treated with HRgpA and Kgp, but at 24 h the only difference between HRgpA
and RgpB was that RgpB treated cultures had more clumps of detached cells, which may
indicate differences in adhesion molecule cleavage. Furthermore, cell cultures treated
with HRgpA and RgpB exhibited apoptosis following detachment. Collectively, these
results confirmed that the gingipains are responsible for BCAEC cell detachment and
suggest that they may have a synergistic function in inducing endothelial cell detachment
and, subsequently, apoptosis.
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Figure 21. Gingipains can cleave N-cadherin and VE-cadherin immunoprecipitated
from BCAEC. N-cadherin and VE-cadherin were immunoprecipitated from BCAEC
lysates. The immunoprecipitated N-cadherin and VE-cadherin were incubated with 0.125
ug of W83 extract (equivalent to 0.19 Units of Rgp activity and 0.01 Units of Kgp
activity), in the presence and absence of TLCK, and 0.125 pg FLL32 extract (0.0037
Units of Rgp activity and 0.0025 Units of Kgp activity) for the indicated times. Control
samples were incubated for the full time course. Samples were separated on SDS-PAGE
and western blots were performed with antibodies to N-cadherin and VE-cadherin.
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Figure 22. Purified gingipains induce BCAEC detachment and apoptosis. BCAEC were treated with purified HRgpA (8
pg/ml), Kgp (3 pg/ml), or RgpB (5.2 pg/ml) (all equivalent to 113 Units of Rgp activity/ml media or 12.4 Units of Kgp activity/ml
media) in the presence of 5 mM L-cysteine for the indicated times. Purified gingipains were pre-incubated on ice with 10 mM
TLCK to inhibit both Rgp and Kgp activity before cell treatment. Arrows indicate cells with apoptotic morphology.
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E. Discussion
In this study, we have demonstrated that gingipains induce detachment and
apoptosis in endothelial cells. This is consistent with reports of gingipain-induced
apoptosis in several other cell types (5, 69, 51, 62, 37, 30). However, the kinetics of cell
adhesion molecule cleavage appear to differ between epithelial and endothelial cells (12).
While heat stable molecules (such as butyric acid and lipopolysaccharide) produced by P.
gingivalis can induce cell death, (32, 42, 43, 27, 36), it is unlikely that apoptosis induced
in our experimental conditions was non-gingipain dependent. Further, there was no
evidence indicating that the gingipains can induce primary necrosis in BCAEC.
Interestingly, however, in BCAEC treated with W83 extract there was the early, transient
appearance of a 45 kD cleavage product of Topo I, usually associated with necrosis (9).
Since gingipains can traverse the plasma membrane and localize within the cell (60), it is
tempting to speculate that the gingipains could directly cleave Topo I, which may have
involvement in the cell death process. Surprisingly, TLCK pretreatment of W83 extracts
was not able to completely inhibit VE-cadherin cleavage, most likely from incomplete
gingipain inhibition. TLCK has been shown to more completely inhibit Kgp activity that
Rgp activity (54).

Alternatively, other bacterial or host factors could be responsible for

this cleavage or it could also be a by-product of apoptosis. This seems unlikely, since
cells treated with FLL32 extracts show no VE-cadherin cleavage, gingipains can directly
cleave immunoprecipitated cadherins, and there was no VE-cadherin cleavage when
apoptosis was induced with staurosporine (data not shown). To our knowledge this is the
first demonstration of gingipain-induced cleavage of VE-cadherin, N-cadherin and
integrin (31 in endothelial cells.
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Since the gingipain adhesin domains can modulate P. gingivalis adherence to
epithelial cells (10, 11), it is not surprising that Kgp and HRgpA were able to induce
morphological changes before RgpB. This would also be consistent with the report that
HRgpA was more effective than RgpA(cat) in causing the loss of integrin (31 expression on
human gingival fibroblasts (61). It is noteworthy that BCAEC treated with Kgp quickly
detached and then over time reattached, with no significant loss in cell viability. It is
possible that the purified Kgp was less stable than purified HRgpA or RgpB, or the Kgp
present in extracellular extracts from W83. Thus, in the continued presence of Kgp with
diminishing activity the endothelial cells are able to recover, possibly through
upregulation of adhesion molecules or cell survival proteins. There is evidence that Kgp
can modulate gene expression in endothelial cells (52). We cannot rule out the
possibility that in the periodontal pocket, where all gingipains would be present, they
synergistically cause endothelial cell damage. Kgp and HRgpA could quickly adhere to
endothelial cells and cause their detachment, while HRgpA and RgpB would be
responsible for inducing cell death.
Because anoikis can be induced by loss of integrin signaling following cell
detachment (23), integrin-extracellular matrix interactions are essential for cell survival
and also protect endothelial cells from anoikis (2). The rapid degradation of integrin pi
suggests that the trigger for endothelial cell death induced by gingipains might be the loss
of integrin signaling, which occurs prior to cell detachment and apoptosis. This would be
consistent with a recent report demonstrating that disruption of focal adhesions and the
actin cytoskeleton by over-expression of integrin p 1 cytoplasmic domains preceded cell
detachment, and was, therefore, the cause, rather than a consequence of, endothelial cell
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detachment (53). Furthermore, it has been demonstrated that ligation of integrin (31 by
antibodies protected fibroblasts from apoptosis through upregulation of
phosphatidylinositol 3-kinase (PI3-K) and Akt/protein kinase B (PKB) activity (66) and
that Akt is deactivated in both caspase-dependent and caspase-independent cell death in
several cell types (46). It has even been suggested that integrins can mediate an apoptotic
cell death distinct from anoikis, called ‘integrin mediated death’, in which caspase-8 is
recruited to unligated integrins (64) and triggers the caspase cascade of apoptosis.
Integrin pi can directly interact with focal adhesion kinase (FAK) (45) to
transduce signals, via Ras, PI3K, and Akt, leading to upregulation of bcl-2 expression
(47), a pro-survival gene. If integrin signaling is prevented by gingipain-induced
cleavage, it is likely that the levels of bcl-2 would decrease, sensitizing cells to die.
Integrin p 1 can also associate with She and signal survival through the MAP kinase
pathway (70). Furthermore, since integrin pi can regulate the pro-apoptotic protein Bim,
it is also conceivable that loss of integrin function could release Bim and signal apoptosis
through the Erk pathway (57). Integrins are associated with numerous survival pathways
[reviewed in reference (63)] and we are currently exploring the involvement of integrin
pi in gingipain-induced endothelial apoptosis/anoikis. In the periodontal pocket, integrin
pi is expressed within the gingival epithelium, junctional epithelium, and in the
endothelial cells of the connective tissue (35). Integrin pi is consistently expressed in
endothelial cells of all vessel types and sizes (49) and several different integrin p 1
molecules are expressed on the luminal side of vessels (14). The tissue distribution of
integrin p 1 and the recent report that P. gingivalis invades aortic tissue in the apoE -/mouse model and accelerates atheroma development (29), raise the possibility that
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gingipains can cause endothelial cell dysfunction and apoptosis in both the periodontal
pocket and the cardiovascular system.
It has been suggested that VE-cadherin, which is specific for endothelial cells of
almost all types of vessels (17), promotes homotypic interactions with endothelial cells
and N-cadherin may be responsible for the anchorage of endothelial cells to other cell
types. VE-cadherin acts as a seal at intercellular junctions, associating with (3-catenin,
plakoglobin, pi20, and the actin cytoskeleton (17), and is a target of agents that increase
vascular permeability. Inhibition of its function produced more damage to the
endothelial monolayer in vivo compared to in vitro (6), suggesting that gingipain-induced
disruption of VE-cadherin integrity may have a considerable role in the tissue damage
that occurs in the periodontal pocket. It appears that the gingipains may be able to trigger
endothelial cell detachment and cell death through degradation of several different
molecules.
In conclusion, we have shown that gingipain active extracts mediate the
detachment and apoptosis of endothelial cells. BCAEC treated with gingipains become
apoptotic, as determined by cell morphology, caspase-3 activation, Annexin-V positivity,
and cleavage of PARE and Topo I. Gingipains cleave N-cadherin, VE-cadherin, and
integrin pi, whereas extracts of FLL32 that have significantly reduced gingipain activity,
do not have cleaved CAMs. Gingipains directly cleave immunoprecipitated N-cadherin
and VE-cadherin. Moreover, purified gingipains induce endothelial cell detachment and
apoptosis, implicating the gingipains in vascular tissue destruction.
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A. Abstract
We have shown previously that gingipains from Porphyromonas gingivalis W83
can induce cell detachment, cell adhesion molecule (CAM) cleavage, and apoptosis in
endothelial cells, however, the specific roles of the individual gingipains are unclear.
Using purified gingipains we determined that each of the gingipains can cleave CAMs to
varying degrees with differing kinetics. Kgp and HRgpA work together to quickly detach
endothelial cells. Interestingly, in the absence of active caspases, both gingipain-active
W83 extracts and purified HRgpA and RgpB induce apoptotic morphology, suggesting
that the gingipains can induce both caspase-dependent and caspase-independent
apoptosis. Using z-VAD-FMK to inhibit Kgp activity and leupeptin to inhibit Rgp
activity in gingipain-active W83 extracts, we investigated the relative significance of the
synergistic role of the gingipains. z-VAD-FMK or leupeptin delayed, but did not inhibit,
cell detachment induced by gingipain-active W83 extracts or purified gingipains. There
was partial cleavage of N-cadherin and cleavage of VE-cadherin was not inhibited.
Degradation of integrin (31 was inhibited only in the presence of z-VAD-FMK. These
results further clarify the role P. gingivalis plays in tissue destruction occurring in the
periodontal pocket.

B. Introduction
Porphyromonas gingivalis has been implicated as a causative agent in chronic
periodontitis [(10, 25, 41) and reviewed in (23)] with strain W83 being very strongly
associated with disease progression (22). Furthermore, there is growing evidence that P.
gingivalis may be associated with other systemic illnesses, and there may be a direct
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relationship between P. gingivalis infection and cardiovascular disease [(14) and
reviewed in references (20, 38)]. The most notable and well studied virulence factors of
this black-pigmented anaerobe are its cysteine proteases, referred to as gingipains. The
rgpA gene encodes the isoforms of the arginine-specific proteases HRgpA, RgpA(cat), and
the membrane type mt-RgpA(cat), while rgpB encodes RgpB and the membrane type mtRgpB. The lysine-specific protease Kgp is encoded by the kgp gene (11, 48). Not only
do the gingipains provide a source of nutrition and heme for this asaccharolytic, Gram
negative bacterium, but also they aid the bacterium in establishing and maintaining its
ecological niche in the gingival pocket (35). They provide a means of attachment to
other bacteria and host cells of the gingival crevice and aid in virulence by inducing
degradation of extracellular matrix proteins, activation of matrix metalloproteinases,
cleavage of cellular receptors, increasing vascular permeability, activation of coagulation
factors, degradation of fibrinogen, and inactivation of members of the complement
system [reviewed in references (27, 29, 36, 46, 48)]. In the diseased periodontal pocket
there is a close proximity between the bacterial biofilm and endothelial cells that can
cause endothelial cell damage (59). Furthermore, there is evidence for the presence of
apoptotic cells in periodontitis (19, 34, 51, 57). Therefore, understanding the
mechanisms of endothelial apoptosis induction in the periodontal pocket by P. gingivalis
could provide new therapeutic targets of periodontitis and insights into the relationship
between P. gingivalis and cardiovascular disease.
Apoptosis is a genetically programmed form of cell death that is typically driven
by either an extrinsic pathway or an intrinsic pathway, ultimately activating the
executioner caspases, such as caspase-3 [reviewed in (53)]. The cleavage of numerous
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intracellular substrates by executioner caspases produces the apoptotic morphology,
characterized by cellular shrinkage, membrane blebbing, chromatin condensation and
DNA fragmentation, mitochondrial membrane permeabilization, and plasma membrane
changes signaling phagocytic uptake (37, 40). Apoptotic cell death can occur in the
absence of active caspases (37, 39, 40). Further, inhibition of caspase activity may even
reveal or enhance secondary caspase-independent cell death (37). It has been proposed
that caspase-independent pathways of cell death exist to ensure that cell death will occur
in cases where there may be non-functional members of the caspase-dependent pathway
(37, 39). Caspase-independent apoptosis can be triggered by proteases, such as calpains,
cathepsins, and granzymes, that cleave some of the same substrates cleaved by caspases
[reviewed in references (39, 43)]. While we have previously established a role for
gingipains in endothelial cell caspase-dependent apoptosis (55), it is unclear whether
these proteases also participate in caspase-independent processes.
Bioinformatic studies of the active site of legumain (family Cl 3), a plant cysteine
endopeptidase, revealed homology to three other families of cysteine proteases:
clostripain (family Cl 1) from Clostridium histolyticum, caspases (family Cl4), and
gingipains (family C25), leading to the grouping of these proteases into the cysteine
protease clan CD (6). They all have a conserved catalytic motif of His-Gly-spacer-AlaCys with a block of hydrophobic amino acids preceding each of the catalytic residues,
which suggests that they may have similar enzymological properties and functions (6).
These similarities have been further confirmed by the analysis of the crystal structure of
RgpB. The three-dimensional structure of RgpB resembles a ‘crooked one-root tooth’,
with the catalytic domain being the crown and topologically similar to caspase-1 and -3,
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while the root has an immunoglobulin-like fold (16). It appears that RgpB is also
activated in a similar manner as the caspases (44). Moreover, natural caspase inhibitors
have been found to modulate gingipain activity. For instance, p35, a baculovirus antiapoptotic protein that inhibits most known caspases, and a point mutant of cowpox viral
cytokine-response modifier A (CrmA), which normally inhibits caspases-1 and -8,
effectively abrogated the activity of Kgp (56). These results hint that other caspaserelated proteases may also possess caspase-like activities (3).
Our previous work has shown that gingipains cause endothelial cell detachment,
cell adhesion molecule cleavage, and apoptosis (55). Because the specific roles of the
individual gingipains in these events are not known, the goal of this study was to
determine the involvement of the different gingipains in bovine coronary artery
endothelial cell (BCAEC) detachment, cell adhesion molecule (CAM) cleavage, and
apoptosis. We report here that the gingipains synergistically cause cell detachment,
CAM cleavage, and apoptosis. Both Kgp and HRgpA can quickly detach endothelial
cells; HRgpA, Kgp, and RgpB can all cleave CAMs to varying degrees; and HRgpA and
RgpB induce apoptosis in both a caspase-dependent and -independent manner. Our
studies extend the relationship between caspases and gingipains by demonstrating that
synthetic peptide caspase inhibitors inhibit Kgp but not Rgp activity. These results raise
an important question about the functional similarities of caspases and gingipains: could
gingipains have ‘caspase-like’ activity in endothelial cells?
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releasing 1 pmol p-nitroanilide per minute as calculated based on maximum velocity and
the extinction coefficient of p-nitroanilide of 9200 at 405 nm. Gingipain activity was
calculated based on the average of three measurements of the maximum velocity of the
enzymatic reaction of specific substrate turnover. The concentration of gingipain activity
used was within reported physiological levels of gingipain activity found in periodontal
lesions (17).

C.3. Treatment of gingipain-active W83 extracts with a panel of peptide easpase
inhibitors
W83 extracts containing 2.1 or 3.3 Units/pl of Rgp activity and 0.16 or 0.35
Units/pl of Kgp activity were preincubated on ice for at least 30 min with a panel of
peptide easpase inhibitors or TLCK (Sigma-Aldrich, St. Louis, MO). Rgp and Kgp
activity were assayed in triplicate as described above. Percent inhibition was determined
by comparison to untreated W83 extract. Standard error of the mean was calculated from
three independent trials. The easpase inhibitors used are as follows (all from Enzyme
Systems Products, Livermore, CA unless otherwise indicated): z-VAD(OMe)-FMK
(Biomol, Plymouth Meeting, PA) and Boc-D(OMe)-FMK, general easpase inhibitors; zYVAD-FMK, a easpase-1 and -4 inhibitor; z-VDVAD(OMe)-FMK, a caspase-2
inhibitor; z-D(OMe)-E(OMe)-VD(OMe)-CH2F, a caspase-3 inhibitor; z-VEID-FMK, a
caspase-6 inhibitor; z-IE(OMe)TD(OMe)-FMK, a caspase-8 inhibitor; and zLE(OMe)HD(OMe)-FMK.TFA, a caspase-9 inhibitor.
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C.4. Purification of gingipains from P. gingivalis strain HG66
Comparisons of strain W83 and HG66 reveal that their Rgp is nearly identical in
protein sequence (48) and is identical in substrate specificity. Kgp from these two strains
is also nearly identical. Therefore, extracts were made from strain W83 and purified
gingipains were isolated from strain HG66. HRgpA, Kgp, and RgpB were purified from
the strain HG66 culture fluid as described previously (47, 49). Briefly, Kgp and HRgpA
were purified using gel filtration and arginine-sepharose chromatography, while RgpB
was purified using a combination of gel filtration and anion-exchange chromatography on
Mono Q (49). In this way, approximately 5 mg of each gingipain from 1 L of bacterial
culture was obtained in homogenous form as determined by SDS-PAGE.

C.5. Eukaryotic cell culture and treatment with gingipains
BCAEC were cultured according to the manufacturer’s specifications, using their
reagents (Cambrex, Walkersville, MD) as previously described (55). Briefly, cells from
passages 6 through 10 were tested for viability prior to seeding in appropriate tissue
culture dishes and allowed to reach near confluency. Culture media was removed from
culture dishes and replaced with fresh media containing 5 mM L-cysteine, to activate the
gingipains. Gingipain-active W83 extracts or purified gingipains were added to the
endothelial cells and allowed to incubate for the indicated times at 37°C in 5% CO2. To
inhibit Rgp and Kgp activity, purified gingipains or W83 extracts were pretreated for at
least 30 min on ice with 10 mM TLCK (Sigma, St. Louis, MO) and then added to the
cells. To inhibit Kgp activity the purified gingipains or W83 extracts were pretreated for
at least 30 min on ice with 100 pM z-VAD-FMK. Leupeptin is known to inhibit Rgp
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activity (11), therefore, purified gingipains or W83 extracts were pretreated for at least 30
min on ice with 100 pM leupeptin (Axxora, LLC, San Diego, CA). Cells were also
treated with 100 pM z-VAD-FMK for 1 h prior to the addition of gingipains, to inhibit
caspase activity, and/or 100 pM leupeptin, for at least 15 h prior to gingipain treatment.
Untreated cells did not have P. gingivalis extracts or purified gingipains added to the
cysteine-containing media. Numerous fields of BCAEC were monitored on an Olympus
1X70 inverted microscope equipped with Hoffman Modulation Contrast for detachment
and apoptosis and representative fields were selected and photographed with a SPOT™
digital camera (Diagnostic Instruments, Inc., Sterling Heights, MI). For quantification of
BCAEC detachment by gingipain-active W83 extracts in the presence and absence of
inhibitors, cells were treated in triplicate as above. At the appropriate time points, the
cells were gently rocked and the medium containing detached cells was transferred to a
culture tube. An aliquot was then placed in a hemacytometer. Cells in the four comer
grids were counted and the average was recorded as the level of detachment. Standard
error of the mean was calculated from two independent trials and significance was
determined using the two tailed, non-paired Student’s t-test.

C.6. Caspase-3 (DEVDase) activity assay
BCAEC were seeded in 6-well plates and allowed to reach near confluency before
the addition of 4 pM staurosporine (Str) (Alexis-Axxora, San Diego, CA) or gingipainactive W83 extracts in fresh cysteine-containing media in the absence and presence of
100 pM z-VAD-FMK. After 18 h, One-step caspase assay buffer (4) was added to the
wells and allowed to incubate for 1 h at 37°C, 5% CO2. Three 150 pi aliquots from each
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well were placed in a black, clear-bottom 96-well plate and read at excitation and
emission wavelengths of 380 and 460 nm, respectively, in a BIO-TEK Instruments
FLx800 Microplate Fluorescence Reader (Winooski, Vermont). To calculate fold
increase in DEVDase activity the average relative fluorescence intensity of three treated
wells was divided by the average relative fluorescence intensity of three untreated wells
with and without z-VAD-FMK pretreatment. Standard deviation was calculated from
five independent trials and significance was determined using the two tailed, non-paired
Student’s t-test.

C.7. Preparation of BCAEC lysates for SDS-PAGE and Western blot analysis
Attached and detached BCAEC were washed once with Dulbecco’s PBS (DPBS),
lysed in cell lysis buffer containing complete protease inhibitor cocktail (Roche Applied
Science, Indianapolis, IN), and electrophoresed on NuPAGE™ 4-12% Bis-Tris gels
(Invitrogen, Carlsbad, CA). Immunoblotting was performed as previously described
(55). The primary antibodies used in these experiments were N-cadherin clone 32 and
integrin pi clone 18 (BD Biosciences, San Diego, CA), VE-cadherin clone C-19 (Santa
Cruz Biotechnology, Santa Cruz, CA), poly(ADP-ribose) polymerase (PARP) clone C210 (R & D Systems, Minneapolis, MN), and a highly specific human autoantibody to
Topoisomerase I (generous gift from Eng M. Tan, The Scripps Research Institute, La
Jolla, CA).
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D. Results
D.l. Kgp activity is inhibited by synthetic peptide caspase inhibitors
Because gingipains share similar features with caspases and Kgp is inhibited by a
naturally occurring caspase-3 inhibitor (56), we investigated the effects of synthetic
peptide caspase inhibitors on gingipain activity. As shown in Figure 23A, the synthetic
peptide caspase inhibitors tested had no inhibitory effect on Rgp activity. In contrast,
Kgp activity was inhibited nearly 100% with z-VAD-FMK, a general caspase inhibitor,
and Ac-YVAD-CMK, an inhibitor of caspases-1 and -4 (Fig. 23B). Moreover, Kgp
activity was partially inhibited by all the caspase inhibitors tested except the general
caspase inhibitor Boc-D-FMK.

D.2. Selective inhibition of gingipain activity by z-VAD-FMK and leupeptin inhibits
synergistic gingipain-induced BCAEC detachment and apoptosis.
z-VAD-FMK was used to monitor the specific function of Kgp in the induction of
the morphological changes seen in BCAEC after treatment with gingipain-active W83
extract. Gingipain-active W83 extracts preincubated with 100 pM z-VAD-FMK to
inhibit Kgp were used to treat BCAEC (this treatment condition was designated W83 + zVAD). Under these conditions, the final concentration of z-VAD-FMK subsequently
exposed to the cells was too low (approximately 3 pM) to inhibit the caspases (1, 18, 42),
thus, only Kgp should have been inhibited. A time course showed that at early time
points, cells treated with gingipain-active W83 extracts pre-treated with 100 pM z-VADFMK displayed significantly (p<0.05 at 3 h, 6 h, and 12 h) less detachment than cells
treated with gingipain-active W83 extracts (Fig. 24 and 26). To assess the involvement
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Figure 23. Inhibition of Kgp activity, but not Rgp activity, after treatment with synthetic peptide
caspase inhibitors. Gingipain-active W83 extracts were incubated with 10 mM or 1 mM TLCK or
100 pM or 20 pM of a panel of caspase inhibitors for at least 30 min on ice and then assayed for Rgp
activity (A) or Kgp activity (B). TLCK inhibited nearly 100% of the Rgp and Kgp activity. Caspase
inhibitors had no effect on Rgp activity. Caspase inhibitors z-VAD-FMK and Ac-YVAD-CMK at
100 pM inhibited Kgp activity by 90%. Other caspase inhibitors, except Boc-D, had partial inhibitory
effects on Kgp activity. Error bars indicate standard error of the mean of three independent trials in
trinlicate.
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Figure 24. z-VAD-FMK delays but does not block gingipain-induced BCAEC
detachment and apoptosis. BCAEC were treated, in the presence of 5 mM Lcysteine, with 200 pg/ml gingipain-active W83 extract (70 Units Rgp activity/ml
media and 5.3 Units Kgp activity/ml media), 100 pM z-VAD-FMK prior to exposure
to gingipain-active W83 extract (100 pM z-VAD prior to W83), or gingipain-active
W83 extract preincubated with 100 pM z-VAD-FMK (W83 + z-VAD). Arrows
indicate cells with significant apoptotic morphology in BCAEC in the presence of 100
pM z-VAD-FMK.
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Figure 25. Gingipain-induced BCAEC detachment was inhibited in the presence of leupeptin and
z-VAD-FMK. BCAEC were treated, in the presence of 5 mM L-cysteine, with 200 pg/ml gingipainactive W83 extract (307.5 Units Rgp activity/ml media and 19.4 Units of Kgp activity/ml media),
100 pM z-VAD-FMK and/or 100 pM leupeptin prior to exposure to gingipain-active W83 extracts, or
gingipain-active W83 extracts preincubated with 100 pM z-VAD-FMK and/or 100 pM leupeptin.
Arrows indicate cells with apoptotic morphology.
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Figure 26. Quantification of gingipain-induced detachment in the presence of z-VAD-FMK and/or leupeptin.
BCAEC were treated in the presence of 5 mM L-cysteine, with 119 pg/ml media gingipain-active W83 extract (113 Units
Rgp activity/ml media and 9 Units Kgp activity/ml media) with and without 10 mM TLCK pre-treatment, 100 pM z-VADFMK and/or 100 pM leupeptin prior to exposure to gingipain-active W83 extracts, or gingipain-active W83 extracts
preincubated with 100 pM z-VAD-FMK and/or 100 pM leupeptin. Detached cells were counted in a hemacytometer at the
indicated time points. Error bars indicate standard error of the mean of two independent trials in triplicate in which
gingipain-active W83 extracts in the presence of inhibitors were compared to gingipain-active W83 extracts alone at the same
time point and * p<0.05.

of caspases in the morphological changes, BCAEC were pretreated with 100 pM z-VADFMK for 1 h and then the gingipain-active W83 extracts were added (this treatment
condition was designated 100 pM z-VAD-FMK prior to W83). This treatment inhibited
Kgp (Fig. 23) and should inhibit all of the caspases (15). As shown in Figure 24 (6 h
panel) and 26, this treatment significantly (p<0.03 at 3 h, 6 h, and 12 h) delayed cell
detachment. However, by 24 h there was more pronounced apoptotic morphology in
BCAEC pretreated with z-VAD-FMK prior to addition of the gingipain-active W83
extracts (Fig. 24). To further ensure that all the caspases were inhibited and Kgp was
completely inhibited a cocktail of caspase inhibitors that included z-VAD-FMK, zYVAD-FMK, and z-DEVD-FMK were used to pre-treat BCAEC. Apoptotic
morphology was still observed in the presence of these inhibitors (data not shown),
suggesting that Rgp present in the gingipain-active W83 extracts induced caspaseindependent apoptosis.
To further elucidate the individual roles of the gingipains in cell detachment and
induction of apoptosis, endothelial cells and gingipain-active W83 extracts were treated
with z-VAD-FMK to inhibit caspases and Kgp, and leupeptin to inhibit Rgp. Similar to
the experiments described above, we treated gingipain-active W83 extracts with 100 pM
z-VAD-FMK and/or 100 pM leupeptin before their addition to BCAEC cells. We also
preincubated BCAEC with these inhibitors before the addition of gingipain-active W83
extracts. Inhibition of Rgp activity either by treatment of gingipain-active W83 extracts
or pretreatment of BCAEC with leupeptin produced only slight inhibition of detachment
as compared to the control (Fig. 25). Only when BCAEC were treated with 100 pM
leupeptin prior to the addition of gingipain-active W83 extracts at 3 h was there a
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significant decrease (p=0.05) in detachment as compared to BCAEC treated with
gingipain-active W83 extracts (Fig. 26). However, a significant inhibition (p<0.05 at all
time points) in cell detachment was apparent when both Rgp and Kgp activities were
inhibited with both z-VAD-FMK and leupeptin (Fig. 25, far right panels and Fig. 26).
Furthermore, treatment of BCAEC or gingipain-active W83 extracts with z-VAD-FMK
and leupeptin produced levels of detachment that were not significantly different than
treatment of gingipain-active extracts with TLCK (p>0.06 at all time points for both W83
+ leupeptin + z-VAD and 100 pM leupeptin and z-VAD prior to W83) (Fig. 26).
To determine the extent of caspase inhibition under these treatment conditions
and to further differentiate caspase-independent apoptosis from necrosis, we monitored
the cleavage of two caspase substrates. During apoptosis, caspases specifically cleave
PARP and Topoisomerase I (Topo I) into 85 kD and 70 kD fragments, respectively.
However, during necrosis PARP is cleaved into a 50 kD product and Topo I into 70 kD
and 45 kD products (5). In cells pretreated with z-VAD-FMK to inhibit caspases (100
pM z-VAD-FMK prior to W83), the apoptotic cleavage product of PARP induced by
treatment with gingipain-active W83 extracts was partially inhibited (Fig. 27) and there
was no necrotic cleavage product (data not shown). Topo I cleavage into the apoptotic 70
kD fragment was completely inhibited by pretreatment with 100 pM z-VAD-FMK prior
to the addition of gingipain-active W83 extracts (Fig. 27). However, the presence of zVAD-FMK did not inhibit the appearance of a faint 45 kD cleavage product of Topo I.
We have shown previously that cleavage of Topo I to a 45 kD product occurs from the
earliest time point of incubation with gingipain-active W83 extracts (data not shown) and
is not indicative of necrosis based on the presence of apoptotic cell morphology, PARP
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Figure 27. In the presence of z-VAD-FMK, partial cleavage of caspase
substrates still occurs in gingipain-induced apoptosis. 20 pg of total protein from
BCAEC treated for 24 h, in the presence of 5 mM L-cysteine, with gingipain-active
W83 extract (70 Units Rgp activity/ml media and 5.3 Units Kgp activity/ml media),
100 pM z-VAD-FMK alone, 100 pM z-VAD-FMK prior to exposure to gingipainactive W83 extract (100 pM z-VAD prior to W83), or gingipain-active W83 extracts
preincubated with 100 pM z-VAD-FMK (W83 + z-VAD), were separated by SDSPAGE and immunoblotted with a monoclonal antibody to PARP and a highly
specific human autoantibody to Topoisomerase L Arrows indicate cleavage
products, whereas lines indicate intact proteins. Un, untreated; +, present.
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cleavage into an 85 kD fragment, and Annexin V positivity (55). These results suggest
that certain caspase substrates, such as PART, may still be cleaved when Kgp and
caspases are inhibited, most likely because of the presence of Rgp activity. Concomitant
with a delay in cell detachment, there was also a partial inhibition of apoptotic PARP
cleavage in cells pretreated with both 100 pM z-VAD-FMK and leupeptin, as suggested
by the presence of both full length PARP and its apoptotic 85 kD fragment under these
conditions at 24 h (Fig. 28). In the absence of z-VAD-FMK, leupeptin was unable to
inhibit PARP cleavage (Fig. 28). Similar results were observed for apoptotic Topo I
cleavage (data not shown). Collectively, it appears that the gingipains work together to
detach endothelial cells and induce apoptosis.

D.3. Inhibition of Kgp activity with z-VAD-FMK and Rgp activity with leupeptin
establishes a role for individual gingipains in the cleavage of specific CAMs
We have shown previously that treatment of BCAEC with gingipain-active W83
extracts induces cleavage of CAMs (55). We investigated the involvement of Kgp in
CAM cleavage by inhibiting its activity with z-VAD-FMK. In the absence of z-VADFMK, N-cadherin was cleaved into products of approximately 65 kD and 30 kD in
BCAEC treated with gingipain-active extracts. Interestingly, only a 30 kD cleavage
product was observed (Fig. 29). VE-cadherin cleavage was not inhibited in the presence
of z-VAD-FMK (Fig. 29). BCAEC treated with gingipain-active W83 extracts also
displayed complete degradation of integrin pi (Fig. 29). However, when Kgp was
inactivated by treatment with z-VAD-FMK, degradation was inhibited (Fig. 29; (55)).
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Figure 28 Cleavage of PARP is partially inhibited in the presence of leupeptin
and z-VAD-FMK. 20 pg of total protein from BCAEC treated, in the presence of 5
mM L-cysteine, with gingipain-active W83 extract (307.5 Units Rgp activity/ml media
and 19.4 Units Kgp activity/ml media), 100 pM z-VAD-FMK and/or 100 pM
leupeptin prior to exposure to gingipain-active W83 extracts (100 pM leupeptin prior
to W83 or 100 pM leupeptin and z-VAD prior to W83), or gingipain-active W83
extracts preincubated with 100 pM z-VAD-FMK and/or 100 pM leupeptin (W83 +
leupeptin or W83 + leupeptin + z-VAD) were separated by SDS-PAGE and
immunoblotted with a monoclonal antibody to PARP. Arrows indicate cleavage
products, whereas lines indicate intact proteins. Un, untreated.
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Figure 29. Cleavage of CAMs is affected by z-VAD-FMK treatment. 10 jag
(N-cadherin and VE-cadherin) or 20 jag (integrin (31) of protein from BCAEC
treated for 12 h, in the presence of 5 mM L-cysteine, with gingipain-active W83
extract (70 Units Rgp activity/ml media and 5.3 Units Kgp activity/ml media), 100
pM z-VAD-FMK alone, 100 pM z-VAD-FMK prior to exposure to gingipainactive W83 extract (100 pM z-VAD prior to W83), or gingipain-active W83
extracts preincubated with 100 pM z-VAD-FMK (W83 + z-VAD) were separated
by SDS-PAGE and immunoblotted with a monoclonal antibody to N-cadherin,
VE-cadherin, or integrin (31. Arrows indicate cleavage products, whereas lines
indicate intact proteins. Un, untreated; +, present.
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We also investigated CAM cleavage in the presence of leupeptin to further determine the
specific roles of Rgp. As established by the inhibition of Kgp activity by z-VAD-FMK,
treatment of BCAEC with leupeptin had little effect on the appearance of the 65 kD
cleavage products of N-cadherin, but did reduce the extent of the 30 kD cleavage product
(Fig. 30). Consistent with the studies with z-VAD-FMK (Fig. 29), VE-cadherin cleavage
was not inhibited in the presence of leupeptin (Fig. 30). Leupeptin treatment had no
effect on the degradation of integrin (31 (Fig. 30). Only when Kgp was inhibited with 100
pM z-VAD-FMK was integrin [31 degradation inhibited (Fig. 30).

D.4. Treatment of endothelial cells with HRgpA induces apoptotic cleavage of
PARP
Our previous work showed that gingipain-active W83 extracts and purified
gingipains can cause endothelial cell detachment and apoptosis, as evidenced by the
presence of apoptotic morphology and signature caspase cleavage products of PARP and
Topo I (55). However, the individual roles of the gingipains in apoptosis induction in
endothelial cells are not known. To confirm which purified gingipains induced apoptosis,
we assayed lysates from BCAEC treated with individual gingipains for evidence of the
85 kD PARP apoptotic cleavage product.

Treatment with HRgpA induced apoptotic

cleavage of PARP as early as 6 h, while treatment with RgpB induced slight PARP
cleavage by 24 h (Fig. 31). Unexpectedly, treatment with Kgp induced a faint apoptotic
cleavage product of PARP (Fig. 31).

Similar kinetics of apoptotic cleavage was

displayed in immunoblots of Topo I (data not shown).
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Figure 30. Cleavage of CAMs is affected by leupeptin and z-VAD-FMK
treatment. 12 |4g (N-cadherin and integrin |31) or 20 |ig (VE-cadherin) of total
protein from BCAEC treated for 6 h, in the presence of 5 mM L-cysteine, with
gingipain-active W83 extract (307.5 Units Rgp activity/ml media and 19.4 Units Kgp
activity/ml media), 100 pM z-VAD-FMK and/or 100 pM leupeptin prior to exposure
to gingipain-active W83 extract (100 pM leupeptin prior to W83), or gingipain-active
W83 extracts preincubated with 100 pM z-VAD-FMK and/or 100 pM (W83 +
leupeptin or W83 + leupeptin + z-VAD) were separated by SDS-PAGE and
immunoblotted with a monoclonal antibody to N-cadherin, VE-cadherin, or integrin
(31. Arrows indicate cleavage products, whereas lines indicate intact proteins. Un,
untreated; +, present.
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Figure 31. Treatment with HRgpA induces apoptotic cleavage of PARP. 15 pg of total protein from BCAEC
treated, in the presence of 5 mM L-cysteine, with 119 pg/ml media gingipain-active W83 extract (113 Units Rgp
activity/ml media and 9 Units Kgp activity/ml media) with and without 10 mM TLCK pre-treatment, purified HRgpA
(8 pg/ml), Kgp (3 pg/ml), or RgpB (5.2 pg/ml) (all equivalent to 113 Units of Rgp activity/ml media or 12.4 Units of
Kgp activity/ml media) and inhibited with 10 mM TLCK were separated by SDS-PAGE and immunoblotted with a
monoclonal antibody to PARP. Arrows indicate cleavage products, whereas lines indicate intact proteins. Un,
untreated.

D.5. Synergism of CAM cleavage is confirmed by treatment of BCAEC with
purified gingipains.
To determine which gingipain(s) was responsible for CAM cleavage, BCAEC
were treated with purified HRgpA, Kgp, and RgpB and then assayed for cleavage of
CAMs. N-cadherin was cleaved to the 65 kD cleavage products by Kgp (Fig. 32),
however, a 30 kD product was produced by both this enzyme and HRgpA. RgpB did not
cleave N-cadherin. All of the gingipains appear to be involved in cleavage of VEcadherin, with HRgpA having a predominant role in cleaving VE-cadherin, and Kgp and
RgpB exhibiting partial cleavage (Fig. 32). Kgp was the most efficient gingipain in
degrading integrin (31 (Fig. 32).

D.6. HRgpA and RgpB induce cell detachment and apoptotic morphology in the
absence of active caspases
To determine if purified HRgpA and RgpB could induce apoptosis in the absence
of active caspases, BCAEC were treated with 100 pM z-VAD-FMK prior to exposure to
purified gingipains. HRgpA and RgpB were able to induce detachment and pronounced
apoptotic morphology in the presence of z-VAD-FMK (Fig. 33). As expected, cell
detachment and apoptosis induced by HRgpA and Rgp were inhibited in the presence of
leupeptin (Fig. 33) and in the presence of z-VAD-FMK, Kgp did not induce initial
detachment (data not shown). To confirm that z-VAD-FMK was in fact inhibiting
caspase function under the different treatments, we monitored caspase-3 activity. Cells
were pretreated with 100 pM z-VAD-FMK and then treated with 4 pM Str, which
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Figure 32. Synergism of purified gingipains in induction of CAM cleavage. 15 |ng of
total protein from BCAEC treated for 6 h (N-cadherin), 24h (VE-cadherin), or 12h
(integrin pi), in the presence of 5 mM L-cysteine, with purified HRgpA (8 pg/ml), Kgp
(3 pg/ml), or RgpB (5.2 pg/ml) (all equivalent to 113 Units of Rgp activity/ml media or
12.4 Units of Kgp activity/ml media) were separated by SDS-PAGE and immunoblotted
with antibodies to N-cadherin, VE-cadherin, and integrin pi. Arrows indicate cleavage
products, whereas lines indicate intact proteins. Un, untreated; +, present.
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Figure 33. HRgpA and RgpB induce cell detachment and apoptotic morphology in the presence of 100
pM z-VAD-FMK. BCAEC were treated with purified HRgpA (40.5 pg/ml media), Kgp (9 pg/ml media), or
RgpB (10 pg/ml media) (all equivalent to 113 Units of Rgp activity/ml media or 6.2 Units of Kgp activity/ml
media) in the presence of 5 mM L-cysteine for 24 h. BCAEC were pretreated for at least 15 h with 100 pM
leupeptin and/or 100 pM z-VAD-FMK for 1 h before addition of individual gingipains. Arrows indicate cells
with significant apoptotic morphology at 24 h in BCAEC with inactive caspases.
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activates caspase-3. Pretreatment of BCAEC with z-VAD-FMK significantly inhibited
Str-induced caspase-3 activation (p<0.0001) (Fig. 34). Furthermore, significant
inhibition of caspase-3 activity was achieved upon BCAEC pretreatment with 100 pM zVAD-FMK prior to the addition of W83 extract (p<0.0003) and RgpB (p<0.002).
Treatment with Kgp, which does not induce apoptosis, caused a slight increase in
caspase-3 activity that could also be inhibited by z-VAD-FMK pretreatment (p<0.03,
data not shown), which may explain the slight induction of the 85 kD apoptotic cleavage
product of PARE (Fig. 31). These results strongly suggest that gingipains have the ability
to trigger both caspase-dependent and caspase-independent apoptosis.

E. Discussion
This study has provided insights into the individual roles of the gingipains in
endothelial cell detachment, CAM cleavage, and induction of apoptosis. We have shown
through selective inhibition of gingipain activity and treatment of endothelial cells with
purified gingipains that all the gingipains cause cell detachment, with cells treated with
Kgp reattaching after the initial detachment (55), and that HRgpA and RgpB can induce
both caspase-dependent and -independent apoptosis. In addition, we demonstrate that all
the gingipains participate in CAM cleavage. However, we cannot rule out the possibility
that other factors in the gingipain-active W83 extracts may contribute to the BCAEC
detachment and death. This alternative is currently being investigated in our laboratory.
Our results further suggest that the gingipains can differentially interact and proteolyse
specific CAMs. All three gingipains cleaved VE-cadherin and integrin pi. Both Kgp
and HRgpA cleaved N-cadherin, but only Kgp cleaved N-cadherin to generate a group of

186

<D
Q

>
LU
D
c

E
o

w
m

9876^ 5.2;
O

4^

§

•kicrk

*

32-

1-

n

Figure 34. Lack of DEVDase activity in BCAEC treated with gingipainactive W83 extract or individual gingipains in the presence of 100 pM zVAD-FMK. BCAEC were treated for 18 h with 4 pM Str, 119 pg/ml media
gingipain-active W83 extract (113 Units Rgp activity/ml media and 9 Units
Kgp activity/ml media), and 10 pg/ml RgpB (113 Units activity/ml media)
with and without 1 h pre-treatment with 100 pM z-VAD-FMK to inhibit
caspase activity and then assayed for cleavage of the fluorescent caspase-3
and -7 substrate Ac-DEVD-AMC. Error bars indicate standard deviation of
the mean of 5 independent trials with § p<0.0001,
p<0.0003, and **
p<0.002, and * p<0.03.
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fragments of approximately 65 kD and a fragment of 30 kD. In contrast, HRgpA cleaved
N-cadherin to generate a 30 kD fragment that was missing in the presence of RgpB.
The ability to bind and interact with N-cadherin could be a function of the adhesin
domains of HRgpA and Kgp. These adhesin domains can modulate bacterial adherence
(7, 8). Moreover, both HRgpA and Kgp can quickly cause cadherin cleavage. This
would be consistent with the report that HRgpA was more effective than RgpA(cat) in
inducing the loss of integrin (31 expression on human gingival fibroblasts (54). It is also
possible that RgpB is inefficient in cleaving N-cadherin. Endothelial cells treated with
gingipain-active W83 extracts displayed cleaved VE-cadherin prior to N-cadherin (55),
indicating that VE-cadherin, in contrast to N-cadherin, is more readily cleaved by the
gingipains. Since RgpB does cleave VE-cadherin, but significantly later than HRgpA
(data not shown), it is possible that a longer incubation time may be required for Ncadherin to be cleaved by RgpB.
Our previous findings show that BCAEC treated with Kgp initially detach, but
over time reattach with little loss of cell viability (55). The inability of leupeptin to
significantly affects gingipain-active W83 extract-induced detachment demonstrates that
Kgp activity has a considerable role in detaching BCAEC in our experimental system.
Based on our studies, Kgp appears to play a prominent role in BCAEC detachment and
CAM cleavage, but under the conditions used for this treatment, it appears that BCAEC
are able to counter the Kgp-induced affects in some way to maintain cell viability. This
sizeable role for Kgp, however, is in contrast to previous reports that have suggested that
Rgp had a greater effect than Kgp in inducing loss of cell adhesion and viability in human
gingival fibroblasts or human umbilical vein endothelial cells (21, 33). The different
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responses previously observed most likely are related to differences in the eukaryotic cell
lines used and possibly the strains of P. gingivalis used. In a previous report (55) we
speculated that purified Kgp could have lost activity during the time course, allowing the
cells to reattach. However, it appears that Kgp does remain active throughout the time
course since integrin p 1 was degraded to completion throughout a 24 h time course (data
not shown) and both N-cadherin and VE-cadherin showed Kgp induced cleavages over
24 h (data not shown). Interestingly, during treatment of BCAEC with Kgp it appears
that full length VE-cadherin may be up-regulated over the 24 h time course (data not
shown), consistent with recent reports that cell adhesion expression can be modulated by
P. gingivalis (26, 45, 58). VE-cadherin is essential for endothelial cell survival, acts as a
seal at intercellular junctions, associating with p-catenin, plakoglobin, pl20, and the actin
cytoskeleton (13), and is a target of agents that increase vascular permeability. Inhibition
of its function produced more damage to the endothelial monolayer in vivo compared to
in vitro (2). It has been demonstrated that P. gingivalis can cause cleavage of pi 20,
which can be inhibited by a caspase inhibitor (24) and, based on our findings, implicates
Kgp involvement. Because pi20 regulates VE-cadherin expression (30), it is tempting to
speculate that the loss of function of pi 20 and VE-cadherin may contribute to the
induction of apoptosis in endothelial cells. Therefore, it may be possible that BCAEC
can up-regulate pi20 and VE-cadherin expression to overcome the effects of Kgp
treatment.
Based on our cumulative results, both Rgp and Kgp seem to be involved in
producing cell detachment and CAM cleavage in BCAEC. There are several examples of
the cooperative action or overlapping functions of the gingipains. Numerous reports that
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used selective Rgp and/or Kgp inhibitors uncovered the similar synergistic actions of Rgp
and Kgp. Collagen degradation, cytokine degradation, enhancement of vascular
permeability, and bacterial coaggregation were inhibited only in the presence of both Rgp
and Kgp inhibitors [reviewed in reference (33)]. The synergistic actions of Rgp and Kgp
are most clearly understood in the clotting system. Rgp is considered the major vascular
permeability enhancement-inducing factor through activation of plasma prekallikrein,
ultimately releasing bradykinin and enhancing vascular permeability. However, both
Rgp and Kgp can release bradykinin from high molecular weight kininogen, also
contributing to vascular permeability and production of gingival crevicular fluid in
periodontitis [(28) and reviewed in reference (27)]. Therefore, in the periodontal pocket
where all the gingipains are present, it is possible that there is cooperative action of the
gingipains to sustain infection, create the pathology of periodontitis, cleave CAMs, and
induce apoptosis.
The ability of peptide caspase inhibitors to inhibit Kgp activity is not surprising,
but until this report it had not been previously demonstrated. It has been shown that zVAD-FMK and DEVD-FMK can inhibit many of the cathepsins, papain, and another
clan CD protease legumain (50, 52). Since RgpB is structurally similar to caspases (16),
it could be expected that peptide caspase inhibitors would affect Rgp activity.
Hintermann and colleagues implied this after determining that caspase inhibitor I, which
inhibits caspase-3, prevented the P. ^mgzva/zT-induced cleavage of pi20, paxillin, and
FAK, while caspase inhibitor III, which is the general caspase inhibitor Boc-Asp(OMe)CH2F, had no effect (24). However, our work with peptide caspase inhibitors would
imply that Kgp activity, not Rgp activity, is most likely responsible for these cleavages.
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Our inhibition results are consistent with the report that Kgp activity could be inhibited
by the natural caspase inhibitors p35 and a point mutant of CrmA (56). Because the
gingipains are structurally similar to each other and can be assumed to all have similarity
to the caspases (27), it will be interesting to determine the structural nature of selective
Kgp inhibition by peptide caspase inhibitors.
Overlapping modes of cell death induced by the same stimulus appears to be a
common phenomenon (31). It is becoming evident that there is a continuum between
apoptosis and necrosis and that cells can die by alternative pathways with all or only
some of the typical characteristics of apoptosis in caspase-independent apoptosis (32).
Gingipains induce classic apoptosis with the characteristic morphology, caspase
activation, phosphatidylserine exposure, and cleavage of the caspase substrates PARP
and Topo I (55). However, to our knowledge this is the first demonstration that
gingipains can also induce caspase-3 independent apoptosis. The inability of z-VADFMK to completely inhibit PARP cleavage was also observed during etoposide-induced
apoptosis, in the absence of DEVDase activity (12). Since we only assayed for caspases3 and -7 activities, we cannot rule out the possibility of other caspases being active and
mediating gingipain-induced apoptosis. However, this seems unlikely because z-VADFMK is a broad caspase inhibitor, especially when used at 100 pM, that was recently
demonstrated to bind and inactivate all the intracellular caspases (15). Interestingly, that
study also reported more pronounced apoptotic blebbing in the presence of z-VAD-FMK,
with nuclear fragmentation as the only apoptotic feature that was inhibited by z-VADFMK (15). It should be noted that serine proteases were implicated in that caspaseindependent apoptosis. Several classes of proteases, such as calpains, cathepsins, and the
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granzyme serine proteases have also been found to induce caspase-independent apoptosis
[reviewed in reference (43)]. It appears that the gingipains can be added to this list.
Current efforts in the laboratory are aimed at elucidating the pathways involved in
gingipain-induced caspase-dependent and -independent apoptosis in endothelial cells.
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CHAPTER FOUR

A. Gingipains induce endothelial cell detachment and apoptosis
Because of the relationship between oral health and overall health, P. gingivalis
being a major causative agent of periodontitis, and the association of P. gingivalis with
atherosclerosis, studying the involvement of the gingipains, its most prominent virulence
factor, in the pathogenesis of these diseases is quite valuable. To this end, the work
presented here elucidates the roles that the gingipains play in endothelial cell adhesion
disruption and apoptosis that could occur in the endothelium of the periodontal pocket
and the vascular system.
We have demonstrated that both coronary artery and micro vascular cells detach
and exhibit apoptotic morphology when treated with gingipain-active W83 extracts (Fig.
16 and 17). These phenomena did not occur if FLL32 extracts, which contain almost
negligible levels of active gingipains, or W83 extracts pre-treated with TLCK, to inhibit
gingipain activity, were used to treat endothelial cells. The observed cell death was
confirmed as apoptosis in four ways. First, the endothelial cell morphology after
treatment with gingipain active W83 extracts viewed with Hoffman Modulation Contrast
displayed shrunken cells with the formation of blebs (Fig. 16 and 17). This is consistent
with the characteristics of apoptosis. Secondly, one of the main defining attributes of
apoptosis is the activation of caspases. There was an approximately 4-fold increase in
caspase-3 and -7 activity 15 h after BCAEC were treated with gingipain-active W83
extracts (Fig. 18). Moreover, there was no increase of caspase-3 and -7 activity over
background levels in cells treated with FLL32. In addition, gingipain-active W83
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extracts pretreated-with TLCK did not exhibit early increased levels of caspase-3 and -7
activity. Thirdly, an early hallmark feature of apoptosis is the exposure of
phosphatidylserine on the cell surface as determined by annexin V binding. We show
that there was an increase to nearly 50% of annexin V positive cells by 24 h after
gingipain-active W83 addition to BCAEC (Fig. 18). In addition there was no evidence of
primary necrosis as evidenced by the lack of PI only positive cells. Finally, the presence
of apoptosis can be determined and distinguished from necrosis by the cleavage of the
caspase substrates PARP and Topo I. BCAEC treated with gingipain-active W83
extracts and not FLL32 extracts or gingipain-active W83 extracts pre-treated with TLCK
clearly displayed apoptotic cleavage fragments of PARP and Topo I (Fig. 19). These
multiple lines of evidence convincingly establish that gingipain-active W83 extracts
induced cell detachment and apoptosis in BCAEC.

B. Gingipains directly cleave CAMs
Because of the disruption in cell adhesion, we investigated whether CAMs were
affected by treatment with gingipain-active W83 extracts. In cell extracts treated with
gingipain-active W83 extracts there was cleavage of N-cadherin, VE-cadherin, and
degradation of integrin pi (Fig. 20). BCAEC integrin pi is cleaved rapidly after
exposure to gingipain-active W83 extracts with complete degradation of the full-length
protein by approximately 30 min. It should be noted that this proteolysis occurred when
BCAEC were still fully adherent. VE-cadherin cleavage begins to appear at 2 h with a
dramatic increase by 4h and almost total disappearance of the full length protein by 24 h.
N-cadherin cleavage occurs somewhat later than VE-cadherin with the appearance of a
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barely visible cleavage product at 2 h and a dramatic increase in cleavage at 6 h. In all
cases there was no cleavage of CAMs in BCAEC treated with FLL32 extracts. Cleavage
of integrin (31 and N-cadherin were prevented when BCAEC were treated with gingipainactive extracts pre-treated with TLCK to inhibit gingipain activity. However, there was
still cleavage of VE-cadherin, but cleavage occurred much later and the cleavage pattern
was different than with gingipain-active W83 extracts, possibly due to incomplete
gingipain inhibition by TLCK (Fig. 18). This could leave low levels of active gingipains
to cleave VE-cadherin, but at a slower rate, possibly producing intermediate fragments of
differing size compared to treatment with gingipain-active W83 extracts. However, it is
unclear why VE-cadherin was susceptible to cleavage in the presence of gingipain-active
W83 extracts inhibited by TLCK and N-cadherin and integrin (31 were not.
Alternatively, other bacterial or host cell factors could be responsible for this cleavage,
although this seems unlikely, since cells treated with FLL32 extracts show no VEcadherin cleavage and immunoprecipitated cadherins are directly degraded by treatment
with gingipain-active W83 extracts [see below]. Since there were low levels of apoptosis
present in BCAEC treated with gingipain-active W83 extracts pre-treated with TLCK
(Fig. 17), VE-cadherin cleavage could be a by-product of apoptosis; however, there was
no VE-cadherin cleavage when apoptosis was induced with staurosporine (data not
shown).
In order to confirm that the CAMs were cleaved directly by gingipains and not
BCAEC-produced proteases, N-cadherin and VE-cadherin were immunoprecipitated
from untreated BCAEC. Immunoprecipitated N-cadherin and VE-cadherin were then
treated with gingipain-active W83 extracts. This in vitro, cell-free system confirmed that
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the gingipains directly cleave CAMs (Fig. 21). As expected, N-cadherin and VEcadherin treated with FLL32 and gingipain-active W83 extracts pre-treated with TLCK
were unaffected. Because immunoprecipitated N-cadherin and VE-cadherin most likely
do not possess their native cellular confirmation, the gingipains had greater access to
cleavage locations producing a more rapid and complete degradation of the full length
proteins and not the cleavage pattern demonstrated in experiments with cells.

C. Synthetic peptide caspase inhibitors modulate Kgp activity
Because of the discovery of the structural similarity of caspase-3 and RgpB (88)
and their relatedness [refer to Chapter 1 section F. 1.], the exploration of caspase activity
and gingipain activity is beginning to be investigated. Recent reports have shown that
gingipain activity can be modulated by caspase inhibitors. For instance, p35 and a point
mutant of CrmA inhibited Kgp activity (323) and P. gingivaUs-m&\icQ& cleavage of pl20,
paxillin, and FAK in epithelial cells was inhibited by caspase inhibitor I [z-Val-AlaAsp(OMe)-CH2F] and not caspase inhibitor III [Boc-Asp(OMe)-CH2F] (150). We
present here in this work the first demonstration of peptide caspase inhibitors modulating
Kgp activity. In light of our results, it would appear that Kgp proteolyses these CAMs in
epithelial cells since our results show that Kgp is inhibited by z-VAD-FMK and not BocD-FMK (Fig. 23). It is tempting to speculate that Kgp would cleave these same proteins
in endothelial cells, as well, and it will be interesting to determine if HRgpA and RgpB
are able cleave these molecules and if they are not cleaved by HRgpA and/or RgpB it
would suggest that they are not involved in inducing apoptosis. However, these
assumptions must be confirmed. The nature of the interaction of z-VAD-FMK and Kgp
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is unknown at this time, but it may involve the ability of the o-methylated aspartic acid,
which is present in the z-VAD-FMK that was used in these experiments, to fit into the
active pocket of Kgp, as lysine would. This would allow the FMK group to form a
covalent bond between the two, thereby rendering the z-VAD-FMK irreversibly bound to
Kgp in the cleavage pocket and inactivating it. Investigations of the three-dimensional
structure of Kgp, its cleavage pocket, and the peptide caspase inhibitors will prove
interesting and should help to explain the different abilities of caspase inhibitors to
interact with Kgp and possibly Rgp.

D. Delineating the involvement of Kgp and Rgp activity in BCAEC detachment and
apoptosis through the use of z-VAD-FMK and/or leupeptin
In order to ascertain the involvement of Kgp in endothelial cell detachment we
incubated gingipain-active W83 extracts with z-VAD-FMK to inhibit Kgp activity [W83
+ z-VAD]. We also pre-treated BCAEC with z-VAD-FMK to inhibit Kgp activity when
gingipains were added to the cells [100 pM z-VAD prior to W83]. This treatment will
also inhibit BCAEC caspase activity, as well. When Kgp activity in gingipain-active
W83 extracts was inhibited by z-VAD-FMK [W83 + z-VAD and 100 pM z-VAD prior to
W83], detachment was significantly (p<0.05) reduced at early time points (3 h, 6h, and
12 h) as compared to gingipain-active W83 extracts (Fig. 24 and 26). These results
implicate Kgp in facilitating the detachment of BCAEC since its activity quickens
cellular detachment. Intriguingly, we found that when the caspases are inhibited by zVAD-FMK that gingipain-active W83 extracts still induced apoptosis with more
pronounced blebbing (Fig. 24). This suggests that Rgp activity induces caspase-
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independent apoptosis. It has been proposed that the most probable reason for caspase
inhibitor failure is its inability to prevent, in some cases, cytochrome c release (68) and
mitochondrial outer membrane permeabilization, a key event and the commitment point
in apoptosis (196). Moreover, it has been suggested that caspase inhibitors only inhibit
death receptor mediated apoptosis and do not inhibit mitochondrial mediated apoptosis
(125, 291), suggesting that gingipains induce the intrinsic pathway of apoptosis.
To elucidate the role of Rgp activity in BCAEC detachment and apoptosis, we
treated gingipain-active W83 extracts with leupeptin [W83 + leupeptin] to inhibit Rgp
activity and also pre-treated endothelial cells with leupeptin prior to the addition of
gingipain-active W83 extracts [100 pM leupeptin prior to W83]. Treatment of BCAEC
with leupeptin prior to the addition of gingipain W83 extracts appeared to delay
detachment as did pre-treatment of gingipain-active W83 extracts with leupeptin (Fig.
25). However, only 100 pM leupeptin prior to W83 at 3 h was detachment significantly
(p=0.05) inhibited (Fig. 26). This indicates that Kgp activity had a considerable
involvement in detachment of BCAEC, which was confirmed by including z-VAD-FMK
in the treatment of BCAEC with leupeptin. BCAEC treated with gingipain-active W83
extracts pretreated with both leupeptin and z-VAD-FMK [W83 + leupeptin + z-VAD],
inhibiting both Rgp and Kgp activity, exhibited significantly (p<0.05 at all time points)
more attached cells than only leupeptin treatment or gingipain-active W83 extracts at
early time points (Fig. 25 and 26). Furthermore, pre-treatment of BCAEC with both
leupeptin and z-VAD-FMK prior to the addition of gingipain-active W83 extracts [100
pM leupeptin + z-VAD prior to W83] displayed even more attached cells (p<0.05 at all
time points) (Fig. 25 and 26). These results implicate both Rgp and Kgp activity in
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endothelial cell detachment, especially since inactivation of Rgp and Kgp activity in
gingipain-active W83 extracts, produced levels of detachment in BCAEC after treatment
that were not significantly different than treatment of gingipain-active W83 extracts with
TLCK (p>0.06 at all time points for both W83 + leupeptin + z-VAD and 100 pM
leupeptin and z-VAD prior to W83) (Fig. 26). The interaction of both Rgp and Kgp to
cause cell detachment has also been demonstrated in KB cells (268).
Experiments with leupeptin produced somewhat confounding results. Treatment
of BCAEC with purified Kgp, at the levels used in our experiments, did not cause
apoptosis (Fig. 22). Therefore, it would be expected that treatment of gingipain-active
W83 extracts and/or pre-treatment of BCAEC with leupeptin, which would leave Kgp
activity unaffected, would not cause apoptosis. However, we found no visible difference
in the levels of cells with apoptotic morphology in cells treated with leupeptin prior to the
addition of gingipain-active W83 extracts [100 pM leupeptin prior to W83] or with
gingipain-active W83 extracts pre-treated with leupeptin [W83 + leupeptin] as compared
to BCAEC treated with gingipain-active W83 extracts (Fig. 25). In addition, pre
treatment of gingipain-active W83 extracts with leupeptin and z-VAD-FMK [W83 +
leupeptin + z-VAD] and cells pre-treated with 100 pM leupeptin and 100 pM z-VADFMK [100 pM leupeptin + z-VAD prior to W83] also had levels of apoptosis that were
indistinguishable from treatment with gingipain-active W83 extracts at 24 h (data not
shown). However, in subsequent experiments that quantified the level of detachment
induced by gingipain-active W83 extracts in the presence of BCAEC pre-treated with
leupeptin and z-VAD-FMK [100 pM leupeptin and z-VAD prior to W83] had
significantly (p<0.05) fewer detached cells than cells treated with gingipain-active W83
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extracts all time points tested (Fig. 26), which would also suggest that the level of
apoptotic cells would also be lower than in cells treated with gingipain-active W83
extracts. These results imply that there were variances in the ability of the inhibitors to
abrogate gingipain activity.
These apoptotic morphological observations were confirmed by monitoring
cleavage of PARP and Topo I to their apoptotic fragments.

Cleavage of PART to the 85

kD apoptotic fragment was largely prevented in BCAEC treated with gingipain-active
W83 extracts in the presence of caspase-inhibiting concentrations of z-VAD-FMK [100
pM z-VAD prior to W83], but was present when only Kgp activity was inhibited [W83 +
z-VAD] (Fig. 27). These results confirm that the caspases are responsible for the
cleavage of PARP and that the cell death produced by Rgp activity in endothelial cells
was apoptotic. In addition, it appears that the caspase-independent apoptosis triggered by
Rgp activity [100 pM z-VAD prior to W83] may be able to produce a low level of PARP
cleavage which may be essential to its progression. Alternatively, it is possible that zVAD-FMK may not have inhibited all of the caspase activity, which does not seem
probable [see Chapter 4 section G.]. It has been reported that nuclear fragmentation was
the only apoptotic feature inhibited by z-VAD-FMK (87) and that z-VAD-FMK could
not prevent PARP cleavage but did prevent DEVDase activity (75), but other reports
indicate that PARP cleavage was completely inhibited (376) and cytochrome c release
was completely blocked (300) by z-VAD-FMK. These seemingly conflicting results may
be explained by the fact that caspase-independent cell death can display any degree and
combination of other apoptotic features, as mentioned in chapter 1 section H.2. and that
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there may be cell type specific aspects to z-VAD-FMK inhibition and/or caspaseindependent apoptosis.
Inhibiting Rgp activity in gingipain-active W83 extracts with leupeptin [W83 +
leupeptin] did not inhibit the cleavage of PARP to its apoptotic fragment (Fig. 28). Pre
treating BCAEC with leupeptin before treating with gingipain-active W83 extracts [100
pM leupeptin prior to W83] only had slight inhibitory effects on the production of the
apoptotic fragment of PARP (Fig. 28). Only in the presence of both leupeptin and zVAD-FMK [W83 + leupeptin + z-VAD and 100 pM leupeptin + z-VAD prior to W83]
did the cleavage of full length PARP appear to be slightly inhibited (Fig. 28).
Collectively, these results confirm that BCAEC died via an apoptotic pathway.
Cleavage of Topo I to the 70 kD apoptotic fragment was inhibited in BCAEC
treated with gingipain-active W83 extracts in the presence of z-VAD-FMK when the
caspases were inhibited [100 pM z-VAD prior to W83], but was present when only Kgp
activity was inhibited [W83 + z-VAD] (Fig. 27). Similar to PARP, these results confirm
that apoptosis was induced in the presence of z-VAD-FMK. In addition, these results
indicate that the caspases were also responsible for the cleavage of Topo I and its
cleavage was not required for the progression of caspase-independent apoptosis triggered
by Rgp activity. However, the results of apoptotic cleavage of Topo I during gingipaininduced apoptosis was not as clear as with PARP cleavage because of the presence of a
45 kD fragment. As mentioned previously, it appears that gingipains cleave Topo I to a
45 kD fragment [Chapter 2 section E. and (318)], which is the same size fragment that
occurs during necrosis (47).
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Monitoring the cleavage of Topo I to its apoptotic fragment during gingipaininduced apoptosis in the presence of leupeptin also indicated that apoptosis occurred. In
all treatment conditions with leupeptin, there appears to be more uncleaved Topo I (Fig.
35). In addition, in the presence of both leupeptin and z-VAD-FMK the cleavage of the
full length Topo I appeared to be inhibited (Fig. 35).

E. Delineation of the roles of Kgp and Rgp activity in CAM cleavage through
inhibition studies
Not only did we investigate the role that Kgp played in cell detachment and
apoptosis, but we also examined CAM cleavage induced by gingipain-active W83
extracts in the presence of z-VAD-FMK. The two treatment conditions [W83 + z-VAD
and 100 pM z-VAD prior to W83] produced very similar results (Fig. 29), indicating that
the caspases do not play a predominant role in the cleavage of N-cadherin, VE-cadherin,
and integrin (31 in gingipain-induced apoptosis. The only slight difference is in the
degradation of integrin (31. There appears to be less undegraded integrin (31 in cells pre
treated with z-VAD-FMK [100 pM z-VAD prior to W83] as compared to gingipainactive W83 extracts pre-treated with z-VAD-FMK [W83 + z-VAD], indicating that Kgp
activity was responsible for the degradation of integrin |31. This effect was most likely
due to more complete inhibition of Kgp activity by pre-treating BCAEC with z-VADFMK, but degradation as a by-product of detachment and/or apoptosis cannot be
completely ruled out. The 30 kD cleavage fragment still occurred in the presence of zVAD-FMK but the group of 65 kD fragments was absent indicating that both Kgp and
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Figure 35. Cleavage of Topo I is partially inhibited in the presence of leupeptin and z-VAD-FMK. 20 pg
of total protein from BCAEC treated, in the presence of 5 mM L-cysteine, with gingipain-active W83 extract
(307.5 Units Rgp activity/ml media and 19.4 Units Kgp activity/ml media), 100 pM z-VAD-FMK and/or
100 pM leupeptin prior to exposure to gingipain-active W83 extracts (100 pM leupeptin prior to W83 or 100
pM leupeptin and z-VAD prior to W83), or gingipain-active W83 extracts preincubated with 100 pM z-VADFMK and/or 100 pM leupeptin (W83 + leupeptin or W83 + leupeptin + z-VAD) were separated by SDS-PAGE
and immunoblotted with a monoclonal antibody to PARP. Arrows indicate cleavage products, whereas lines
indicate intact proteins. Un, untreated.

Rgp cleave N-cadherin (Fig. 29). Similarly, VE-cadherin is cleaved by both Rgp and
Kgp activity (Fig.29).
We also examined CAM cleavage induced by gingipain-active W83 extracts in
the presence of leupeptin. The inhibition of Rgp activity by treating either gingipainactive W83 extracts [W83 + leupeptin] or BCAEC prior to the addition of gingipainactive W83 extracts with 100 pM leupeptin [100 pM leupeptin prior to W83] revealed
that N-cadherin is cleaved to a 30 kD fragment by Rgp activity and the group of 65 kD
fragments by Kgp activity (Fig. 30). In addition, these experiments demonstrated that
VE-cadherin was cleaved by both Rgp and Kgp while integrin (31 was degraded by Kgp
activity. These experiments also further suggest that gingipain activity was not
completely inhibited by leupeptin or the combination of leupeptin and z-VAD-FMK. At
later time points there was complete degradation of integrin pi (Fig. 36) and almost
complete disappearance of full length N-cadherin (Fig. 37) and VE-cadherin (Fig. 38) in
the presence of both leupeptin and z-VAD-FMK. Therefore, in our experiments a greater
concentration of leupeptin may have been needed and possibly the addition of
ethylenediaminetetraacetic acid (EDTA), which also inhibits Rgp activity (56, 74), to
inhibit the functional ability of gingipain extracts to induce cell detachment, CAM
cleavage, and apoptosis.

F. Purified gingipains induce BCAEC detachment and apoptotic morphology
As a final confirmation that the gingipains directly caused BCAEC detachment
and apoptosis, BCAEC were treated with purified HRgpA, Kgp, and RgpB. All three
gingipains were able to cause detachment with RgpB-induced detachment occurring).
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Figure 37. Cleavage of N-cadherin is less affected by leupeptin and z-VAD-FMK
treatment at later time points. 12 jug of total protein from BCAEC, in the presence
of 5 mM L-cysteine, with gingipain-active W83 extract (307.5 Units Rgp activity/ml
media and 19.4 Units Kgp activity/ml media), 100 pM z-VAD-FMK and/or 100 pM
leupeptin prior to exposure to gingipain-active W83 extract (100 pM leupeptin prior to
W83), or gingipain-active W83 extracts preincubated with 100 pM z-VAD-FMK
and/or 100 pM leupeptin (W83 + leupeptin + z-VAD or W83 + leupeptin) were
separated by SDS-PAGE and immunoblotted with a monoclonal antibody to Ncadherin. Arrows indicate cleavage products, whereas lines indicate intact proteins.
Un, untreated.
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Figure 38. Cleavage of VE-cadherin is less affected by leupeptin and z-VAD-FMK
treatment at later time points. 20 pg of total protein from BCAEC, in the presence of
5 mM L-cysteine, with gingipain-active W83 extract (307.5 Units Rgp activity/ml media
and 19.4 Units Kgp activity/ml media), 100 pM z-VAD-FMK and/or 100 pM leupeptin
prior to exposure to gingipain-active W83 extract (100 pM leupeptin prior to W83), or
gingipain-active W83 extracts preincubated with 100 pM z-VAD-FMK and/or 100 pM
leupeptin (W83 + leupeptin + z-VAD or W83 + leupeptin) were separated by SDSPAGE and immunoblotted with a monoclonal antibody to VE-cadherin. Arrows
indicate cleavage products, whereas lines indicate intact proteins. Un, untreated.
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much later than HRgpA- or Kgp-induced detachment (Fig. 22 Unexpectedly, BCAEC
treated with Kgp, after initially detaching and displaying cellular blebs, were able to re
adhere to the culture surface with no apparent loss of cell viability. In addition, the
detached cells produced by Kgp appear to still adhere to one another, whereas cells
detached in the presence of HRgpA or RgpB were single, individual cells that
subsequently died with apoptotic morphology. The later detachment and apoptosis
produced by RgpB is not unexpected and can be explained by absence of an adhesin
domain. The adhesin domain of HRgpA, and most likely Kgp as well, provides a means
of attachment to cells (53, 54) through integrin pi (314) that RgpB does not have.
Moreover, HRgpA has been shown to be more effective than RgpA(cat) in decreasing the
expression of integrin pi (314) because of the adhesion domain accelerating the binding
of HRgpA to the cell.
We also treated BCAEC with purified gingipains in the presence of 100 pM
leupeptin and/or 100 pM z-VAD-FMK (Fig. 33). As we expected, the leupeptin
inhibition of HRgpA and RgpB activity strongly inhibited cell detachment and apoptosis
and did not affect Kgp reattachment and viability. As expected, purified Kgp in the
presence of 100 pM z-VAD-FMK did not cause BCAEC detachment (Fig. 33). When
both leupeptin and z-VAD-FMK were present, inhibiting both Rgp and Kgp activity,
there was no detachment or apoptosis induced by the purified gingipains. HRgpA and
RgpB still induced apoptosis with more pronounced blebbing (Fig. 33).
In our experiments we used a final concentration of 100 pM leupeptin, which may
be sufficient to inhibit Rgp activity of purified HRgpA and RgpB in which much lower
total protein amounts and activity units were used, but may not inhibit all of the Rgp
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activity in gingipain-active W83 extracts. To inhibit gingipain proteolytic activity,
concentrations of 1 pM, 20 pM, 200 pM, and even 500 pM leupeptin have been used
(38, 107, 180, 283), with RgpB being less affected by leupeptin treatment than RgpA(cat),
leaving approximately 0 to 30% active RgpB after treatment with 1 pM leupeptin (38)
and 6% active RgpA and 34% active RgpB after treatment with 20 pM leupeptin (107).
These concentrations of leupeptin may be sufficient to inhibit Rgp activity in vitro, but
higher amounts of leupeptin may be necessary to prevent effects produced in cell culture.
There is a recent report that used 3.3 mM leupeptin to inhibit the ability of P. gingivalis
to migrate through matrigel (7).
Similarly, we routinely incubate gingipain-active W83 extracts with 10 mM
TLCK to prevent gingipain-induced cell detachment and apoptosis when lower levels are
usually used to inhibit gingipain activity. 100 pM TLCK has been demonstrated to
inhibit 80% of purified Rgp activity and 100% of purified Kgp activity (280) whereas
treatment with 8 mM TLCK still leaves approximately 10 to 20% of Rgp activity (38).
However, 1 mM TLCK is routinely used to inhibit gingipain activity (56, 74). In our
system 10 mM TLCK inhibits approximately 96% of Rgp activity and 98% of Kgp
activity in gingipain-active W83 extracts in vitro (Fig. 23). This incomplete inhibition
would leave low levels of active gingipains that could still induce cell detachment and
apoptosis (Fig. 24) and cleavage of VE-cadherin (Fig. 29).
It is conceivable that the remaining Rgp activity in gingipain-active W83 extracts
that was not inhibited by 100 pM leupeptin could either induce the observed cellular
changes or it could work together with the effects of Kgp activity over a 24 h time course
to trigger the observed apoptosis. However, we cannot rule out the possibility that there
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are other factors that could also induce apoptosis. In support of this, a recent report
demonstrated that a gingipain-inactive P. gingivalis mutant induced low levels of
apoptosis, suggesting that the gingipains were not absolutely necessary, but were required
for optimal apoptosis induction (354). This is not surprising since their system employed
live, infective P. gingivalis bacteria which have been shown to modulate both antiapoptotic and pro-apoptotic pathways [see Chapter 1 section I.]. However, in our noninfective system, these other factors would appear to be protease(s) and be inhibited by
TLCK treatment, since detachment and apoptosis are not seen in cells treated with
gingipain-active W83 extracts that were pre-treated with TLCK (Fig. 16). These factors
would also be insensitive to leupeptin treatment, ruling out calpains, lysosomal cysteine
proteases, and the proteasome (178) as possible proteases involved. In addition, these
proteases would not be present in extracts from FLL32, which are prepared similarly to
gingipain-active W83 extracts, or activated in cells treated with FLL32 extracts do not
induce endothelial cell detachment and apoptosis (Fig. 16). From these facts it would
seem unlikely that under our tested conditions there would be proteases other than the
gingipains that induce detachment and apoptosis in our preparations of gingipain-active
W83 extracts and it would seem that incomplete inhibition of gingipain activity would be
a more probable explanation.
As confirmation of apoptotic morphology, cleavage of the caspase substrates
PART and Topo I were monitored in BCAEC treated with purified gingipains. As
expected apoptotic cleavage products were present in BCAEC treated with HRgpA by 6
h and RgpB at 24 h and only a barely visible 85 kD PARP fragment was present in
BCAEC treated Kgp (Fig. 31), possibly explained by the slight increase in DEVDase
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activity [see Chapter 4 section G. and Fig. 34]. Results of apoptotic cleavage of Topo I
exhibited similar involvement of the purified gingipains with similar kinetics (data not
shown).

G. Gingipains induce caspase-independent apoptosis
We found that when the caspases are inhibited by z-VAD-FMK that gingipainactive W83 extracts, HRgpA, and RgpB still induced apoptosis with more pronounced
blebbing (Fig. 24 and 33). This suggests that HRgpA and RgpB induce caspaseindependent apoptosis. This was similar to a recent study implicating a serine protease in
the induction of caspase-independent apoptosis. It reported that in the presence of zVAD-FMK there was more pronounced apoptotic blebbing and that nuclear
fragmentation was the only apoptotic feature inhibited by z-VAD-FMK (87).
In the presence of 100 pM z-VAD-FMK apoptosis was induced, but the caspases
could still be active. To ensure that the caspases were inhibited we treated BCAEC with
a cocktail of caspase inhibitors [z-VAD-FMK, z-YVAD-FMK, and z-DEVD-FMK] with
similar results as BCAEC treated with z-VAD-FMK (data not shown). To verify that in
the presence of z-VAD-FMK that at least these caspases were, in fact, inhibited, we
tested for caspase-3 and -7 activity. Figure 34 demonstrated that gingipain-active W83
extracts and purified gingipains did trigger DEVDase activity that was prevented in the
presence of 100 pM z-VAD-FMK 18 h after the addition of gingipains. These results
confirm that z-VAD-FMK was still active, as has been demonstrated in other long time
course assays (383). Unexpectedly, BCAEC treated with purified Kgp, which did not
induce apoptosis, had a slight, increase in DEVDase activity that could be significantly
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(p<0.03) inhibited by z-VAD-FMK, which may explain the slight induction of the 85 kD
apoptotic PARP cleavage product (Fig. 31). It is known that Kgp expression is upregulated with prolonged host cell contact (8). Therefore, the slight increase in DEVDase
activity in BCAEC treated with purified Kgp raises the possibility that Kgp activity at
higher levels may be able to induce apoptosis. The gingipain concentration in GCF at
inflamed sites was found to be 0.1 pM, but the local concentration could be much higher
around P. gingivalis since gingipains are not only secreted, but also are bound to the
bacterial cell surface and released from the bacteria as outer membrane blebs (335). In
the bulk of our experiments, we used much less than 0.1 pM, but an initial experiment
that used purified gingipains at higher levels than what may be found in vivo,
demonstrated that all three gingipains, including Kgp, induce cell detachment and
apoptosis (Fig. 39). This is consistent with a study that found that low concentrations of
HRgpA did not induce cell detachment and cell death while higher concentrations did
(313) and the threshold level varied for different cell types.
The apoptotic morphology in the confirmed absence of active caspase-3 and -7
strongly suggests that HRgpA and RgpB can induce caspase-independent apoptosis
However, we cannot rule out the possibility that other caspases could be active in the
presence of z-VAD-FMK and mediate HRgpA- and RgpB- induced apoptosis. This does
not seem plausible since apoptotic morphology still occurred in the presence of a cocktail
of caspase inhibitors that contained z-VAD-FMK, a general caspase inhibitor, z-YVADFMK, which inhibits caspase-1 and -4, and z-DEVD-FMK, which inhibits caspase-3 and
-7. It has been demonstrated that z-VAD-FMK penetrates cells and inhibits all caspases,
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Figure 39. High levels of purified Kgp induce cell detachment and apoptosis.
BCAEC were treated with 50mM potassium phosphate (control) or 200 pg/ml HRgpA
and Kgp or 100 pg/ml RgpB in the presence of 5 mM L-cysteine for the times indicated.
The arrows indicate cells with typical apoptotic morphology. Note at 20 h BCAEC
treated with purified Kgp are still detached and apoptotic and this effect was inhibited
by pre-incubation of Kgp with 10 mM TLCK.
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but can only prevent caspase-dependent apoptosis, such as death receptor signaling, and
cannot prevent a co-stimulated caspase-independent pathway, such as ER stress (87).
Interestingly, this same report describes a currently unknown serine protease-induced
apoptosis with extensive surface blebbing in the absence of caspases that occurs via
perforation of the mitochondrial membrane (87).

H. The roles of HRgpA, Kgp, and RgpB in CAM cleavage
It should be noted that BCAEC treated with purified Kgp, which reattach and
remain viable during the time course, still exhibited cleaved/degraded CAMs, most
notably integrin (31 (Fig. 32). This indicates that Kgp remains active throughout the
experiment and the re-attachment of the cells was not because of the loss of Kgp activity.
In viable BCAEC treated with purified Kgp there is no full length integrin pi, whereas
detached apoptotic BCAEC treated with HRgpA or RgpB still have some full length
protein (Fig. 32 and 36). This would suggest that signaling pathways triggered by the
loss of functional integrin pi do not play a role in gingipain-induced apoptosis. P.
gingivalis activates PI3-K/Akt pathways to increase host cell survival in response to
apoptotic triggers (387), raising the possibility that in BCAEC treated with purified Kgp
that these same pathways are activated to prevent initiation of apoptosis in response to
cell detachment. In addition, the cytosolic domain of integrin requires membrane
localization to promote apoptosis, and it is possible that cleavage of the p integrin
cytosolic domain observed in ECM-deprived cells may even act to delay apoptosis by
preventing integrin mediated death (332). Studies of the survival and/or apoptotic
pathways that are activated in response to the different gingipains will be very exciting.
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Since N-cadherin signaling exerts an anti-apoptotic function by complexing with procaspase-8 which interferes with the recruitment of procaspase-8 to the DISC and
initiation of apoptosis (133), cleavage of N-cadherin, and the possible loss of functional
N-cadherin, may be integral to the initiation of gingipain-induced apoptosis. N-cadherin
cleavage by HRgpA produces a single cleavage product of 30 kD, whereas Kgp cleavage
produces a group of products approximately 65 kD and a 30 kD product and RgpB does
not cleave N-cadherin within the time frame tested (Fig. 32). This suggests that cleavage
of N-cadherin is not vital to the apoptotic trigger by gingipains since BCAEC treated with
RgpB have no cleaved N-cadherin, but are apoptotic and BCAEC treated with Kgp have
cleaved N-cadherin, but are healthy. Interestingly, at 24 h there appears to be decreased
levels of N-cadherin cleavage by Kgp, as evidenced by the disappearance of some of the
cleavage products in the 64 kD group and the 30 kD cleavage product (Fig. 40). As
stated earlier, Kgp is still able to cleave integrin p 1 and, therefore, is still functioning, but
it does not cleave N-cadherin as readily as at earlier time points. This suggests that
BCAEC in some way are able to protect N-cadherin from cleavage by Kgp. A similar
phenomenon was exhibited by Kgp in cleavage of TNF-a. HRgpA was shown to have
the most activity toward TNF-a, but Kgp was able to cleave TNF-a if its re-expression
was prevented, suggesting that its loss could be compensated for by de novo synthesis
(250).
The kinetics of VE-cadherin cleavage parallel the detachment produced by
HRgpA, Kgp, and RgpB, but is most apparent in cells treated with RgpB. At 6 h BCAEC
are still attached in the presence of RgpB and there is no cleavage of VE-cadherin, but at
12 h nearly all cells are detached and a 52 kD cleavage product is visible (Fig. 41). In
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Figure 40. Synergism of purified gingipains in induction of N-cadherin cleavage over 24 h. 15 pg
of total protein from BCAEC in the presence of 5 mM L-cysteine, with purified HRgpA (8 pg/ml), Kgp
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to integrin pi. Arrows indicate cleavage products, whereas lines indicate intact proteins. Un, untreated.
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Figure 41. Synergism of purified gingipains in induction of VE-cadherin cleavage over 24 h. 15 jug of total protein
from BCAEC treated in the presence of 5 mM L-cysteine, with purified HRgpA (8 pg/ml), Kgp (3 jug/ml), or RgpB (5.2
pg/ml) (all equivalent to 113 Units of Rgp activity/ml media or 12.4 Units of Kgp activity/ml media) were separated by
SDS-PAGE and immunoblotted with monoclonal antibodies to VE-cadherin. Arrows indicate cleavage products, whereas
lines indicate intact proteins. Un, untreated.

addition, full length VE-cadherin levels from cells incubated with Kgp appear initially
low and increase to levels found in untreated BCAEC (Fig. 41). Because the half-life of
VE-cadherin on the cell membrane is approximately six to seven hours (24) it is possible
that increased expression could be seen within this 24 h time course. Collectively, these
results suggest that BCAEC treated with purified Kgp are able to counteract its effects
and recover, possibly somehow protecting N-cadherin from cleavage and/or upregulation of VE-cadherin. The possible up-regulation of VE-cadherin may be a result of
the loss of integrin ligation (371) by gingipain cleavage. The protection of N-cadherin
from cleavage, may be in order to maintain cell growth, because the loss of N-cadherin
induces growth arrest (235), and the up-regulation of VE-cadherin may be an inter
related phenomenon since N-cadherin expression can regulate VE-cadherin expression
(235). Because of the apparent synchronicity between detachment and VE-cadherin
cleavage and the possibility of increased expression levels of VE-cadherin in cells treated
with Kgp, VE-cadherin may be a key player in gingipain-induced endothelial cell
detachment and apoptosis. However, the role N-cadherin plays in gingipain-induced
BCAEC apoptosis cannot be completely eliminated because of its apparent lack of
cleavage in apoptotic cells induced by treatment with RgpB. It may be that in cells
treated with Kgp, N-cadherin and VE-cadherin expression were linked and used to
overcome the loss of functional integrin p 1, while in cells treated with RgpB other
molecules were involved that were able to over-ride the presence of functional full length
N-cadherin and induce apoptosis. Because of the different abilities of the gingipains to
cleave CAMs, to induce detachment, and apoptosis, it can be assumed that HRgpA,
RgpB, and Kgp have differing abilities to cleave other cellular proteins producing the
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dramatic divergence in cell survival between these gingipains. Further investigation to
define these differences in cleaved proteins and the apoptotic pathway members involved
between the purified gingipains will help pinpoint the nature of the Rgp-induced
apoptotic trigger. For example, this work has only focused on the involvement of
gingipains with integrin (31, but there are several other (3 integrins, not to mention all of
the a integrins. It is conceivable that there may be differences in the ability of the
specific gingipains to cleave one of these other integrins that may be the pivotal protein
involved in gingipain-induced apoptosis in BCAEC. While these experiments must be
done and the results from these experiments will be enlightening, they will need to be
compared to experiments with purified HRgpA, Kgp, and RgpB in combination and with
gingipain-active W83 extracts to fully delineate the apoptotic pathway triggered by
gingipain treatment.

I. Implications for atherosclerosis
Because of the association of P. gingivalis with atherosclerosis, it is interesting
that the gingipains can induce apoptosis in coronary artery and microvascular endothelial
cells. It has been well established that endothelial cell death is an important feature of
atherogenesis (61), it is present in human atherosclerotic lesions (5), and numerous risk
factors for atherosclerosis induce endothelial cell apoptosis in vitro or increase the
number of circulating endothelial cells in vivo [reviewed in (330)]. The balance of
endothelial cell apoptosis and endothelial cell regeneration may determine the degree and
progression of atherosclerosis (379).
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Infectious agents need to invade and survive within a viable cell (118) in a
chronic or latent manner, rather than produce a productive or lytic infection in order to
maintain altered cellular functions for the long period of time necessary for atherogenesis
(190). A latent infection could have no effect on the vascular wall, it could induce
chronic alterations in vascular cell metabolism and functions, or it could be suddenly
reactivated and provoke inflammation and changes in the plaque promoting plaque
rupture (190). Secreted bacterial factors present in P. gingivalis culture may directly
target myocardial cells (208). Moreover, in the presence of P. gingivalis culture fluid
myocardial cells displayed phosphorylated ERK-1, DNA fragmentation, and condensed
nuclei that were all mediated via MEK-1/2 (208). The interaction of P. gingivalis factors
with the ERK pathway appear to be cell type specific (208). Recently, it was reported
that the mechanism by which P. gingivalis adheres or invades vascular tissue is critical
for the stimulating the accelerated development of atheromas (121). Furthermore, P.
gingivalis was localized to areas adjacent to apoptotic cells in atherosclerotic plaque (58).
In an experimental swine model of atherosclerosis Hasdai and colleagues demonstrated
for the first time that apoptotic cells are present in the vasculature before atheromatous
plaques developed, suggesting that apoptosis may be an integral process of early
atherosclerosis (142). The trigger for this apoptosis could be the proteolysis of molecules
involved in integrin-matrix interactions and could be of a bacterial origin (251).
Furthermore, it has been proposed that a disruption of the endothelial layer could
constitute the insult to start the atherosclerotic process (83). Collectively, these results
may suggest that not only could the gingipains of P. gingivalis play a dominant role in
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the vascular damage of the periodontal pocket, but also they may have a role in causing
the dysfunction of endothelial cells which can lead to atherosclerosis.
EPC express VE-cadherin (379). This fact has interesting consequences for our
work with VE-cadherin. EPC are involved in the regeneration of damaged or
dysfunctional endothelium and decreased numbers of EPC is associated with increased
risk of cardiovascular disease (379). Since gingipains can cleave VE-cadherin on
BCAEC, it is tempting to speculate that gingipains could also cleave VE-cadherin on
EPC. If VE-cadherin cleavage proves to be the key molecule in the induction of
apoptosis, this could have dire consequences for the endothelium and its regeneration and
repair, not mention for increased risk for atherosclerosis.

J. Similarities between bacterial-induced apoptosis pathways
This work demonstrates that gingipains induce cell detachment, CAM cleavage,
and apoptosis, which appears to be both caspase-dependent and caspase-independent.
Other bacteria bind integrins during their invasion processes and induce apoptosis to
infect other cells. For instance, invasion of epithelial cells by Neisseria gonorrhoea is
mediated by bacterial binding through integrins and the subsequent epithelial apoptosis is
thought to disrupt the mucosal lining and allow bacteria access to deeper tissues (111).
Moreover, apoptosis of either epithelial or endothelial cells could break the
epithelial/endothelial cell barrier permitting pathogens to reach the submucosa (123).
Like P. gingivalis, Yersinia species modulate the ECM. Yops affect the ECM of
mammalian cells. YopH binds pl40Cas and FAK and destabilizes focal adhesion points
and YopE depolymerizes actin microfilaments (255).
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The bimodal apoptotic induction is also not unique to P. gingivalis.
Streptococcus pneumoniae induces dendritic cell (65) and cerebral endothelial cell
apoptosis (30) by two distinct pathways one that is rapid and caspase-independent via
pneumolysin (30, 65) and H2O2 (30) and a second that has a delayed onset (30, 65) and is
dependent on caspases and cell maturation (65). Moreover, the structural similarity of a
virulence factor with caspases is also not unique to P. gingivalis. For example,
streptococcal pyogenic exotoxin B is structurally similar to caspase-1 and has been
speculated to synergize with caspase-1 in apoptosis induction (111).
Interestingly, P. gingivalis can recognize different host cell types and is capable
of targeting specific and distinct eukaryotic signaling pathways (8). For example, P.
gingivalis has been shown to be uniquely capable of selectively activating one MAPK
pathway and down-regulating another which may cause responses of epithelial cells to be
species and even strain specific (373). In addition, the effects that are produced in a
particular host cell may be specific to the infecting bacterial strain. Out of 15 clinical
isolates and a reference American Type Culture Collection (ATCC) strain 33277 of P.
gingivalis only one strain was cytotoxic to KB epithelial cells (89), Interestingly, the
strains used in this investigation had a higher lysine-specific cysteine protease activity
than the reference strain and there was no decrease in arginine-specific activity in strains
that did not possess an rgpB gene (89). These results suggest that not only may the
effects triggered be dependent on the host cell, but that the triggered effects may also be
related to the strain of P. gingivalis used, especially since our group has shown that P.
gingivalis W83 induced apoptosis in KB cells (55). P. gingivalis has also exhibited the
ability to modulate the NF-kB pathway differently during the course of infection. In
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gingival fibroblasts early NF-kB activation occurred with a later decrease in activity via a
PI3-K mediated pathway that appeared to not be mediated by the gingipains (354). It
may be possible that the anti-apoptotic effects of P. gingivalis infection in some cell
types early on signal through NF-kB similar to Rickettsia rickettsii, whose primary target
is vascular endothelial cells (377).
The recent findings that in human aortic endothelial cells fimbriae from P.
gingivalis modulated both pro-apoptotic and anti-apoptotic genes (60) and in gingival
fibroblasts both pro-apoptotic and anti-apoptotic Bcl-2 family members were regulated
(354) confirm that P. gingivalis could induce either apoptosis or resistance to apoptosis.
It appears that the pathway that prevails in a given cell depends on the balance of cell
death and survival pathways possessed by a particular cell type. Moreover, cells that
appear to be rather resistant detachment and to most types of apoptotic stimuli, such as
the osteosarcoma cell line U20S, may be sensitive to gingipain-induced apoptosis (data
not shown). These results also raise some questions. In cells that P. gingivalis can
induce apoptosis, is this because of pro-apoptotic signaling by P. gingivalis or is it
because of a specific survival signal that is absent in a particular host cell type which P.
gingivalis is exploiting? For instance, a recent report demonstrated that the same
apoptotic stimulus induced an intrinsic apoptosis that was caspase-dependent in one cell
type and caspase-independent in a different cell type (166), implying cellular differences
and not apoptotic stimulus differences. In cells that survive despite P. gingivalis
infection, is this because of P. gingivalis overriding the cell’s apoptotic reflex or because
the host cell is ‘ambivalent’ to the presence of the invading bacterium? It has been
proposed that the cell is responding to some change that bacteria cause by activating the
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apoptotic mechanism; they are not acting primarily to cause apoptosis (364). However,
an intriguing possibility is that the induction of apoptosis by P. gingivalis is a means to
acquire iron for its growth. Apoptosis releases into the cytosol cytochrome c that can
provide hemin following proteolytic processing (206). It would be interesting to
determine if in the presence of P. gingivalis cytochrome c is broken down to release
hemin or if apoptosis is not induced, if P. gingivalis uses some other molecule for hemin.
Nevertheless, further investigation that reveals the individual contributions of P.
gingivalis and the host cell in either apoptosis or cell survival, as appropriate, will be
quite fascinating.

K. P. gingivalis and calcium regulation
Gingipains have been shown to facilitate bacterial penetration (7), as well as,
modulate adherence to host cells (8, 54), but as yet a positive correlation between
gingipain activity and invasion efficiency has not yet been demonstrated (165).
However, during invasion of human coronary artery endothelial cells 62 genes were
differentially regulated (294) which did not include genes encoding the gingipains,
indicating that gingipain expression levels were unchanged before and after invasion,
similar to another recent report (399). In brief contact with primary gingival epithelial
cultures, secretion of gingipains was inhibited, while prolonged contact induced increased
secretion of Kgp (8). Furthermore, once inside the epithelial cell, P. gingivalis released
outer membrane vesicles that possess gingipain activity (8). These facts imply that the
expression of gingipains could affect numerous host cell signaling pathways both
extracellularly and intracellularly. One possible pathway that could be modulated by
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gingipains is that of calcium signaling. A report a decade ago demonstrated that infection
of gingival epithelial cells by P. gingivalis causes transient cytosolic calcium
concentration spikes (170). In this report the authors suggested that the rise in calcium
levels was needed by P. gingivalis for successful cell invasion (170). However, their
recent report revealed that increased calcium via entry through a calcium-permeable
channel was not needed for invasion, but may be required to maintain the intracellular
niche of P. gingivalis (27). In addition, they demonstrate that the oscillatory calcium
increases were both nuclear and cytoplasmic, were highest in nuclei and perinuclear
cytoplasm, and were not caused by a factor in P. gingivalis culture supernatants (27).
Evidence is emerging that the cell’s calcium distribution can protect cells or cause their
demise and even non-disruptive changes in calcium signaling could have adverse effects
on cell proliferation, differentiation, and viability (276). Increases cytoplasmic calcium
levels are relayed to the mitochondria and induce permeability transition pore opening
(195, 291) and loss of mitochondrial membrane potential (72). Interestingly, increases in
intracellular calcium levels also modulate the levels of endothelial nitric oxide synthase
(331), which may have a role in atherosclerosis. The pathway that modulates calcium
levels in host cells that is signaled by P. gingivalis infection is not yet defined. A
possible calcium signaling pathway that could be triggered by P. gingivalis involves
calcineurin. Calcineurin is a calcium/calmodulin-activated protein phosphatase that is
involved in calcium signaling and the activation of pro-apoptotic Bad via its
dephosphorylation and translocation to the mitochondria (276). P. gingivalis was shown
to increase the levels of calcineurin and Bad in myocardial cells (209).
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Another possible calcium signaling molecule that can be affected by P. gingivalis
is Bcl-2. Bcl-2 members, among other actions, act as cellular sensors for infection (196).
Bcl-2 is located on the mitochondria and on the endoplasmic reticulum, where the
concentration of calcium is very high (81). Gingival epithelial cells initially respond to
P. gingivalis infection by increasing Bax levels, DNA fragmentation (262), and
phosphatidylserine exposure via caspase activation (387), which are all features of
apoptosis. However, P. gingivalis was able to over-ride this response by increasing the
levels of Bcl-2 and decreasing the levels of Bax (262), reversing the initial progression of
apoptosis and keeping the cell viable. Moreover, these effects actually increased the
cells’ resistance to apoptosis to certain apoptotic inducers (262). At present, it is unclear
the effect that Bcl-2 has on cellular calcium levels. Some reports indicate that calcium
levels decrease in response to increased Bcl-2 levels, while other reports indicate that
calcium levels do not decrease [reviewed in (81)]. It will be interesting, as new evidence
emerges, defining the role that Bcl-2 has on the cell’s calcium levels, if P. gingivalis
modulates host cell survival through regulation of Bcl-2 and if the gingipains are able to
affect the levels of Bcl-2 and calcium in order to modulate apoptosis. Alternatively, it
has been proposed that P. gingivalis could affect mitochondrial function since P.
gingivalis and mitochondria co-localize to the perinuclear region and increases in calcium
levels would increase levels of ATP produced by the mitochondria, linking calcium
levels and mitochondrial energy production to cell activity (27). Another possibility is
that gingipains could modulate calcium levels directly initiating caspase activity and
apoptosis. Mitochondrial membrane permeability transition is a key mechanism
underlying apoptosis (186) and is calcium sensitive (72, 186, 213). There appears to be
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ample evidence for crosstalk between calpains, caspases, and other protease families and
have indicated new pathways that lead directly from a calcium signal to caspase
activation and apoptosis (276).

L. Involvement of anoikis in gingipain-induced apoptosis
A recent report speculated that P. gingivalis invaded epithelial cells and did not
cause cell death to acquire intracellular persistence, but if the invasion is rather quick
there was probably not enough time for complete P. gingivalis-mduced anti-apoptotic
signaling to initiate before pro-apoptotic signals induced some apoptotic morphology
(165). However, it has also been suggested that an initial delay of apoptosis would allow
P. gingivalis extra time to replicate intracellularly to a higher yield while providing
protection from the host immune system before inducing apoptosis for bacterial spread to
other cells (354). Anoikis could be triggered to prevent the lateral spread of bacteria and
aid in the removal of the infected host cell (320).
A recent report surmised that anoikis was induced in their system because the
levels of apoptosis were the same in endothelial cells grown in suspension in the presence
and absence of the tested apoptotic trigger (342). In addition, it has been reported that
suspension culture of endothelial cells produced 20 to 30% apoptosis by 24 to 30 h (249)
and 50% to 90% by 24 h to 48 h (144). These results suggest that the higher levels of
apoptosis in BCAEC induced by gingipains at earlier time points (Fig. 18) may not be
due to anoikis alone, but similar experiments comparing apoptotic levels of non-adherent
endothelial cells in the presence and absence of gingipains need to be performed.
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In intestinal epithelial cells, anoikis involved the activation of the initiator
caspases-2 and -9 within minutes of detachment followed by the activation of caspases-7,
-3, and -6, with caspase-8 activation occurring downstream of caspase-9 and -2 activation
(129). Caspase-1 and-10 remain inactive (129). Caspase-8 activation occurred
independently of downstream caspases or caspase-9 (129). Yet, the caspase-8 inhibitor zIETD was also able to block anoikis, suggesting that, indeed, at least two pathways of
caspase activation were activated for induction and execution of anoikis (129). This is
not unlike the caspase activation pathways signaled during P. gingivalis infection.
Because caspase-6, -7, -9, and -3 were activated and not caspase-8, -10, or -12, this
strongly points to a mitochondrial mediated apoptosis pathway in gingival fibroblasts
infected with P. gingivalis (354). Further investigations that define the hierarchy of
caspase activation in BCAEC need to be done to further clarify the role that anoikis plays
gingipain-induced apoptosis.
A recent report described two independent apoptotic mechanisms simultaneously
induced by a single stimulus. In the first pathway, there was breakdown of focal
adhesion components leading to anoikis, while the second was a direct effect through
receptor-mediated signal transduction pathways initiated by a cell adhesion domain
(342). This appears to be similar to gingipain-induced apoptosis in BCAEC. Gingipains
cleave many proteins involved in focal adhesion which can lead to anoikis. Secondly, the
cleavage of CAMs by gingipains, such as N-cadherin which is involved in pro-caspase-8
recruitment to the DISC (133), may induce apoptosis concurrently. Additionally,
gingipains can signal a third pathway of cell death that is caspase-independent [Chapter 3
and (319)]. This pathway is not caused by cell detachment since z-VAD-FMK has been
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shown to block anoikis (301) and is not mediated by the JNK pathway since active
caspases are needed for JNK to respond to the loss of cell-matrix contact (105).
The ability of gingipains to cleave other CAMs needs to be determined. For
example, it would be interesting to discover that gingipains up-regulate integrin-a3.
Increased integrin-a3 in calprotectin expressing cells may enhance cell-cell and cellmatrix adhesion, therefore limiting access and the time necessary for protease digestion
and cell detachment from the monolayer (268). It has been shown that gingipains cleave
FAK in oral keratinocytes which could be inhibited by peptide caspase inhibitors (150),
suggesting Kgp involvement in this cleavage [Chapter 3 and (319)]. The cleavage of
FAK has several consequences related to apoptosis induction. For example, loss of FAK
signaling triggers Bid and Bax translocation (290). In addition, FAK interacts directly
with receptor-interacting protein (RIP), which is a Fas binding protein that induces
apoptosis, and the caspase cleavage fragment of FAK inhibits FAK survival signaling
(290), raising the possibility that a gingipain-induced FAK cleavage fragment may also
be self inhibitory. Furthermore, the cleavage of FAK may disrupt its ability to be
phosphorylated and thereby activating p53 and cell death (163). The fact that Kgp may
cleave FAK and the inability of Kgp to induce apoptosis at the levels used in our studies
needs to be reconciled.

M. Non-caspase proteases and their involvement in apoptosis
The involvement of non-caspase proteases in some cases of apoptosis is suggested
by observations that inhibition of caspases generally causes delays, but does not fully
block cell death resulting from most apoptotic stimuli (178). The ability of proteases to
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implement apoptotic signaling in the absence of caspase activity is not uncommon, but to
our knowledge our work is the first demonstration that HRgpA and RgpB can induce a
caspase-3 and -7 independent apoptosis. The non-caspase proteases most closely
associated with apoptosis are cathepsins, calpains, and granzymes (178). Cathepsins are
translocated to the cytoplasm during apoptosis, the location where most of the known
apoptosis execution pathways occur, allowing these proteases to intersect with and
augment other apoptosis signaling mechanisms (178). Since HRgpA has been shown to
rapidly traverse the plasma membrane (313) there is the possibility that the gingipains
could interact with apoptotic signaling pathways similar to the cathepsins. Furthermore,
HRgpA enters the nucleus (313) which may provide even more possibilities for HRgpA
and possibly Kgp, since catalytic activity was not required for protease translocation, to
modulate host cell survival pathways. Calpains are known to cleave many important
proteins that are involved in cellular architecture which may be particularly important
during apoptosis [reviewed in (178)]. Because of the ability of gingipains to cleave FAK,
a substrate of both caspases (99) and calpains (178), paxillin, (P-catenin, y-catenin, pi 20,
integrin p4, Src, and pl30Cas (150) and other CAMs, such as N-cadherin, VE-cadherin,
integrin pi [Chapters 2 and 3 and (318, 319)], gingipains may have a similar role in
apoptosis as calpains. Further similarities reside in the ability of calpains (178) and
gingipains (354) to cleave pro-caspases, although the calpain-induced cleavage neither
activates nor inactivates caspase-3 and -9 (178), whereas gingipain cleavage does activate
procaspase-3. Calpain apoptotic pathways and caspase-mediated pathways can be inter
related (178) which raises a similar possibility for gingipains in light of our discovery of
the caspase-independence of gingipain-induced apoptosis [Chapter 3 and (319)].
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Because of the ability of granzyme A to cleave after lysine and arginine residues
and its ability to induce caspase-independent cell death, it is tempting to make a case that
gingipains may behave similar to granzyme A. While granzyme A is the most abundant
protease found in the granules of CTL cells and induces apoptosis after prolonged
exposure, its role in apoptosis induction is far more subtle than that of granzyme B (178).
However, treatment of cells with granzyme A and perforin, a protein also released from
granules that permeabilizes cell membranes, can induce a caspase-independent, rapid
accumulation of DNA strand breaks with subsequent nuclear condensation without the
cleavage of PARP and lamin B (178). Granzyme A-induced cell death is marked by
rapid induction of other apoptotic features, including loss of membrane integrity with
blebbing, loss of mitochondrial membrane potential and production of ROS, chromatin
condensation, and nuclear fragmentation (28, 94, 95). Mitochondrial cytochrome c
release, oligonucleosomal DNA fragmentation, caspase activation, and Bcl-2 over
expression, all hallmarks of caspase-dependent apoptosis, are absent from granzyme Ainduced apoptosis (94). The single stranded DNA (ssDNA) breaks are formed by a
granzyme A activation of a DNase in the acute undifferentiated leukemia patient SE gene
T (SET) complex (29), reported to be non-metastatic protein 1 (NM23-H1) (94).
Independent of caspases and Bcl-2 granzyme A cleaves lamins A, B, and C disrupting the
nuclear lamina, a critical step in the progression of apoptosis (395). After gaining access
to the nucleus (94, 95), perhaps through the cleavage of lamins (395), granzyme A
rapidly degrades histone HI and the core histones disturbing the chromatin and
facilitating exogenous DNase access to the DNA (396). In comparison, granzyme
B/perforin-mediated apoptosis is strictly dependent on caspase activation, which
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granzyme B can initiate by the processing of pro-caspase-3, -7, and -9 to the active forms,
and produces cleaved PARP and lamin B (178). However, a recent report has shown that
the cleavage of Bid by granzyme B occurs at a residue distinct from the caspase cleavage
site and initiates apoptosis that is mediated by cytochrome c and SMAC release upstream
of caspase activation and loss of mitochondrial transmembrane potential, which required
active caspases to prevent the regeneration of mitochondrial transmembrane potential
(375). Granzyme A may be more of a default or specialized mediator of target cell
apoptosis, with the pathways of initiated by granzyme A being distinctly different from
those initiated by granzyme B (178).
There are several commonalities between granzyme A and gingipains such as
cleavage of lysine and arginine residues, translocation to the nucleus, the possible
degradation of lamin B, induction of caspase-independent cell death, however, the
apoptosis induced by gingipains needs to be further characterized. For example, it is
unknown whether ssDNA nicks are produced during caspase-independent gingipaininduced apoptosis in BCAEC or if only oligosomal DNA fragmentation is produced in
both caspase-dependent and -independent gingipain-induced apoptosis. The morphology
of the nucleus and chromatin during both caspase-dependent and -independent gingipaininduced apoptosis in BCAEC needs to be visualized for more detailed classification of
the cell death induced [see Chapter 1 section H.2.]. In addition, the effects that
gingipains have on the mitochondria of BCAEC are completely unknown at this time. It
would also be interesting to ascertain what classical apoptotic signaling molecules are
activated during both types of apoptosis triggered by gingipains in BCAEC. For
example, granzyme A-induced apoptosis is not characterized by Bcl-2 over-expression,
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since it is caspase-independent (94). However, Bcl-2 can prevent caspase-independent
apoptosis by preventing the release of cytochrome c in some systems (87) and can
prevent granzyme B-mediated apoptosis (352). It is tempting to speculate that Rgp
activity could induce caspase-independent apoptosis via proteolytic activation of Bid at
Arg65, similar to lysosomal proteases (352), with subsequent cytochrome c release and
caspase-9 activation. A recent report demonstrated that Clostridium difficile Toxin-Ainduced apoptosis is mediated by the cleavage of Bid prior to the activation of caspase-8,
-9, -6, and -3 (46), so a bacterial mediated activation of Bid in the absence of active
caspases is not improbable, but it needs to be determined if gingipains can directly cleave
or activate Bid. Clearly, much more information is needed of the specific molecules
activated and the characteristics of both the caspase-dependent and -independent
pathways induced in BCAEC by gingipains before granzyme A-induced apoptosis can be
successfully proposed as a model (Fig 42).
To our knowledge this work is the first demonstration of peptide caspase
inhibitors modulating Kgp activity. The ability of caspase inhibitors to inhibit other
proteases has been established, such that pan-caspase inhibitors and many active site
inhibitors of other proteases are unspecific at the concentrations used to test their role in
apoptosis (211, 231). Moreover, z-VAD-FMK inhibited legumain (clan CD) and other
peptide caspase-inhibitors can inhibit several of the cathepsins (298). The ability of
caspase inhibitors to interact with proteases other than the caspases raises the question of
whether other proteases can cleave caspase substrates. For example, calpain can cleave
the caspase substrates PART and FAK and has even been shown to process pro-caspase3, although not to its active form (367). Even though cathepsins can be inhibited by
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Figure 42. Potential granzyme-like model of gingipain-induced
apoptosis. Through adhesion and cleavage of CAMs, most likely integrin
pi (314), gingipains gain access to the host cell cytoplasm. In the cytoplasm
gingipains may cleave pro-caspase-3 to the active caspase-3 (354) (as
indicated by the scissors) that can cleave other cellular substrates, which may
be cleaved by gingipains as well, to produce apoptotic morphology. It
remains to be seen if gingipain activity could cleave Bid (352) (as indicated
by the dashed arrow) producing MOMP, cytochrome c release, and
apoptosis. Similar to granzyme A (29), gingipain activity could activate the
SET complex that once inside the nucleus produces DNA nicks and
fragmentation and apoptosis. Finally, it is conceivable that the possible
degradation of lamin B by gingipain activity provides a means for gingipains
to enter the nucleus and interact with nuclear proteins, such as Topo I, or
allows escape of nuclear proteins to the cytoplasm where gingipains could
cause their cleavage. Modified from (375) and (94).
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peptide caspase substrates, cathepsins cannot cleave caspase peptide substrates (230,
298). Therefore, the inability of gingipains to cleave peptide caspase substrates is not
surprising (data not shown). However, gingipain activity may be responsible for caspaselike activity in cells (36) and it appears that gingipains may be able to cleave some of the
same cellular substrates as caspases, such as FAK (150), N-cadherin [Chapters 2 and 3
and (318, 319)], Topo I [Chapter 2 and (318)], and Lamin B (data not shown).
Remarkably, it was recently demonstrated that gingipains can process and activate procaspase-3 in vitro (354). In some systems calpain appears to assist in the degradation of
key cellular proteins and can be viewed as having an auxiliary and augmentative role in
apoptosis (367). These results make it tempting to speculate that the gingipains can aid
the progression and possibly initiate the progression of apoptosis.

N. Potential caspase-independent pathway members in gingipain-induced apoptosis
Our results clearly show that gingipain-active W83 extracts, HRgpA, and RgpB
induce apoptosis in the absence of active caspases (Fig. 24, 33, and 34). Because of the
more pronounced blebbing present in BCAEC treated with gingipains in the presence of
z-VAD-FMK (Fig. 24), it will be interesting to determine if death-associated protein
kinase (DAP kinase) as well as DAP kinase-related kinase (DRP kinase) are involved.
They are members of a family of calcium/calmodulin-regulated serine/threonine death
kinases (131) that have been shown to be involved in membrane blebbing and
independent of caspase activity (402). Other proteins that may be activated by gingipains
in the presence of z-VAD-FMK are p21-activated kinase 2 or Rho-activated
serine/threonine kinase, which also produce cellular blebbing (211). Other
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morphological features that appear to be caspase-independent, in some cases, are loss of
mitochondrial membrane potential, cytochrome c and AIF release, zeiosis,
phosphatidylserine translocation, chromatin cleavage to 50 kD pieces, and chromatin
condensation and margination (383).
One possible member of the caspase-independent pathway induced by Rgp
activity could be AIF. AIF was identified in human coronary artery endothelial cells
outside the nucleus in the basal state and translocated to the nucleus upon induction of
apoptosis by oxidized-LDL that was unaffected by z-VAD-FMK pre-treatment (398), in
contrast to other reports that caspase-inhibition prevents AIF release in some cases (12).
In addition, caspase-3 inhibition could not completely block apoptosis, indicating that
there are other pathways beyond caspases and AIF that are present and activated in
coronary artery endothelial cells (397). Treatment of BCAEC with gingipains may affect
mitochondrial function (27). This direct perturbation of mitochondrial function may
release AIF and/or endoG that produces the apoptotic morphology (166). A recent report
demonstrated that the same apoptotic stimulus induced an intrinsic apoptosis that was
caspase-dependent in one cell type and caspase-independent in a different cell type (166).
Another possible protein involved in the caspase-independent pathway could be Bax
since it induces cytochrome c release that is not inhibited by z-VAD-FMK (12). P.
gingivalis modulates Bcl-2 levels (262) and Bcl-2 has been shown to block caspaseindependent apoptosis via antioxidant effects (33). It will be interesting to compare the
modulation of Bcl-2 in gingipain-induced caspase-dependent and -independent apoptosis.
Interestingly, Topo I is cleaved to a 45 kD fragment in the presence of active gingipains
[Chapter 2 and (318)]. A fragment of this size usually is indicates the presence of
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necrosis, but there is no other evidence of necrosis. This suggests that gingipains may be
able to directly cleave Topo I. The ability of gingipains to cleave Topo I [Chapter 2 and
(318)] and the possibility that they can degrade lamin B (data not shown) could be
involved in the gingipain-induced caspase-independent pathway. Experiments using zVAD-FMK to inhibit Kgp activity and leupeptin to inhibit Rgp activity both display this
45 kD fragment, suggesting that both Kgp activity and Rgp activity can cleave Topo I to
a 45 kD fragment (Fig. 35). Confirming these results, treatment of BCAEC with purified
gingipains displayed various intermediate sized Topo I fragments along with the 45 kD
product (unpublished observations). However, BCAEC treated with HRgpA produced a
45 kD fragment that was barely visible. These results suggest that the gingipains are all
able to cleave Topo I to varying degrees, but it may not be relevant to gingipain-induced
apoptosis since endothelial cells treated with Kgp that are attached and viable also
possess this 45 kD cleavage fragment. Lamins are major structural proteins of the
nuclear envelope (64), that are cleaved by caspases contributing to chromatin
condensation (345) and possibly disrupting lamin-lamin interactions, as well as,
interactions of lamins with other nuclear components (64). Cleavage of lamins also
results in nuclear shrinkage (211). HRgpA localizes to the nucleus (313) and may be able
to cleave lamin B and subsequently gain access to the nucleus to cleave Topo I and
possibly modulate other nuclear proteins, producing the nuclear apoptotic morphology
(Fig. 43). Kgp may function similarly, since the nuclear targeting ability was not
dependent on proteolytic activity (313).
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Figure 43. Comparison of potential caspase-dependent and -independent
apoptosis pathway members induced by gingipain activity. Treatment of
endothelial cells with gingipains causes the cleavage of CAMs and possibly
Topo I and lamin B. In the presence of active caspases, this produces classically
defined apoptosis and/or anoikis that is most likely mediated by the
mitochondrial pathway of apoptosis (354). Apoptosis triggers the cleavage of
PART and Topo I. Other proteins that have yet to have their role defined in
gingipain-induced apoptosis are Bid and AIF. In addition, it is unknown at this
time whether DNA cleavage is a significant feature of gingipain-induced
caspase-dependent apoptosis. Alternatively, the cleavage of CAMs and possibly
Topo I and lamin B in the absence of active caspases, may provide the
opportunity for gingipain-activity to initiate apoptosis that may also be
mitochondrial in nature. The roles of PARP and Topo I cleavage in caspaseindependent apoptosis, as well as, Bid, AIF, and DNA fragmentation need to be
clarified.
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O. Conclusions
Collectively, our results establish that gingipain-active W83 extracts induce
endothelial cell detachment, cleave CAMs, and induce apoptosis that can occur in a
caspase-independent manner. Moreover, we demonstrate that HRgpA, Kgp, and RgpB
can cause cell detachment, but BCAEC treated with low levels of Kgp reattached and
remained viable, while cells treated with HRgpA and RgpB maintained a detached state
and died via apoptosis, which may depend on VE-cadherin function. These results also
suggest that the gingipains may have different affects on BCAEC that may allow them to
work together for increased function. To our knowledge this is the first demonstration of
gingipain-induced cleavage of VE-cadherin, N-cadherin and integrin pi in endothelial
cells, inhibition of Kgp activity by peptide caspase inhibitors, and induction of caspaseindependent apoptosis by gingipains.
The evidence is overwhelming that host cell responses to pathogenic bacteria can
involve either elevated apoptosis or suppression of cell death (262) and that host cells
appear to be able to distinguish between infecting organisms and their components (401).
Recently it has been proposed that the possibly finite number of pathways that the
pathogen may have evolved to modulate could be characteristic of the organism’s genus
(137). This suggests that the outcome of infection may be more determined by the
presence or absence of the host cells’ repertoire of defensive molecules than by
components of the pathogen’s virulence arsenal. A review of the literature indicates that
P. gingivalis induces apoptosis in only some cell types. The molecules involved in
triggering apoptosis by P. gingivalis are only beginning to be elucidated. It will be
interesting to determine if the same molecules are involved in both gingipain-induced
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apoptosis and gingipain-induced resistance to apoptosis and to compare the
morphological characteristics and pathways of caspase-dependent and -independent
apoptosis mediated by the gingipains. Furthermore, the potential involvement of
gingipains in atherogenesis could make attractive treatment modalities for
atherosclerosis. Since the mouth reflects the health of the whole body, as suggested by
the Surgeon General (355), preventing gingipain activity in the oral cavity and the
cardiovascular system may be a means to greatly improve the overall health status.
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